BindingDB logo
myBDB logout

Search by PubMed Identification


PubMed Identification:

Starting with   __   _1   _2   _3   _4   _5   _6   _7   _8   _9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34

PMIDDataArticle TitleCitationOrganizationData Download
22998443 69 Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.EBI J Med Chem 55: 9312-30 (2012) CNRS 2D 3D TSV
22998419 47 Conformational restriction approach toß-secretase (BACE1) inhibitors: effect of a cyclopropane ring to induce an alternative binding mode.EBI J Med Chem 55: 8838-58 (2012) Shionogi & Co., Ltd 2D 3D TSV
22996261 11 Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.EBI Drug Metab Dispos 41: 24-9 (2012) Washington State University 2D 3D TSV
22995819 4 Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.EBI Eur J Med Chem 56: 246-253 (2012) TBA 2D 3D TSV
22995624 20 Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: synthesis, biological evaluation and structure-activity relationships.EBI Bioorg Med Chem Lett 22: 6338-42 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22995620 60 Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors.EBI Bioorg Med Chem Lett 22: 6503-8 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22995619 22 Trypsin resistance of a decapeptide KISS1R agonist containing an N¿-methylarginine substitution.EBI Bioorg Med Chem Lett 22: 6328-32 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22995617 7 Substrate-like water soluble lipase inhibitors from Filipendula kamtschatica.EBI Bioorg Med Chem Lett 22: 6410-2 (2012) Hokkaido University 2D 3D TSV
22995061 37 Opioid activity profiles of oversimplified peptides lacking in the protonable N-terminus.EBI J Med Chem 55: 10292-6 (2012) University of Bologna 2D 3D TSV
22994852 3 Identification and Characterization of Small Molecule Inhibitors of a Plant Homeodomain Finger.BDB Biochemistry 51: 8293-306 (2012) University of Wisconsin 2D 3D TSV
22994801 7 Synthesis and paroxonase activities of novel bromophenols.BDB J Enzyme Inhib Med Chem 28: 1073-9 (2013) Atatürk University 2D 3D TSV
22994608 12 Synthesis and characterization of phenolic Mannich bases and effects of these compounds on human carbonic anhydrase isozymes I and II.BDB J Enzyme Inhib Med Chem 28: 337-42 (2013) Dumlupinar University 2D 3D TSV
22992107 34 Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.EBI J Med Chem 55: 8958-62 (2012) Eberhard-Karls University 2D 3D TSV
22992024 21 Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.EBI J Med Chem 55: 8685-99 (2012) Janssen-Cilag S.A. 2D 3D TSV
22991951 10 Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.EBI J Med Chem 55: 9988-97 (2012) University Health Network 2D 3D TSV
22989913 18 Curcumin is an inhibitor of calcium/calmodulin dependent protein kinase II.EBI Bioorg Med Chem 20: 6040-7 (2012) Rajiv Gandhi Centre for Biotechnology 2D 3D TSV
22989912 4 Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases.EBI Bioorg Med Chem 20: 6162-70 (2012) Humboldt Universit£t zu Berlin 2D 3D TSV
22989911 16 Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates.EBI Bioorg Med Chem 20: 6080-8 (2012) Cardiff University 2D 3D TSV
22989910 56 Characterization, bioinformatic analysis and dithiocarbamate inhibition studies of two newa-carbonic anhydrases, CAH1 and CAH2, from the fruit fly Drosophila melanogaster.EBI Bioorg Med Chem 21: 1516-21 (2013) University of Tampere and Tampere University Hospital 2D 3D TSV
22989533 28 Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.EBI Bioorg Med Chem Lett 22: 6333-7 (2012) Sejong University 2D 3D TSV
22989379 8 Synthesis and biological evaluation of 1a,25-dihydroxyvitamin D3 analogues with a long side chain at C12 and short C17 side chains.EBI J Med Chem 55: 8642-56 (2012) Universidad de Santiago de Compostela 2D 3D TSV
22989333 43 Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation.EBI J Med Chem 55: 9331-45 (2012) Merck Research Laboratories 2D 3D TSV
22985961 99 Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.EBI Bioorg Med Chem 20: 6097-108 (2012) GlaxoSmithKline 2D 3D TSV
22985959 26 Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors.EBI Bioorg Med Chem 20: 6073-9 (2012) University of Colorado at Boulder 2D 3D TSV
22985958 7 Potent small molecule Hedgehog agonists induce VEGF expression in vitro.EBI Bioorg Med Chem 20: 6465-81 (2012) Universit£t Leipzig 2D 3D TSV
22985853 22 Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: synthesis and SAR study as tyrosine kinase c-Met inhibitors.EBI Bioorg Med Chem Lett 22: 6368-72 (2012) China Pharmaceutical University 2D 3D TSV
22985112 49 Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.EBI J Med Chem 55: 9416-33 (2012) Genentech 2D 3D TSV
22985069 18 Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design.EBI J Med Chem 55: 8549-58 (2012) Sun Yat-sen University 2D 3D TSV
22984987 24 Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening.EBI J Med Chem 55: 8341-9 (2012) State Key Laboratory of Bioreactor Engineering 2D 3D TSV
22984902 59 Selective fluorescent nonpeptidic antagonists for vasopressin V2 GPCR: application to ligand screening and oligomerization assays.EBI J Med Chem 55: 8588-602 (2012) University of Strasburg 2D 3D TSV
22984865 43 Spirocyclic sulfamides asß-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.EBI J Med Chem 55: 9224-39 (2012) Pfizer Inc 2D 3D TSV
22984835 66 Identification of high-affinity P2Y12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone.EBI J Med Chem 55: 8615-29 (2012) Sanofi-Aventis Deutschland GmbH 2D 3D TSV
22984809 111 Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors.EBI J Med Chem 55: 8827-37 (2012) AstraZeneca 2D 3D TSV
22984634 16 Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes.EBI ACS Med Chem Lett 3: 759-763 (2012) TBA 2D 3D TSV
22983304 4 Metabolic chiral inversion of brivanib and its relevance to safety and pharmacology.EBI Drug Metab Dispos 40: 2374-80 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22982527 6 Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.EBI Eur J Med Chem 56: 225-236 (2012) TBA 2D 3D TSV
22982525 32 Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.EBI Eur J Med Chem 56: 210-216 (2012) TBA 2D 3D TSV
22981333 103 Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kß inhibitors.EBI Bioorg Med Chem Lett 22: 6381-4 (2012) Sanofi 2D 3D TSV
22981332 58 Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossover.EBI Bioorg Med Chem Lett 22: 6481-5 (2012) Vanderbilt University Medical Center 2D 3D TSV
22981331 14 Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.EBI Bioorg Med Chem Lett 22: 6498-502 (2012) Sun Yat-sen University 2D 3D TSV
22981330 7 Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.EBI Bioorg Med Chem Lett 22: 6401-4 (2012) Universit£ degli Studi di Parma 2D 3D TSV
22980219 55 Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy.EBI Bioorg Med Chem 20: 6171-80 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22980218 2 Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity.EBI Bioorg Med Chem 20: 6144-53 (2012) National Taiwan University Hospital 2D 3D TSV
22978849 13 Molecular mechanisms of acquired proteasome inhibitor resistance.EBI J Med Chem 55: 10317-27 (2012) University of California San Diego 2D 3D TSV
22978824 17 Multitarget-directed benzylideneindanone derivatives: anti-ß-amyloid (Aß) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.EBI J Med Chem 55: 8483-92 (2012) Sun Yat-sen University 2D 3D TSV
22978415 8 Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L.BDB Chem Biol Drug Des 80: 971-80 (2012) Epizyme Inc 2D 3D TSV
22975593 62 Oncoepigenomics: making histone lysine methylation count.EBI Eur J Med Chem 56: 179-194 (2012) TBA 2D 3D TSV
22975302 45 Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides.EBI Bioorg Med Chem Lett 22: 6391-6 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22975301 128 Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators.EBI Bioorg Med Chem Lett 22: 6469-74 (2012) Lundbeck Research USA 2D 3D TSV
22974493 13 Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity.EBI Bioorg Med Chem 21: 1522-5 (2013) Agri Ibrahim Cecen University 2D 3D TSV
22974355 3 Effect of daurisoline on HERG channel electrophysiological function and protein expression.EBI J Nat Prod 75: 1539-45 (2012) Huazhong University of Science and Technology 2D 3D TSV
22974325 54 Identification of multiple 5-HT4 partial agonist clinical candidates for the treatment of Alzheimer's disease.EBI J Med Chem 55: 9240-54 (2012) Pfizer Inc 2D 3D TSV
22971011 26 Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonists.EBI J Med Chem 55: 8450-63 (2012) Eisai Co., Ltd 2D 3D TSV
22967811 62 Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.EBI Bioorg Med Chem 20: 5738-44 (2012) Tianjin Medical University 2D 3D TSV
22967810 102 Synthesis of quinolinomorphinan derivatives as highly selectived opioid receptor ligands.EBI Bioorg Med Chem 20: 5810-31 (2012) Kitasato University 2D 3D TSV
22967796 8 Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.EBI Eur J Med Chem 56: 155-165 (2012) TBA 2D 3D TSV
22967236 2 Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae.EBI J Agric Food Chem 60: 9874-81 (2012) Northeast Agricultural University 2D 3D TSV
22966938 20 cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.EBI J Med Chem 55: 8477-82 (2012) Universit£ di Chieti-Pescara G. d'Annunzio 2D 3D TSV
22963764 17 Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonists.EBI Bioorg Med Chem Lett 22: 6454-9 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22963135 7 Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.EBI J Med Chem 55: 8735-44 (2012) Shionogi & Co., Ltd. 2D 3D TSV
22963087 17 Enhanced anti-influenza agents conjugated with anti-inflammatory activity.EBI J Med Chem 55: 8493-501 (2012) National Taiwan University 2D 3D TSV
22963052 38 Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.EBI J Med Chem 55: 8745-56 (2012) VU University Amsterdam 2D 3D TSV
22961681 621 Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.EBI Drug Metab Dispos 40: 2332-41 (2012) AstraZeneca 2D 3D TSV
22960696 5 D-proline-based peptidomimetic inhibitors of anthrax lethal factor.EBI Eur J Med Chem 56: 96-107 (2012) TBA 2D 3D TSV
22959556 57 Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.EBI Bioorg Med Chem 20: 5705-19 (2012) Mitsubishi Tanabe Pharma Corporation 2D 3D TSV
22959526 14 Identification of novel ?7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric ?7 receptor ligand binding domain.EBI Bioorg Med Chem 20: 5992-6002 (2012) Bezmialem Vakif University 2D 3D TSV
22959249 79 JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.EBI Bioorg Med Chem Lett 22: 6173-80 (2012) Jenrin Discovery 2D 3D TSV
22959248 18 Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors.EBI Bioorg Med Chem Lett 22: 6301-5 (2012) Zhejiang Betapharma 2D 3D TSV
22959247 20 Isomannide derivatives as new class of inhibitors for human kallikrein 7.EBI Bioorg Med Chem Lett 22: 6072-5 (2012) Universidade Federal do Tri£ngulo Mineiro 2D 3D TSV
22959246 24 Camptothecins in tumor homing via an RGD sequence mimetic.EBI Bioorg Med Chem Lett 22: 6509-12 (2012) Sigma-Tau Industrie Farmaceutiche Riunite SpA 2D 3D TSV
22959245 175 As(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).EBI Bioorg Med Chem Lett 22: 6053-8 (2012) The University of Sydney 2D 3D TSV
22959244 20 Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.EBI Bioorg Med Chem Lett 22: 6048-52 (2012) Theravance, Inc. 2D 3D TSV
22957923 20 The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2.EBI J Med Chem 55: 8418-28 (2012) Biological Research Center of the Hungarian Academy of Sciences 2D 3D TSV
22957890 174 Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.EBI J Med Chem 55: 8164-77 (2012) University of Copenhagen 2D 3D TSV
22957834 8 Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor.EBI J Med Chem 55: 8440-9 (2012) Institute of Genetics and Molecular and Cellular Biology (IGBMC) 2D 3D TSV
22957803 156 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.EBI J Med Chem 55: 8392-408 (2012) Seoul National University 2D 3D TSV
22957724 30 Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors.BDB J Enzyme Inhib Med Chem 28: 311-5 (2013) Dumlupinar University 2D 3D TSV
22957721 3 In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B.BDB J Enzyme Inhib Med Chem 28: 1067-72 (2013) Chulalongkorn University 2D 3D TSV
22957720 5 Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors.BDB J Enzyme Inhib Med Chem 28: 1080-7 (2013) Ankara University 2D 3D TSV
22954899 16 Novel interleukin-5 inhibitors based on hydroxyethylaminomethyl-4H-chromen-4-one scaffold.EBI Bioorg Med Chem 20: 5757-62 (2012) Chungnam National University 2D 3D TSV
22954737 28 Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors.EBI Bioorg Med Chem Lett 22: 6237-41 (2012) Array BioPharma 2D 3D TSV
22954736 2 Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?EBI Bioorg Med Chem Lett 22: 6039-47 (2012) Leo Pharma A/S 2D 3D TSV
22954387 8 Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.EBI J Med Chem 55: 7998-8006 (2012) National Institute of Allergy and Infectious Diseases 2D 3D TSV
22954357 29 Structure-based design of highly selectiveß-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure.EBI J Med Chem 55: 9195-207 (2012) Purdue University 2D 3D TSV
22951255 12 A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.EBI Bioorg Med Chem 20: 5915-27 (2012) Kyoto University 2D 3D TSV
22951114 16 A frozen analogue approach to aminopyridinylimidazoles leading to novel and promising p38 MAP kinase inhibitors.EBI J Med Chem 55: 8429-39 (2012) University of Tuebingen 2D 3D TSV
22951074 11 Novel aromatase inhibitors by structure-guided design.EBI J Med Chem 55: 8464-76 (2012) State University of New York Upstate Medical University 2D 3D TSV
22950983 81 Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI J Med Chem 55: 7759-71 (2012) Brandeis University 2D 3D TSV
22950366 6 Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta.EBI J Nat Prod 75: 1546-52 (2012) Hokkaido University 2D 3D TSV
22949627 3 Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo.EBI Drug Metab Dispos 40: 2315-23 (2012) Johns Hopkins School of Medicine 2D 3D TSV
22946614 9 The design and identification of brain penetrant inhibitors of phosphoinositide 3-kinasea.EBI J Med Chem 55: 8007-20 (2012) Genentech 2D 3D TSV
22946585 19 Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.EBI J Med Chem 55: 8318-29 (2012) Universita` degli Studi di Sassari 2D 3D TSV
22944772 15 Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.EBI Eur J Med Chem 56: 30-38 (2012) TBA 2D 3D TSV
22944335 43 O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-ß aggregation.EBI Bioorg Med Chem 20: 5884-92 (2012) Sun Yat-sen University 2D 3D TSV
22944334 9 Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.EBI Bioorg Med Chem 20: 5763-73 (2012) Northwestern University 2D 3D TSV
22944118 27 Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.EBI Bioorg Med Chem Lett 22: 6286-91 (2012) Glenmark Pharmaceuticals Limited 2D 3D TSV
22944117 3 Ago-allosteric modulators of human glucagon-like peptide 2 receptor.EBI Bioorg Med Chem Lett 22: 6126-35 (2012) Eisai Co., Ltd 2D 3D TSV
22942319 16 Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048.EBI Drug Metab Dispos 40: 2297-306 (2012) CHDI Management/CHDI Foundation 2D 3D TSV
22940704 23 Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors.EBI Eur J Med Chem 56: 10-16 (2012) TBA 2D 3D TSV
22940448 8 Rhododendric acid A, a new ursane-type PTP1B inhibitor from the endangered plant Rhododendron brachycarpum G. Don.EBI Bioorg Med Chem Lett 22: 6116-9 (2012) Yeungnam University 2D 3D TSV
22939697 4 Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-a receptors.EBI Bioorg Med Chem Lett 22: 6233-6 (2012) Washington University 2D 3D TSV
22939696 85 Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationship.EBI Bioorg Med Chem Lett 22: 6108-15 (2012) AstraZeneca 2D 3D TSV
22939234 31 Potent and orally efficacious benzothiazole amides as TRPV1 antagonists.EBI Bioorg Med Chem Lett 22: 6205-11 (2012) AstraZeneca 2D 3D TSV
22939233 23 Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.EBI Bioorg Med Chem Lett 22: 6181-4 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22938786 86 Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors.EBI Bioorg Med Chem 20: 5864-83 (2012) Dainippon Sumitomo Pharma Co., Ltd 2D 3D TSV
22938723 4 Oxygenation of monoenoic fatty acids by CYP175A1, an orphan cytochrome P450 from Thermus thermophilus HB27.BDB Biochemistry 51: 7880-90 (2012) Tata Institute of Fundamental Research 2D 3D TSV
22938093 14 Structures and mechanisms of antitumor agents: xestoquinones uncouple cellular respiration and disrupt HIF signaling in human breast tumor cells.EBI J Nat Prod 75: 1553-9 (2012) University of Mississippi 2D 3D TSV
22938049 29 Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.EBI J Med Chem 55: 8188-92 (2012) Korea Institute of Science and Technology 2D 3D TSV
22938030 22 EC144 is a potent inhibitor of the heat shock protein 90.EBI J Med Chem 55: 7786-95 (2012) Biogen Idec Inc 2D 3D TSV
22934600 1 Potent HGF/c-Met axis inhibitors from Eucalyptus globulus: the coupling of phloroglucinol and sesquiterpenoid is essential for the activity.EBI J Med Chem 55: 8183-7 (2012) Chinese Academy of Sciences 2D 3D TSV
22934575 124 Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors.EBI J Med Chem 55: 8110-27 (2012) Array BioPharma Inc 2D 3D TSV
22934537 4 Plakilactones from the marine sponge Plakinastrella mamillaris. Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor¿.EBI J Med Chem 55: 8303-17 (2012) Universit£ di Napoli Federico II 2D 3D TSV
22932317 4 Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.EBI Bioorg Med Chem Lett 22: 6242-7 (2012) Yale University 2D 3D TSV
22932316 8 Amide-based derivatives ofß-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.EBI Bioorg Med Chem Lett 22: 6200-4 (2012) University of Sydney 2D 3D TSV
22932315 28 An investigation into the structure-activity relationships associated with the systematic modification of theß(2)-adrenoceptor agonist indacaterol.EBI Bioorg Med Chem Lett 22: 6280-5 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22932313 9 Design and synthesis of diarylamines and diarylethers as cytotoxic antitumor agents.EBI Bioorg Med Chem Lett 22: 6224-8 (2012) Beijing Institute of Pharmacology & Toxicology 2D 3D TSV
22932312 4 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.EBI Bioorg Med Chem Lett 22: 6185-9 (2012) University of Puerto Rico 2D 3D TSV
22931526 31 Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.EBI J Med Chem 55: 8193-7 (2012) Sapienza University of Rome 2D 3D TSV
22931505 69 Chemokine receptor antagonists.EBI J Med Chem 55: 9363-92 (2012) National Heart and Lung Institute 2D 3D TSV
22930276 25 Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors.EBI Drug Metab Dispos 40: 2239-49 (2012) Amgen Inc 2D 3D TSV
22929233 72 A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.EBI Bioorg Med Chem Lett 22: 6190-4 (2012) The University of Queensland 2D 3D TSV
22929232 89 Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.EBI Bioorg Med Chem Lett 22: 6212-7 (2012) Amgen Inc 2D 3D TSV
22929231 3 Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.EBI Bioorg Med Chem Lett 22: 6160-5 (2012) University of Hyderabad Campus 2D 3D TSV
22928967 12 Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges.EBI J Nat Prod 75: 1632-6 (2012) National Cancer Institute-Frederick 2D 3D TSV
22928944 12 Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands toa4ß2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.EBI J Med Chem 55: 8028-37 (2012) University of Illinois at Chicago 2D 3D TSV
22928914 104 Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.EBI J Med Chem 55: 9156-69 (2012) Amgen Inc 2D 3D TSV
22928876 10 Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.EBI J Med Chem 55: 7978-87 (2012) Georgia State University 2D 3D TSV
22926225 200 The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists.EBI Eur J Med Chem 56: 348-360 (2012) TBA 2D 3D TSV
22926069 28 Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetes.EBI Bioorg Med Chem Lett 22: 6218-23 (2012) Amgen Inc 2D 3D TSV
22926067 22 Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.EBI Bioorg Med Chem Lett 22: 6256-60 (2012) University of Lisbon 2D 3D TSV
22924815 97 Design and synthesis ofß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction ofß-amyloid peptides.EBI J Med Chem 55: 9346-61 (2012) AstraZeneca 2D 3D TSV
22924785 85 Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.EBI J Med Chem 55: 8066-74 (2012) Baylor College of Medicine 2D 3D TSV
22924757 16 Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.EBI J Med Chem 55: 8137-51 (2012) University of Kansas 2D 3D TSV
22924734 87 Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment ofEBI J Med Chem 55: 8091-109 (2012) Pfizer Inc 2D 3D TSV
22924688 128 PI3Kd and PI3K¿ as targets for autoimmune and inflammatory diseases.EBI J Med Chem 55: 8559-81 (2012) Amgen Inc 2D 3D TSV
22924434 4 Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.EBI J Med Chem 55: 9393-413 (2012) University of Oxford 2D 3D TSV
22924342 15 Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.EBI J Med Chem 55: 8199-208 (2012) Cylene Pharmaceuticals 2D 3D TSV
22924094 41 Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.EBI ACS Med Chem Lett 3: 544-549 (2012) TBA 2D 3D TSV
22921745 1 [¹8F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches.EBI Bioorg Med Chem 20: 5936-40 (2012) Medical University of Vienna 2D 3D TSV
22921743 4 Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.EBI Bioorg Med Chem 20: 5550-8 (2012) University of Texas 2D 3D TSV
22921742 11 Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid ?-protein.EBI Bioorg Med Chem 20: 5844-9 (2012) University of Tsukuba 2D 3D TSV
22921279 2 Armeniaspiroles, a new class of antibacterials: Antibacterial activities and total synthesis of 5-chloro-Armeniaspirole A.EBI Bioorg Med Chem Lett 22: 6292-6 (2012) Sanofi Research & Development 2D 3D TSV
22921089 62 Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.EBI J Med Chem 55: 8075-90 (2012) National Institute of Diabetes and Digestive and Kidney Diseases 2D 3D TSV
22921080 42 2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-ß-lactamases.EBI Bioorg Med Chem Lett 22: 6229-32 (2012) Baylor College of Medicine 2D 3D TSV
22920150 35 An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.EBI J Med Chem 55: 7437-49 (2012) Universit£t Leipzig 2D 3D TSV
22920039 9 Crystal structure of human aurora B in complex with INCENP and VX-680.EBI J Med Chem 55: 7841-8 (2012) University of Oxford 2D 3D TSV
22917520 45 Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents.EBI Bioorg Med Chem Lett 22: 5857-62 (2012) Zydus Research Centre 2D 3D TSV
22917519 106 Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).EBI Bioorg Med Chem Lett 22: 5811-3 (2012) University of Copenhagen 2D 3D TSV
22916727 18 Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.EBI J Med Chem 55: 8152-63 (2012) Hokkaido University 2D 3D TSV
22916707 76 7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.EBI J Med Chem 55: 7967-77 (2012) University of Bonn 2D 3D TSV
22913577 43 Pd-catalyzed direct C-H bond functionalization of spirocyclics1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of thes1 receptor.EBI J Med Chem 55: 8047-65 (2012) Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster 2D 3D TSV
22913544 12 Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils andß-amyloid plaques in Alzheimer's disease models.EBI J Med Chem 55: 9170-80 (2012) Technische Universit£t Darmstadt 2D 3D TSV
22913511 91 Discovery of (2S)-1-[4-(2-{6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a purine-based Hsp90 inhibitor.EBI J Med Chem 55: 7480-501 (2012) Myrexis Inc. 2D 3D TSV
22913487 4 Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases.EBI J Med Chem 55: 8021-7 (2012) Indiana University School of Medicine 2D 3D TSV
22910224 11 Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors.EBI Bioorg Med Chem 20: 5496-506 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22910138 96 Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.EBI Eur J Med Chem 56: 282-291 (2012) TBA 2D 3D TSV
22910137 1 Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.EBI Eur J Med Chem 56: 292-300 (2012) TBA 2D 3D TSV
22910039 66 Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.EBI Bioorg Med Chem Lett 22: 5936-41 (2012) Vanderbilt University Medical Center 2D 3D TSV
22910038 2 Phenolic compounds as antiangiogenic CMG2 inhibitors from Costa Rican endophytic fungi.EBI Bioorg Med Chem Lett 22: 5885-8 (2012) Harvard Medical School 2D 3D TSV
22909088 6 Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.EBI J Med Chem 55: 7560-70 (2012) Universitat Ramon Llull 2D 3D TSV
22905906 10 Synthesis, crystal structure, in vitro acetohydroxyacid synthase inhibition, in vivo herbicidal activity, and 3D-QSAR of new asymmetric aryl disulfides.EBI J Agric Food Chem 60: 8286-93 (2012) Nankai University 2D 3D TSV
22905713 9 Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor.EBI J Med Chem 55: 7772-85 (2012) Astellas Pharma Inc 2D 3D TSV
22904561 6 Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.EBI Drug Metab Dispos 40: 2174-84 (2012) University of Arkansas for Medical Sciences 2D 3D TSV
22902659 4 Ras inhibition via direct Ras binding--is there a path forward?EBI Bioorg Med Chem Lett 22: 5766-76 (2012) Genentech 2D 3D TSV
22902658 31 Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agents.EBI Bioorg Med Chem Lett 22: 5795-800 (2012) GE Healthcare 2D 3D TSV
22902656 42 Novel triazines as potent and selective phosphodiesterase 10A inhibitors.EBI Bioorg Med Chem Lett 22: 5876-84 (2012) Pfizer Inc 2D 3D TSV
22902653 99 Modulation of cofilin phosphorylation by inhibition of the Lim family kinases.EBI Bioorg Med Chem Lett 22: 5995-8 (2012) Bristol-Myers Squibb Research and Development 2D 3D TSV
22901900 92 Discovery and optimization of a series of liver X receptor antagonists.EBI Bioorg Med Chem Lett 22: 5966-70 (2012) Amgen Inc 2D 3D TSV
22901899 15 Novel oxysterols activate the Hedgehog pathway and induce osteogenesis.EBI Bioorg Med Chem Lett 22: 5893-7 (2012) Fate Therapeutics 2D 3D TSV
22901672 15 UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.EBI Bioorg Med Chem 20: 5483-95 (2012) Bar-Ilan University 2D 3D TSV
22901671 43 Synthesis and pharmacological evaluation of indolinone derivatives as novel ghrelin receptor antagonists.EBI Bioorg Med Chem 20: 5623-36 (2012) Sanofi Research 2D 3D TSV
22901670 61 Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors.EBI Bioorg Med Chem 20: 5649-57 (2012) Solapur University 2D 3D TSV
22901393 11 Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.EBI Bioorg Med Chem Lett 22: 5889-92 (2012) University of California 2D 3D TSV
22901392 27 A novel aminopeptidase N inhibitor developed by virtual screening approach.EBI Bioorg Med Chem Lett 22: 5863-9 (2012) Shandong Academy of Sciences 2D 3D TSV
22901390 44 Synthesis and biological activity of pyridopyridazin-6-one p38a MAP kinase inhibitors. Part 2.EBI Bioorg Med Chem Lett 22: 5979-83 (2012) Merck Research Laboratories 2D 3D TSV
22901389 28 Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11ß-hydroxysteroid dehydrogenase type I.EBI Bioorg Med Chem Lett 22: 5909-14 (2012) Merck Serono 2D 3D TSV
22901388 76 Inhibition ofa-class cytosolic human carbonic anhydrases I, II, IX and XII, andß-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors.EBI Bioorg Med Chem Lett 22: 5801-6 (2012) Universit£ di Sassari 2D 3D TSV
22901387 18 Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.EBI Bioorg Med Chem Lett 22: 5870-5 (2012) Nanjing University 2D 3D TSV
22901310 18 Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents.EBI Eur J Med Chem 55: 395-408 (2012) Virginia Commonwealth University 2D 3D TSV
22901043 9 Probing the peripheral site of human butyrylcholinesterase.BDB Biochemistry 51: 7046-53 (2012) Dalhousie University 2D 3D TSV
22898529 58 Discovery of 1-(ß-amino substituted-ß-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: efficient design, synthesis, and structure-activity relationship studies.EBI Eur J Med Chem 55: 228-42 (2012) Pfizer Inc 2D 3D TSV
22898255 22 Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.EBI Bioorg Med Chem 20: 5473-82 (2012) Chinese Academy of Sciences 2D 3D TSV
22898254 9 Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility.EBI Bioorg Med Chem 20: 5507-17 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22897946 34 N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.EBI Bioorg Med Chem Lett 22: 5948-51 (2012) University of Ljubljana 2D 3D TSV
22897945 15 Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.EBI Bioorg Med Chem Lett 22: 6010-5 (2012) Indian Institute of Chemical Technology 2D 3D TSV
22897611 2 Discovery of diarylhydantoins as new selective androgen receptor modulators.EBI J Med Chem 55: 8225-35 (2012) GALAPAGOS, Parc Biocitech 2D 3D TSV
22897589 100 Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511.EBI J Med Chem 55: 7796-816 (2012) Amgen Inc 2D 3D TSV
22897496 69 Targeting the hinge glycine flip and the activation loop: novel approach to potent p38a inhibitors.EBI J Med Chem 55: 7862-74 (2012) Eberhard Karls University T£bingen 2D 3D TSV
22894757 69 Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.EBI J Med Chem 55: 7920-39 (2012) F. Hoffmann-La Roche Inc 2D 3D TSV
22894736 99 Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.EBI J Med Chem 55: 7875-82 (2012) The Hebrew University of Jerusalem 2D 3D TSV
22894131 4 Water mediated ligand functional group cooperativity: the contribution of a methyl group to binding affinity is enhanced by a COO(-) group through changes in the structure and thermodynamics of the hydration waters of ligand-thermolysin complexes.EBI J Med Chem 55: 8283-302 (2012) The State University of New York 2D 3D TSV
22893598 12 A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2.BDB Chembiochem 13: 2128-36 (2012) Moffitt Cancer Center 2D 3D TSV
22892213 168 Natural product coumarins that inhibit human carbonic anhydrases.EBI Bioorg Med Chem 21: 1539-43 (2013) Griffith University 2D 3D TSV
22892116 30 Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia.EBI Bioorg Med Chem Lett 22: 5903-8 (2012) Merck Research Laboratories 2D 3D TSV
22891752 18 Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.EBI J Med Chem 55: 7525-45 (2012) Universidade Federal do Rio de Janeiro 2D 3D TSV
22891675 46 Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease.EBI J Med Chem 55: 7696-705 (2012) Showa Pharmaceutical University 2D 3D TSV
22891645 83 Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).EBI J Med Chem 55: 7061-79 (2012) GlaxoSmithKline 2D 3D TSV
22889803 19 Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.EBI Bioorg Med Chem Lett 22: 5919-23 (2012) AstraZeneca 2D 3D TSV
22889562 3 Synthesis, cytotoxicity of new 4-arylidene curcumin analogues and their multi-functions in inhibition of both NF-¿B and Akt signalling.EBI Eur J Med Chem 55: 346-57 (2012) Sun Yat-sen University 2D 3D TSV
22889560 16 The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.EBI Eur J Med Chem 55: 358-74 (2012) University of Patras 2D 3D TSV
22889387 2 Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.EBI J Med Chem 55: 7719-35 (2012) Universit£ di Ferrara 2D 3D TSV
22889351 40 Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.EBI J Med Chem 55: 7828-40 (2012) Chugai Pharmaceutical Co. Ltd 2D 3D TSV
22889281 36 Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate.EBI J Med Chem 55: 7472-9 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22884991 9 Antiplasmodial activities of 4-aminoquinoline-statine compounds.EBI Bioorg Med Chem Lett 22: 5915-8 (2012) Universit£ degli Studi di Milano 2D 3D TSV
22884989 42 Phosphodiesterase inhibitors. Part 4: design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones.EBI Bioorg Med Chem Lett 22: 5833-8 (2012) Kyorin Pharmaceutical Co., Ltd 2D 3D TSV
22884988 49 Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus.EBI Bioorg Med Chem Lett 22: 5942-7 (2012) Amgen Inc 2D 3D TSV
22884355 31 Design, synthesis and structure-activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands.EBI Bioorg Med Chem 20: 5568-82 (2012) Dainippon Sumitomo Pharma Co., Ltd 2D 3D TSV
22884354 36 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.EBI Bioorg Med Chem 20: 5928-35 (2012) Korea Research Institute of Bioscience and Biotechnology 2D 3D TSV
22884353 15 Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls.EBI Bioorg Med Chem 20: 5583-91 (2012) McGill University 2D 3D TSV
22883029 80 The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.EBI Bioorg Med Chem 21: 1534-8 (2013) Universit£ degli Studi di Firenze 2D 3D TSV
22883027 1 Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.EBI Bioorg Med Chem 20: 5527-36 (2012) Shandong University 2D 3D TSV
22883026 34 Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.EBI Bioorg Med Chem 20: 5600-15 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22882897 7 Synthesis, in vitro Biological Evaluation and Molecular Docking Studies of Benzimidamides as Potential BACE1 Inhibitors.BDB Chem Biol Drug Des 80: 775-80 (2012) Peking University Health Science Center 2D 3D TSV
22882119 4 A new class of selective and potent 7-dehydrocholesterol reductase inhibitors.EBI J Med Chem 55: 7614-22 (2012) Martin-Luther-Universit£t Halle-Wittenberg 2D 3D TSV
22882079 26 Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase.EBI J Med Chem 55: 7900-8 (2012) Aarhus University 2D 3D TSV
22881866 57 Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library.EBI J Med Chem 55: 7417-24 (2012) University of Ljubljana 2D 3D TSV
22877871 3 Synthesis and biological evaluation of tyrosine modified analogues of thea4ß7 integrin inhibitor biotin-R8ERY.EBI Bioorg Med Chem 20: 5139-49 (2012) University of Auckland 2D 3D TSV
22877636 60 Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.EBI Bioorg Med Chem Lett 22: 5396-404 (2012) Exelixis Inc 2D 3D TSV
22877635 6 Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.EBI Bioorg Med Chem Lett 22: 5360-2 (2012) Menarini Ricerche Pomezia 2D 3D TSV
22877633 28 Highly potent aminopyridines as Syk kinase inhibitors.EBI Bioorg Med Chem Lett 22: 5419-23 (2012) Rhône-Poulenc Rorer 2D 3D TSV
22877632 49 Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.EBI Bioorg Med Chem Lett 22: 5600-7 (2012) AstraZeneca 2D 3D TSV
22877630 46 Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1).EBI Bioorg Med Chem Lett 22: 5748-51 (2012) ActivX Biosciences Inc 2D 3D TSV
22877629 42 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1¿) inhibitors.EBI Bioorg Med Chem Lett 22: 5392-5 (2012) Amgen Inc 2D 3D TSV
22877245 6 Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase.EBI J Med Chem 55: 7425-36 (2012) University of Washington 2D 3D TSV
22877157 356 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase AKR1C3.EBI J Med Chem 55: 7746-58 (2012) University of Auckland 2D 3D TSV
22877085 33 Potent and highly selective benzimidazole inhibitors of PI3-kinase delta.EBI J Med Chem 55: 7686-95 (2012) Genentech 2D 3D TSV
22876979 2 Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.EBI J Med Chem 55: 7378-91 (2012) Wayne State University 2D 3D TSV
22876881 72 Discovery and in vivo evaluation of dual PI3Kß/d inhibitors.EBI J Med Chem 55: 7667-85 (2012) Amgen Inc 2D 3D TSV
22873824 4 Halicloic acids A and B isolated from the marine sponge Haliclona sp. collected in the Philippines inhibit indoleamine 2,3-dioxygenase.EBI J Nat Prod 75: 1451-8 (2012) University of British Columbia 2D 3D TSV
22873709 45 Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.EBI J Med Chem 55: 7360-77 (2012) The University of Tokyo 2D 3D TSV
22873688 10 Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.EBI J Med Chem 55: 7623-35 (2012) Bar-Ilan University 2D 3D TSV
22871582 29 Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists.EBI Bioorg Med Chem Lett 22: 5372-8 (2012) Eisai Co., Ltd 2D 3D TSV
22871580 6 Near-infrared fluorescent divalent RGD ligand for integrinavß3-targeted optical imaging.EBI Bioorg Med Chem Lett 22: 5405-9 (2012) Washington University 2D 3D TSV
22871578 44 High-affinity and selective dopamine D3 receptor full agonists.EBI Bioorg Med Chem Lett 22: 5612-7 (2012) University of Michigan 2D 3D TSV
22871134 34 Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors.BDB J Enzyme Inhib Med Chem 28: 1040-7 (2013) Anadolu University 2D 3D TSV
22868229 2 A fluorescent reporter of ATP binding-competent receptor kinases.EBI Bioorg Med Chem Lett 22: 5532-5 (2012) University of Miami 2D 3D TSV
22868228 57 N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.EBI Bioorg Med Chem Lett 22: 5485-92 (2012) AstraZeneca 2D 3D TSV
22867529 14 Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.EBI Eur J Med Chem 61: 84-94 (2013) Chinese Academy of Sciences 2D 3D TSV
22867097 1 Inhibition of human topoisomerases I and II by simocyclinone D8.EBI J Nat Prod 75: 1485-9 (2012) University of Minnesota Medical School 2D 3D TSV
22866979 19 Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy.EBI J Med Chem 55: 7957-66 (2012) Pfizer Inc 2D 3D TSV
22864521 25 Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.BDB Dalton Trans 41: 11116-24 (2012) Shanxi University 2D 3D TSV
22863529 31 Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.EBI Bioorg Med Chem 20: 5169-80 (2012) Chinese Academy of Sciences 2D 3D TSV
22863527 2 C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase.EBI Bioorg Med Chem 20: 5127-38 (2012) University of Hyderabad Campus 2D 3D TSV
22863525 36 Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.EBI Bioorg Med Chem 20: 5117-26 (2012) Poznan University of Medical Sciences 2D 3D TSV
22863204 17 Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potentß-secretase inhibitors.EBI Bioorg Med Chem Lett 22: 5460-5 (2012) Purdue University 2D 3D TSV
22863203 1 GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor.EBI Bioorg Med Chem Lett 22: 5625-9 (2012) GlaxoSmithKline 2D 3D TSV
22863202 94 Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway.EBI Bioorg Med Chem Lett 22: 5445-50 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22862294 118 The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist.EBI J Med Chem 55: 7849-61 (2012) Actelion Pharmaceuticals Ltd 2D 3D TSV
22861813 42 Novelß-amino acid derivatives as inhibitors of cathepsin A.EBI J Med Chem 55: 7636-49 (2012) Sanofi-Aventis Deutschland GmbH 2D 3D TSV
22861193 60 Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer.EBI J Med Chem 55: 7080-9 (2012) Saarland University & Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) 2D 3D TSV
22858142 121 Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition.EBI Bioorg Med Chem Lett 22: 5563-8 (2012) AstraZeneca 2D 3D TSV
22858141 113 Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes.EBI Bioorg Med Chem Lett 22: 5721-6 (2012) Pfizer Inc 2D 3D TSV
22858139 25 Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitors.EBI Bioorg Med Chem Lett 22: 5428-37 (2012) Chinese Academy of Sciences 2D 3D TSV
22858099 52 Discovery of potent and selective rhodanine type IKKß inhibitors by hit-to-lead strategy.EBI Bioorg Med Chem Lett 22: 5668-74 (2012) Korea University 2D 3D TSV
22858098 1 Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.EBI Bioorg Med Chem Lett 22: 5675-8 (2012) Northeast Ohio Medical University 2D 3D TSV
22858096 12 The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine.EBI Bioorg Med Chem Lett 22: 5574-8 (2012) Wroclaw University of Technology 2D 3D TSV
22854677 32 New cytosine derivatives as inhibitors of DNA methylation.EBI Eur J Med Chem 55: 243-54 (2012) Polish Academy of Sciences 2D 3D TSV
22854195 17 Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.EBI Bioorg Med Chem 20: 5181-7 (2012) Industrial Research Limited 2D 3D TSV
22853998 164 Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles.EBI Bioorg Med Chem Lett 22: 5498-502 (2012) Shionogi & Co., Ltd 2D 3D TSV
22853997 3 Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors.EBI Bioorg Med Chem Lett 22: 5681-4 (2012) Astellas Pharma Inc 2D 3D TSV
22853995 57 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.EBI Bioorg Med Chem Lett 22: 5536-40 (2012) Tufts University School of Medicine 2D 3D TSV
22853993 18 A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.EBI Bioorg Med Chem Lett 22: 5579-83 (2012) University of Siena 2D 3D TSV
22853801 7 New positron emission tomography (PET) radioligand for imagings-1 receptors in living subjects.EBI J Med Chem 55: 8272-82 (2012) Stanford University 2D 3D TSV
22850212 30 Selected chromone derivatives as inhibitors of monoamine oxidase.EBI Bioorg Med Chem Lett 22: 5480-4 (2012) North-West University 2D 3D TSV
22850210 20 Exploration of ring size in a series of cyclic vicinal diamines withs1 receptor affinity.EBI Bioorg Med Chem Lett 22: 5493-7 (2012) The University of Sydney 2D 3D TSV
22850208 60 Dipeptidyl peptidase-4 inhibitor withß-amino amide scaffold: synthesis, SAR and biological evaluation.EBI Bioorg Med Chem Lett 22: 5545-9 (2012) Dong-A Pharm. Co., Ltd 2D 3D TSV
22849725 28 Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV).EBI J Med Chem 55: 7650-66 (2012) Boehringer Ingelheim (Canada) Ltd 2D 3D TSV
22849615 2 Synthesis and study of 2-(pyrrolesulfonylmethyl)-N-arylimines: a new class of inhibitors for human glutathione transferase A1-1.EBI J Med Chem 55: 6802-13 (2012) Agricultural University of Athens 2D 3D TSV
22846798 48 Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands.EBI Eur J Med Chem 55: 255-61 (2012) University of Tartu 2D 3D TSV
22845329 2 Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity.EBI J Nat Prod 75: 1436-40 (2012) University of Utah 2D 3D TSV
22845053 100 Structure-functional selectivity relationship studies ofß-arrestin-biased dopamine D2 receptor agonists.EBI J Med Chem 55: 7141-53 (2012) University of North Carolina at Chapel Hill 2D 3D TSV
22844551 8 Inhibitors for Bacterial Cell-Wall Recycling.EBI ACS Med Chem Lett 3: 238-242 (2012) TBA 2D 3D TSV
22841436 51 Novel 2-methoxyacylhydrazones as potent, selective PDE10A inhibitors with activity in animal models of schizophrenia.EBI Bioorg Med Chem Lett 22: 5595-9 (2012) Omeros Corp. 2D 3D TSV
22841006 5 Click-based synthesis of triazolobithiazole ?F508-CFTR correctors for cystic fibrosis.EBI Bioorg Med Chem 20: 5247-53 (2012) University of California Davis 2D 3D TSV
22840775 7 Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.BDB Chem Biol 19: 875-82 (2012) Yale University School of Medicine 2D 3D TSV
22840695 52 Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.EBI Eur J Med Chem 55: 94-107 (2012) NeurAxon Inc 2D 3D TSV
22837811 12 Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine Induction.EBI ACS Med Chem Lett 3: 501-504 (2012) TBA 2D 3D TSV
22836190 8 Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.EBI Bioorg Med Chem 20: 5235-46 (2012) Astellas Pharma Inc 2D 3D TSV
22835872 6 Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors.EBI Bioorg Med Chem Lett 22: 5523-6 (2012) University of Athens 2D 3D TSV
22835870 29 Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.EBI Bioorg Med Chem Lett 22: 5352-9 (2012) AstraZeneca 2D 3D TSV
22835719 3 Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2.EBI Eur J Med Chem 55: 58-66 (2012) Universit£ degli Studi del Piemonte Orientale A. Avogadro 2D 3D TSV
22834902 30 Discovery of a novel noniminosugar acida glucosidase chaperone series.EBI J Med Chem 55: 7546-59 (2012) National Center for Advancing Translational Sciences 2D 3D TSV
22834877 119 Current landscape of phosphodiesterase 10A (PDE10A) inhibition.EBI J Med Chem 55: 7299-331 (2012) Pfizer Inc 2D 3D TSV
22832322 40 Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold.EBI Bioorg Med Chem Lett 22: 5714-20 (2012) Amgen Inc 2D 3D TSV
22832319 4 Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease.EBI Bioorg Med Chem Lett 22: 5700-3 (2012) Kyoto University 2D 3D TSV
22832315 85 Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers.EBI Bioorg Med Chem Lett 22: 5618-24 (2012) AstraZeneca 2D 3D TSV
22832311 75 N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators.EBI Bioorg Med Chem Lett 22: 5658-62 (2012) Lundbeck Research USA, Inc. 2D 3D TSV
22831803 9 New hypotheses for the binding mode of 4- and 7-substituted indazoles in the active site of neuronal nitric oxide synthase.EBI Bioorg Med Chem 20: 5296-304 (2012) Universit£ de Caen Basse-Normandie 2D 3D TSV
22831802 9 Small molecules that protect against ?-amyloid-induced cytotoxicity by inhibiting aggregation of ?-amyloid.EBI Bioorg Med Chem 20: 4921-35 (2012) Korea Institute of Science and Technology 2D 3D TSV
22831801 8 Virtual screening leads to the discovery of novel non-nucleotide P2Y1 receptor antagonists.EBI Bioorg Med Chem 20: 5254-61 (2012) National Institutes of Health 2D 3D TSV
22831800 32 Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.EBI Bioorg Med Chem 20: 4901-14 (2012) Meiji Pharmaceutical University 2D 3D TSV
22831799 22 Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).EBI Bioorg Med Chem 20: 4936-41 (2012) Kanazawa University 2D 3D TSV
22827615 2 Stabilization and structural alteration of the G-quadruplex DNA made from the human telomeric repeat mediated by Tröger's base based novel benzimidazole derivatives.EBI J Med Chem 55: 7460-71 (2012) India Institute of Science 2D 3D TSV
22827572 67 Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK).EBI J Med Chem 55: 7193-207 (2012) GlaxoSmithKline 2D 3D TSV
22827545 11 Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.EBI J Med Chem 55: 7010-20 (2012) Leiden/Amsterdam Center for Drug Research 2D 3D TSV
22824762 39 Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.EBI Bioorg Med Chem 20: 5033-41 (2012) Mitsubishi Tanabe Pharma Corporation 2D 3D TSV
22824761 4 Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors.EBI Bioorg Med Chem 20: 4889-94 (2012) Liaoning Normal University 2D 3D TSV
22823910 2 Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening.EBI J Med Chem 55: 7706-18 (2012) Ume£ University 2D 3D TSV
22822714 6 Synthesis and evaluation of novela-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.EBI J Med Chem 55: 7154-62 (2012) Institute of Technology (ETH) Zurich 2D 3D TSV
22822035 10 Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.EBI Drug Metab Dispos 40: 2009-20 (2012) Chinese Academy of Sciences 2D 3D TSV
22819942 2 Synthesis of benzo-annulated tryptanthrins and their biological properties.EBI Bioorg Med Chem 20: 4962-7 (2012) Yeungnam University 2D 3D TSV
22819766 173 SAR studies around a series of triazolopyridines as potent and selective PI3K¿ inhibitors.EBI Bioorg Med Chem Lett 22: 5257-63 (2012) Cellzome Ltd 2D 3D TSV
22819764 35 Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.EBI Bioorg Med Chem Lett 22: 5208-14 (2012) Spanish National Cancer Research Centre (CNIO) 2D 3D TSV
22819505 46 Discovery and characterization of novel allosteric FAK inhibitors.EBI Eur J Med Chem 61: 49-60 (2013) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22819191 17 Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.EBI Bioorg Med Chem 20: 4895-900 (2012) Changzhou University 2D 3D TSV
22818971 3 (+)-Pinoresinol is a putative hypoglycemic agent in defatted sesame (Sesamum indicum) seeds though inhibitinga-glucosidase.EBI Bioorg Med Chem Lett 22: 5215-7 (2012) Chulalongkorn University 2D 3D TSV
22818849 36 Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.EBI Eur J Med Chem 55: 23-31 (2012) P. J. Safarik University 2D 3D TSV
22818848 29 Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases.EBI Eur J Med Chem 55: 39-48 (2012) China Pharmaceutical University 2D 3D TSV
22818082 41 The optimization of pyridazinone series of glucan synthase inhibitors.EBI Bioorg Med Chem Lett 22: 5268-71 (2012) Merck Research Laboratories 2D 3D TSV
22818040 26 Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors.EBI Eur J Med Chem 55: 32-8 (2012) National Health Research Institutes 2D 3D TSV
22817559 4 Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.EBI J Med Chem 55: 6716-23 (2012) Institute for Medical Research and Occupational Health 2D 3D TSV
22815313 10 Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.EBI Drug Metab Dispos 40: 2002-8 (2012) University of Connecticut 2D 3D TSV
22815312 3 Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy.EBI Drug Metab Dispos 41: 270-4 (2013) Amgen 2D 3D TSV
22814212 10 Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.EBI Bioorg Med Chem Lett 22: 5150-6 (2012) AstraZeneca 2D 3D TSV
22813531 141 Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.EBI J Med Chem 55: 7262-72 (2012) University of California 2D 3D TSV
22809559 31 Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide.EBI Eur J Med Chem 54: 626-36 (2012) Universit£ Paul Sabatier 2D 3D TSV
22809456 2 Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.EBI J Med Chem 55: 7021-36 (2012) Hoffmann-La Roche Inc 2D 3D TSV
22809299 4 A straightforward approach for engineering efficacy and selectivity at GPCRs.EBI J Med Chem 55: 6687-8 (2012) Universit£ degli Studi di Siena 2D 3D TSV
22809106 4 Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.BDB J Enzyme Inhib Med Chem 27: 528-32 (2012) Wuhan Textile University 2D 3D TSV
22808911 18 Conformation-specific effects of Raf kinase inhibitors.EBI J Med Chem 55: 7332-41 (2012) Takeda California Inc 2D 3D TSV
22803959 196 Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.EBI J Med Chem 55: 7114-40 (2012) Boehringer Ingelheim Pharmaceuticals Inc 2D 3D TSV
22803810 79 Development of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors.BDB J Med Chem 55: 7392-416 (2012) Moffitt Cancer Center 2D 3D TSV
22803662 7 Synthesis, antielastase, antioxidant and radical scavenging activities of 4-(aza substituted) methylene substituted dihydroxy coumarines.BDB J Enzyme Inhib Med Chem 28: 870-5 (2013) Giresun University 2D 3D TSV
22801646 49 4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy.EBI Bioorg Med Chem Lett 22: 5222-6 (2012) GlaxoSmithKline 2D 3D TSV
22801643 6 Selective non-lipid modulator of LPA5 activity in human platelets.EBI Bioorg Med Chem Lett 22: 5239-43 (2012) Sanofi-Aventis Deutschland GmbH 2D 3D TSV
22801642 2 Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors.EBI Bioorg Med Chem Lett 22: 5169-73 (2012) Gakushuin University 2D 3D TSV
22800535 5 Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.EBI J Med Chem 55: 6762-75 (2012) Universit£ Paris-Sud 11 2D 3D TSV
22800498 26 Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-ß3-pseudopeptide agonist.EBI J Med Chem 55: 7516-24 (2012) Institute for Research and Innovation in Biomedicine (IRIB) 2D 3D TSV
22796349 34 Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.EBI Bioorg Med Chem 20: 4942-53 (2012) Universit£ de Haute Alsace 2D 3D TSV
22796184 53 The SAR analysis of TRPV1 agonists with thea-methylated B-region.EBI Bioorg Med Chem Lett 22: 5227-31 (2012) Seoul National University 2D 3D TSV
22796182 7 Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.EBI Bioorg Med Chem Lett 22: 5317-21 (2012) University of Siena 2D 3D TSV
22796181 51 C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.EBI Bioorg Med Chem Lett 22: 5322-5 (2012) University of Hawaii at Manoa 2D 3D TSV
22795900 3 Identification of new¿-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.EBI Bioorg Med Chem 20: 5012-6 (2012) University of Salerno 2D 3D TSV
22795831 73 Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.EBI Eur J Med Chem 54: 764-70 (2012) Chinese Academy of Sciences 2D 3D TSV
22795665 24 Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.EBI Eur J Med Chem 54: 750-63 (2012) Universit£ de Sfax 2D 3D TSV
22795629 59 Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.EBI Bioorg Med Chem Lett 22: 5264-7 (2012) University of Washington 2D 3D TSV
22795332 66 Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.EBI Bioorg Med Chem Lett 22: 5244-8 (2012) F. Hoffmann-La Roche Inc 2D 3D TSV
22795331 51 Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket.EBI Bioorg Med Chem Lett 22: 5326-9 (2012) Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. 2D 3D TSV
22793665 190 Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selectivea4ß2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.EBI J Med Chem 55: 9181-94 (2012) Targacept Inc 2D 3D TSV
22793499 19 Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.EBI J Med Chem 55: 7054-60 (2012) University of Oxford 2D 3D TSV
22793372 66 Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor.EBI J Med Chem 55: 6975-9 (2012) Vanderbilt University Medical Center 2D 3D TSV
22793255 16 Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.EBI J Med Chem 55: 7208-18 (2012) Universit£ Libre de Bruxelles 2D 3D TSV
22789708 15 Benzimidazole-2-one: a novel anchoring principle for antagonizing p53-Mdm2.EBI Bioorg Med Chem 21: 3982-95 (2013) University of Pittsburgh 2D 3D TSV
22789707 8 Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.EBI Bioorg Med Chem 20: 5027-32 (2012) Groningen Research Institute of Pharmacy 2D 3D TSV
22789706 38 Synthesis and in vitro evaluation ofa-synuclein ligands.EBI Bioorg Med Chem 20: 4625-34 (2012) Washington University 2D 3D TSV
22789427 1 Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1?-p300 interaction by a small molecule.EBI Bioorg Med Chem Lett 22: 5249-52 (2012) Korea Institute of Science and Technology 2D 3D TSV
22788964 2 Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.EBI J Med Chem 55: 6888-97 (2012) Virginia Commonwealth University 2D 3D TSV
22788932 18 Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.BDB Biochemistry 51: 6246-59 (2012) University of Pittsburgh 2D 3D TSV
22788843 46 Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.EBI J Med Chem 55: 6629-33 (2012) Saarland University and Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) 2D 3D TSV
22784805 260 Synthesizing Selective Agonists for the ?7 Nicotinic Receptor with in situ Click-Chemistry on Acetylcholine Binding Protein Templates.BDB Taylor Research Group (2014) University of California San Diego 2D 3D TSV
22784640 36 Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor.EBI Bioorg Med Chem Lett 22: 4955-61 (2012) iTherX Pharmaceuticals, Inc. 2D 3D TSV
22784008 100 Synthesis and biological evaluation of the 1-arylpyrazole class ofs(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).EBI J Med Chem 55: 8211-24 (2012) Esteve 2D 3D TSV
22783984 4 Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.EBI J Med Chem 55: 6948-67 (2012) Universit£ di Siena 2D 3D TSV
22781190 102 Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B.EBI Bioorg Med Chem Lett 22: 4926-9 (2012) University of Mississippi 2D 3D TSV
22780961 3 Predicting new indications for approved drugs using a proteochemometric method.EBI J Med Chem 55: 6832-48 (2012) Georgetown University Medical Center 2D 3D TSV
22780914 35 Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders.EBI J Med Chem 55: 9045-54 (2012) Pfizer Inc 2D 3D TSV
22779702 53 Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.EBI J Med Chem 55: 6898-915 (2012) Universit£ degli Studi di Siena 2D 3D TSV
22779424 31 Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.EBI J Med Chem 55: 6916-33 (2012) AstraZeneca 2D 3D TSV
22778800 24 Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity.EBI ACS Med Chem Lett 2: 929-932 (2011) TBA 2D 3D TSV
22776417 7 Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5a-reductase inhibitors: a legitimate approach.EBI Eur J Med Chem 54: 728-39 (2012) Panjab University 2D 3D TSV
22775474 9 Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species.EBI J Nat Prod 75: 1400-4 (2012) Kieler Wirkstoff-Zentrum (KiWiZ) at the Helmholtz-Zenrum f�r Ozeanforschung GEOMAR 2D 3D TSV
22775345 74 Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.EBI J Med Chem 55: 6776-83 (2012) Istituto di Biostrutture e Bioimmagini-CNR 2D 3D TSV
22775318 3 Double-headed sulfur-linked amino acids as first inhibitors for betaine-homocysteine S-methyltransferase 2.EBI J Med Chem 55: 6822-31 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22771232 18 Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.EBI Bioorg Med Chem 20: 4760-73 (2012) Indiana University 2D 3D TSV
22771010 3 An efficient synthesis of 3-OBn-6ß,14-epoxy-bridged opiates from naltrexone and identification of a related dual MOR inverse agonist/KOR agonist.EBI Bioorg Med Chem Lett 22: 6801-5 (2012) University of New England 2D 3D TSV
22771009 9 Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening.EBI Bioorg Med Chem Lett 22: 4946-50 (2012) Sejong University 2D 3D TSV
22771008 4 Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine.EBI Bioorg Med Chem Lett 22: 4990-3 (2012) Washington University 2D 3D TSV
22771007 64 Design, synthesis, modeling, biological evaluation and photoaffinity labeling studies of novel series of photoreactive benzamide probes for histone deacetylase 2.EBI Bioorg Med Chem Lett 22: 5025-30 (2012) University of Illinois at Chicago 2D 3D TSV
22770928 15 The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents.EBI Bioorg Med Chem Lett 22: 5093-7 (2012) Virginia Commonwealth University 2D 3D TSV
22770610 2 Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.EBI Eur J Med Chem 61: 41-8 (2013) Martin-Luther-University Halle-Wittenberg 2D 3D TSV
22770609 11 The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.EBI Eur J Med Chem 54: 740-9 (2012) University of Thessaly 2D 3D TSV
22770608 35 Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases.EBI Eur J Med Chem 61: 61-72 (2013) Palack£ University 2D 3D TSV
22770607 54 Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.EBI Eur J Med Chem 54: 771-83 (2012) Virginia Commonwealth University 2D 3D TSV
22770529 7 Novel trisubstituted harmine derivatives with original in vitro anticancer activity.EBI J Med Chem 55: 6489-501 (2012) University of Namur (FUNDP) 2D 3D TSV
22770500 219 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.EBI J Med Chem 55: 6866-80 (2012) AstraZeneca 2D 3D TSV
22766219 67 Discovery and SAR of orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancer.EBI Bioorg Med Chem 20: 4635-45 (2012) Abbott Laboratories 2D 3D TSV
22765901 43 Synthesis and SAR studies of bicyclic amine series GPR119 agonists.EBI Bioorg Med Chem Lett 22: 5123-8 (2012) Sanwa Kagaku Kenkyusho Co., Ltd 2D 3D TSV
22765900 24 Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors.EBI Bioorg Med Chem Lett 22: 5114-7 (2012) Pfizer Inc 2D 3D TSV
22765895 72 Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.EBI Bioorg Med Chem Lett 22: 4967-74 (2012) Amgen Inc 2D 3D TSV
22765894 223 The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors.EBI Bioorg Med Chem Lett 22: 4979-85 (2012) Exelixis Inc 2D 3D TSV
22765893 32 Discovery and optimization of novel purines as potent and selective CB2 agonists.EBI Bioorg Med Chem Lett 22: 4962-6 (2012) Eli Lilly and Company 2D 3D TSV
22765892 48 Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors.EBI Bioorg Med Chem Lett 22: 4998-5002 (2012) Janssen Infectious Diseases-Diagnostics BVBA 2D 3D TSV
22765237 28 Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.EBI J Med Chem 55: 6306-15 (2012) McGill University 2D 3D TSV
22764122 9 Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization.BDB Chembiochem 13: 1628-34 (2012) University of Southampton 2D 3D TSV
22763369 1 Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption.EBI Bioorg Med Chem 20: 4680-92 (2012) Takeda Pharmaceutical Company Limited 2D 3D TSV
22763201 1 Oxoquinoline acyclonucleoside phosphonate analogues as a new class of specific inhibitors of human immunodeficiency virus type 1.EBI Bioorg Med Chem Lett 22: 5055-8 (2012) Universidade Federal Fluminense 2D 3D TSV
22762530 2 Conformationally-locked N-glycosides with selectiveß-glucosidase inhibitory activity: identification of a new non-iminosugar-type pharmacological chaperone for Gaucher disease.EBI J Med Chem 55: 6857-65 (2012) Universitat Rovira i Virgili 2D 3D TSV
22761000 123 Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.EBI J Appl Toxicol 32: 858-66 (2012) Jagiellonian University 2D 3D TSV
22759374 3 Identification of Type-II Inhibitors Using Kinase Structures.BDB Chem Biol Drug Des 80: 657-64 (2012) Pfizer Inc 2D 3D TSV
22758660 2 Saquayamycins G-K, cytotoxic angucyclines from Streptomyces sp. Including two analogues bearing the aminosugar rednose.EBI J Nat Prod 75: 1383-92 (2012) University of Kentucky 2D 3D TSV
22754607 6 S-Farnesyl-Thiopropionic Acid (FTPA) Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase.EBI ACS Med Chem Lett 3: 15-19 (2012) TBA 2D 3D TSV
22753086 6 Kinetics Studies on the Inhibition Mechanism of Pancreatic α-Amylase by Glycoconjugated 1H-1,2,3-Triazoles: A New Class of Inhibitors with Hypoglycemiant Activity.BDB Chembiochem 13: 1584-93 (2012) Yonsei University 2D 3D TSV
22752007 1 Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.EBI Drug Metab Dispos 40: 1917-26 (2012) Toyama Prefectural University 2D 3D TSV
22750139 28 Methylation of imidazoline related compounds leads to loss ofa2-adrenoceptor affinity. Synthesis and biological evaluation of selective I1 imidazoline receptor ligands.EBI Bioorg Med Chem 20: 4710-5 (2012) University of Strasburg 2D 3D TSV
22750138 8 ¿-amino-ß-fluorocyclopropanecarboxylic acids as a new tool for drug development: synthesis of glutamic acid analogs and agonist activity towards metabotropic glutamate receptor 4.EBI Bioorg Med Chem 20: 4716-26 (2012) INSA de Rouen and Universit£ de Rouen 2D 3D TSV
22750010 30 Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.EBI Bioorg Med Chem 20: 4661-7 (2012) China Pharmaceutical University 2D 3D TSV
22749871 92 Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012.EBI Bioorg Med Chem Lett 22: 5035-40 (2012) Vanderbilt University Medical Center 2D 3D TSV
22749870 48 Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors.EBI Bioorg Med Chem Lett 22: 5108-13 (2012) Xenon Pharmaceuticals Inc 2D 3D TSV
22749869 82 Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors.EBI Bioorg Med Chem Lett 22: 5067-70 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22749826 28 Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.EBI Bioorg Med Chem Lett 22: 4951-4 (2012) Toray Industries Inc 2D 3D TSV
22749643 69 Structure-based optimization of oxadiazole-based GSK-3 inhibitors.EBI Eur J Med Chem 61: 26-40 (2013) Technische Universit£t Darmstadt 2D 3D TSV
22749641 15 Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.EBI Eur J Med Chem 54: 647-59 (2012) Georgia State University 2D 3D TSV
22749640 36 Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine.EBI Eur J Med Chem 54: 483-98 (2012) University of Strathclyde 2D 3D TSV
22749422 43 Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists.EBI Bioorg Med Chem Lett 22: 4986-9 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22749420 13 Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives.EBI Bioorg Med Chem Lett 22: 5031-4 (2012) University of Hamburg 2D 3D TSV
22749419 22 Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Ka and mTOR.EBI Bioorg Med Chem Lett 22: 5098-103 (2012) Pfizer Inc 2D 3D TSV
22749391 72 Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands.EBI Eur J Med Chem 54: 660-8 (2012) Boehringer Ingelheim RCV GmbH & Co KG 2D 3D TSV
22749282 12 Design and synthesis of novel p38a MAP kinase inhibitors: discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety.EBI Bioorg Med Chem Lett 22: 5118-22 (2012) Toray Industries Inc 2D 3D TSV
22749281 1 Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.EBI Bioorg Med Chem Lett 22: 5104-7 (2012) Columbia University College of Physicians and Surgeons 2D 3D TSV
22749278 16 Diazaspirocyclic compounds as selective ligands for thea4ß2 nicotinic acetylcholine receptor.EBI Bioorg Med Chem Lett 22: 5089-92 (2012) Targacept Inc 2D 3D TSV
22749190 23 Wake-promoting agents: search for next generation modafinil: part IV.EBI Eur J Med Chem 54: 949-51 (2012) Cephalon (France) 2D 3D TSV
22749189 24 Inhibitors of the TAM subfamily of tyrosine kinases: synthesis and biological evaluation.EBI Eur J Med Chem 61: 2-25 (2013) Institut Curie 2D 3D TSV
22748707 8 Synthesis and biological evaluation of new N-acyl-homoserine-lactone analogues, based on triazole and tetrazole scaffolds, acting as LuxR-dependent quorum sensing modulators.EBI Bioorg Med Chem 20: 4727-36 (2012) INSA Lyon 2D 3D TSV
22748706 52 Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D1 receptor.EBI Bioorg Med Chem 20: 4862-71 (2012) Shenyang Pharmaceutical University 2D 3D TSV
22748705 2 Total synthesis of grassystatin A, a probe for cathepsin E function.EBI Bioorg Med Chem 20: 4774-80 (2012) Fudan University 2D 3D TSV
22748377 1 Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones.EBI Bioorg Med Chem 20: 4737-43 (2012) Ghent University 2D 3D TSV
22747598 33 Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.EBI J Med Chem 55: 6149-61 (2012) University of Michigan 2D 3D TSV
22746350 41 Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators.EBI J Med Chem 55: 6316-27 (2012) University of Eastern Finland 2D 3D TSV
22746324 8 Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.EBI J Med Chem 55: 7104-13 (2012) University of Gothenburg 2D 3D TSV
22746295 91 Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach.EBI J Med Chem 55: 6700-15 (2012) Teijin Pharma Ltd. 2D 3D TSV
22746274 4 Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.EBI J Med Chem 55: 6738-50 (2012) Emory University 2D 3D TSV
22743085 21 Experimental and 'in silico' analysis of the effect of pH on HIV-1 protease inhibitor affinity: implications for the charge state of the protein ionogenic groups.EBI Bioorg Med Chem 20: 4838-47 (2012) Universidad de Santiago de Compostela 2D 3D TSV
22742909 24 Essential structure of opioid¿ receptor agonist nalfurafine for binding to the¿ receptor 2: synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies.EBI Bioorg Med Chem Lett 22: 5071-4 (2012) Kitasato University 2D 3D TSV
22742641 113 (1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis.EBI J Med Chem 55: 6363-74 (2012) AstraZeneca 2D 3D TSV
22742586 13 Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.EBI J Med Chem 55: 6512-22 (2012) Research Triangle Institute 2D 3D TSV
22742537 3 Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors.EBI J Med Chem 55: 9120-35 (2012) Seoul National University 2D 3D TSV
22739090 86 Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents.EBI Bioorg Med Chem 20: 4217-25 (2012) Duquesne University 2D 3D TSV
22739089 42 Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups.EBI Bioorg Med Chem 20: 4422-9 (2012) Washington University 2D 3D TSV
22739087 3 Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.EBI Bioorg Med Chem 20: 4194-200 (2012) Soochow University 2D 3D TSV
22739085 29 Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors.EBI Bioorg Med Chem 20: 4237-44 (2012) Kurukshetra University 2D 3D TSV
22739084 15 Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with ??-adrenoceptor antagonistic properties.EBI Bioorg Med Chem 20: 4245-57 (2012) Jagiellonian University Medical College 2D 3D TSV
22738639 6 Contribution of indazolinone tautomers to kinase activity.EBI Bioorg Med Chem Lett 22: 4502-5 (2012) Abbott Laboratories 2D 3D TSV
22738638 59 Assay and inhibition of diacylglycerol lipase activity.EBI Bioorg Med Chem Lett 22: 4585-92 (2012) Northeastern University 2D 3D TSV
22738637 19 Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor.EBI Bioorg Med Chem Lett 22: 5084-8 (2012) Vanderbilt University Medical Center 2D 3D TSV
22738635 87 Discovery of novel PI3K¿/d inhibitors as potential agents for inflammation.EBI Bioorg Med Chem Lett 22: 4546-9 (2012) Cellzome Ltd 2D 3D TSV
22738633 4 'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells.EBI Bioorg Med Chem Lett 22: 4693-6 (2012) Universit£ degli Studi di Milano 2D 3D TSV
22738631 6 New farnesyltransferase inhibitors in the phenothiazine series.EBI Bioorg Med Chem Lett 22: 4517-22 (2012) Al. I. Cuza University of Iasi 2D 3D TSV
22738630 76 Structure-based optimization of aminopyridines as PKC¿ inhibitors.EBI Bioorg Med Chem Lett 22: 4645-9 (2012) Vertex Pharmaceuticals Inc 2D 3D TSV
22738629 47 CCLab--a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design.EBI Bioorg Med Chem Lett 22: 4540-5 (2012) Chinese Academy of Sciences 2D 3D TSV
22738628 38 Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.EBI Bioorg Med Chem Lett 22: 4550-4 (2012) University of Li£ge 2D 3D TSV
22738356 2 Antidiabetic compounds from Sarracenia purpurea used traditionally by the Eeyou Istchee Cree First Nation.EBI J Nat Prod 75: 1284-8 (2012) University of Ottawa 2D 3D TSV
22738316 35 Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.EBI J Med Chem 55: 6375-80 (2012) Universit£ degli Studi di Bari A. Moro 2D 3D TSV
22738293 7 Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.EBI J Med Chem 55: 6391-402 (2012) University of Lille 2D 3D TSV
22738271 250 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.EBI J Med Chem 55: 6608-23 (2012) Universit£ di Ferrara 2D 3D TSV
22738238 29 Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.EBI J Med Chem 55: 6467-77 (2012) University of North Carolina at Chapel Hill 2D 3D TSV
22737278 44 Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors.EBI ACS Med Chem Lett 3: 490-495 (2012) TBA 2D 3D TSV
22734674 81 The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer.EBI J Med Chem 55: 6523-40 (2012) Amgen Inc 2D 3D TSV
22734650 6 Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.EBI J Med Chem 55: 6554-65 (2012) Massachusetts General Hospital 2D 3D TSV
22734622 78 Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associatedµ opioid receptor (MOR-1) splice variants.EBI J Med Chem 55: 6352-62 (2012) Memorial Sloan-Kettering Cancer Center 2D 3D TSV
22732695 26 Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor.EBI Bioorg Med Chem Lett 22: 4719-22 (2012) Bristol-Myers Squibb R & D 2D 3D TSV
22731815 14 Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.EBI J Med Chem 55: 6576-81 (2012) Rheinische Friedrich-Wilhelms-Universit£t 2D 3D TSV
22727780 17 Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).EBI Bioorg Med Chem 20: 4290-302 (2012) The State University of New York 2D 3D TSV
22727779 6 Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.EBI Bioorg Med Chem 20: 4303-9 (2012) National Cancer Institute 2D 3D TSV
22727645 42 The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1.EBI Bioorg Med Chem Lett 22: 4723-7 (2012) Bristol-Myers Squibb Research & Development 2D 3D TSV
22727644 43 Synthesis and structure-activity relationship studies of 1,3-disubstituted 2-propanols as BACE-1 inhibitors.EBI Bioorg Med Chem Lett 22: 4740-4 (2012) University of South Florida 2D 3D TSV
22727640 68 Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases.EBI Bioorg Med Chem Lett 22: 4599-604 (2012) AstraZeneca 2D 3D TSV
22727639 24 Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.EBI Bioorg Med Chem Lett 22: 4532-5 (2012) Vanderbilt University School of Medicine 2D 3D TSV
22727637 85 Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors.EBI Bioorg Med Chem Lett 22: 4528-31 (2012) Abbott Laboratories 2D 3D TSV
22727448 16 Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPAR¿ modulators.EBI Eur J Med Chem 54: 522-33 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22727447 8 Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents.EBI Eur J Med Chem 54: 512-21 (2012) Instituto de Tecnologia em F£rmacos - Farmanguinhos 2D 3D TSV
22727372 14 Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold.EBI Bioorg Med Chem 20: 4201-7 (2012) Cardiff University 2D 3D TSV
22727371 22 Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists.EBI Bioorg Med Chem 20: 4208-16 (2012) School of Chemical Engineering & the Environment 2D 3D TSV
22727369 6 Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.EBI Bioorg Med Chem 20: 4226-36 (2012) Nanjing University 2D 3D TSV
22726934 58 Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors.EBI Bioorg Med Chem Lett 22: 4561-6 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22726931 113 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).EBI Bioorg Med Chem Lett 22: 4654-9 (2012) National Health Research Institutes 2D 3D TSV
22726930 7 Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.EBI Bioorg Med Chem Lett 22: 4640-4 (2012) Kobe Gakuin University 2D 3D TSV
22726929 118 Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype.EBI Bioorg Med Chem Lett 22: 4660-4 (2012) Actelion Pharmaceuticals Ltd 2D 3D TSV
22726925 216 Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease.EBI Bioorg Med Chem Lett 22: 4613-8 (2012) Cellzome Ltd 2D 3D TSV
22726924 14 Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.EBI Bioorg Med Chem Lett 22: 4839-43 (2012) AstraZeneca 2D 3D TSV
22726686 4 Acyclic Immucillin Phosphonates: Second-Generation Inhibitors of Plasmodium falciparum Hypoxanthine- Guanine-Xanthine Phosphoribosyltransferase.BDB Chem Biol 19: 721-30 (2012) Albert Einstein College of Medicine 2D 3D TSV
22726671 8 Neoflavonoids and Tetrahydroquinolones as Possible Cancer Chemopreventive Agents.BDB Chem Biol Drug Des 80: 616-624 (2012) Central Institute of Medicinal and Aromatic Plants 2D 3D TSV
22726458 28 Synthesis and Biological Evaluation of 3-thiazolocoumarinyl Schiff-base Derivatives as Cholinesterase Inhibitors.BDB Chem Biol Drug Des 80: 605-15 (2012) COMSATS Institute of Information Technology 2D 3D TSV
22725979 23 Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.EBI J Med Chem 55: 6209-23 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22724510 84 Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.EBI J Med Chem 55: 6639-43 (2012) University of Oxford 2D 3D TSV
22724451 23 Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties.EBI J Med Chem 55: 6624-8 (2012) University of Southern Denmark 2D 3D TSV
22724433 76 A new class of highly potent and selective endomorphin-1 analogues containinga-methylene-ß-aminopropanoic acids (map).EBI J Med Chem 55: 6224-36 (2012) Lanzhou University 2D 3D TSV
22721924 16 Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.EBI Bioorg Med Chem 20: 4323-9 (2012) Academy of Military Medical Sciences 2D 3D TSV
22721713 200 Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines.EBI Bioorg Med Chem Lett 22: 4681-5 (2012) Ecole Nationale Sup£rieure de Chimie de Montpellier 2D 3D TSV
22720744 8 Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.EBI J Med Chem 55: 6342-51 (2012) University of Washington 2D 3D TSV
22715973 32 1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitors.EBI J Med Chem 55: 6427-37 (2012) Taiho Pharmaceutical Co., Ltd 2D 3D TSV
22712652 23 New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.EBI J Med Chem 55: 6634-8 (2012) Sapienza University of Rome 2D 3D TSV
22712585 106 Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a.EBI J Med Chem 55: 6502-11 (2012) Universit£ de Montr£al 2D 3D TSV
22712432 5 Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents.EBI J Med Chem 55: 5965-81 (2012) The University of Illinois at Chicago 2D 3D TSV
22711749 1 The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.EBI Drug Metab Dispos 40: 1834-45 (2012) Vanderbilt University Medical Center 2D 3D TSV
22708927 14 Selective mode of action of guanidine-containing non-peptides at human NPFF receptors.EBI J Med Chem 55: 6124-36 (2012) Leipzig University 2D 3D TSV
22708897 100 Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.EBI J Med Chem 55: 6328-41 (2012) Sanford-Burnham Medical Research Institute 2D 3D TSV
22708876 106 Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-ß-alanine (MK-0893) for the treatment of type II diabetes.EBI J Med Chem 55: 6137-48 (2012) Merck Research Laboratories 2D 3D TSV
22708838 13 Lead optimization of antimalarial propafenone analogues.EBI J Med Chem 55: 6087-93 (2012) St. Jude Children's Research Hospital 2D 3D TSV
22707871 12 Kinetic studies of novel inhibitors of endomorphin degrading enzymes.EBI Med Chem Res 21: 1445-1450 (2012) TBA 2D 3D TSV
22705191 45 Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.EBI Bioorg Med Chem 20: 4336-47 (2012) North-West University 2D 3D TSV
22705189 24 Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.EBI Bioorg Med Chem 20: 4371-6 (2012) Imperial College 2D 3D TSV
22705188 73 Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors.EBI Bioorg Med Chem 21: 1555-63 (2013) Superacide et Chimie des syst£mes£ team-Universit£ de Poitiers 2D 3D TSV
22705022 32 Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.EBI Bioorg Med Chem 20: 4430-6 (2012) Nanjing University 2D 3D TSV
22704921 34 Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.EBI Bioorg Med Chem Lett 22: 4707-12 (2012) University of Waterloo 2D 3D TSV
22704887 12 Synthesis and evaluation of novel potent HCV NS5A inhibitors.EBI Bioorg Med Chem Lett 22: 4864-8 (2012) Emory University 2D 3D TSV
22704238 18 Design, synthesis and biological evaluation ofß-carboline derivatives as novel inhibitors targeting B-Raf kinase.EBI Bioorg Med Chem Lett 22: 4783-6 (2012) China Pharmaceutical University 2D 3D TSV
22704236 64 Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO.EBI Bioorg Med Chem Lett 22: 4907-11 (2012) AstraZeneca 2D 3D TSV
22703704 3 New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714.EBI Eur J Med Chem 54: 439-46 (2012) Instituto Cajal (CSIC) 2D 3D TSV
22703703 6 In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-¿-pyrone skeleton.EBI Eur J Med Chem 54: 914-8 (2012) Universidade do Porto 2D 3D TSV
22698785 28 Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.EBI Bioorg Med Chem 20: 4377-89 (2012) Link£ping University 2D 3D TSV
22698782 16 Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC-EGFR dual inhibitors.EBI Bioorg Med Chem 20: 4405-12 (2012) Xi'an Jiaotong University 2D 3D TSV
22698084 99 Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.EBI J Med Chem 55: 6176-93 (2012) Genentech 2D 3D TSV
22697905 21 N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.EBI J Med Chem 55: 6111-23 (2012) GlaxoSmithKline 2D 3D TSV
22696418 36 Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.EBI Drug Metab Dispos 40: 1797-802 (2012) University of Kansas 2D 3D TSV
22695182 4 Hyrtioreticulins A-E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus.EBI Bioorg Med Chem 20: 4437-42 (2012) Kumamoto University 2D 3D TSV
22695132 56 Identification of a duald OR antagonist/µ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d).EBI Bioorg Med Chem Lett 22: 4869-72 (2012) Janssen Research and Development LLC 2D 3D TSV
22695131 24 Inhibition of therapeutically important polymerases with high affinity bis-intercalators.EBI Bioorg Med Chem Lett 22: 4844-8 (2012) University of Missouri 2D 3D TSV
22695126 98 Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases.EBI Bioorg Med Chem Lett 22: 4750-5 (2012) Abbott Laboratories 2D 3D TSV
22694270 5 Isolation and structural elucidation of cyclic tetrapeptides from Onychocola sclerotica.EBI J Nat Prod 75: 1210-4 (2012) Fundacion MEDINA 2D 3D TSV
22694147 17 Nanomolar potency and metabolically stable inhibitors of kidney urea transporter UT-B.EBI J Med Chem 55: 5942-50 (2012) San Francisco State University 2D 3D TSV
22694121 5 An ultrahigh affinity d-peptide antagonist Of MDM2.EBI J Med Chem 55: 6237-41 (2012) University of Maryland 2D 3D TSV
22694093 16 Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.EBI J Med Chem 55: 5749-59 (2012) National Institute of Biological Sciences 2D 3D TSV
22691057 32 Discovery of a potent, selective, and orally bioavailable acidic 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017).EBI J Med Chem 55: 5951-64 (2012) AstraZeneca 2D 3D TSV
22690646 6 Structure and bioassay of triterpenoids and steroids isolated from Sinocalamus affinis.EBI J Nat Prod 75: 1160-6 (2012) Chinese Academy of Medical Sciences and Peking Union Medical College 2D 3D TSV
22689580 90 Simple Pseudo-dipeptides with a P2' Glutamate: A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS.BDB J Biol Chem 287: 26647-56 (2012) Commissariat á l'Energie Atomique 2D 3D TSV
22688609 2 Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.EBI Drug Metab Dispos 40: 1778-84 (2012) Diakonhjemmet Hospital 2D 3D TSV
22687744 24 Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors.EBI Bioorg Med Chem Lett 22: 4896-9 (2012) Albany Molecular Research, Inc. (AMRI) 2D 3D TSV
22687439 51 Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: vidalol B.EBI Eur J Med Chem 54: 423-8 (2012) Atat£rk University 2D 3D TSV
22686946 12 Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata.BDB Org Med Chem Lett 2: 21 (2012) University of the West Indies 2D 3D TSV
22686657 60 Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.EBI J Med Chem 55: 5982-6 (2012) University of Bonn 2D 3D TSV
22685215 1 Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.EBI Drug Metab Dispos 40: 1765-70 (2012) University of Michigan 2D 3D TSV
22683343 27 Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists.EBI Bioorg Med Chem Lett 22: 4756-61 (2012) Eisai Co., Ltd 2D 3D TSV
22683242 47 Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.EBI Eur J Med Chem 54: 311-23 (2012) University of Salerno 2D 3D TSV
22683241 33 Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.EBI Eur J Med Chem 54: 324-42 (2012) Piramal Healthcare Limited 2D 3D TSV
22683222 21 Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.EBI Bioorg Med Chem Lett 22: 4849-53 (2012) Theravance, Inc. 2D 3D TSV
22682919 26 Furin inhibitors: importance of the positive formal charge and beyond.EBI Bioorg Med Chem 20: 4462-71 (2012) Torrey Pines Institute for Molecular Studies 2D 3D TSV
22682301 15 Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.EBI Bioorg Med Chem 20: 4590-7 (2012) Emory University CSI 2D 3D TSV
22682300 11 Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.EBI Bioorg Med Chem 20: 4514-21 (2012) University of Copenhagen 2D 3D TSV
22680612 11 Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.EBI J Med Chem 55: 5859-67 (2012) The University of Queensland 2D 3D TSV
22679214 13 Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.EBI Drug Metab Dispos 40: 1757-64 (2012) University of Washington 2D 3D TSV
22677529 3 Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.EBI Bioorg Med Chem 20: 4582-9 (2012) University of Alabama at Birmingham 2D 3D TSV
22677527 38 Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.EBI Bioorg Med Chem 20: 4556-63 (2012) University of Maryland 2D 3D TSV
22677319 64 Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.EBI Bioorg Med Chem Lett 22: 5134-40 (2012) H. Lundbeck A/S 2D 3D TSV
22677318 8 Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction.EBI Bioorg Med Chem Lett 22: 4810-5 (2012) Shionogi & Co., Ltd 2D 3D TSV
22677317 23 Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.EBI Bioorg Med Chem Lett 22: 4769-72 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22677316 35 Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.EBI Bioorg Med Chem Lett 22: 4281-7 (2012) Pfizer Inc 2D 3D TSV
22677314 14 Xanthine oxidase inhibitory activity of constituents of Cinnamomum cassia twigs.EBI Bioorg Med Chem Lett 22: 4625-8 (2012) National Institute of Medicinal Materials 2D 3D TSV
22677030 29 New chromene scaffolds for adenosine A(2A) receptors: synthesis, pharmacology and structure-activity relationships.EBI Eur J Med Chem 54: 303-10 (2012) Universidade do Minho 2D 3D TSV
22676247 8 Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents.EBI J Med Chem 55: 5720-33 (2012) Second Military Medical University 2D 3D TSV
22676210 116 Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase.EBI J Med Chem 55: 5868-77 (2012) Eberhard-Karls University 2D 3D TSV
22672803 57 Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3ß inhibitors.EBI Bioorg Med Chem Lett 22: 4221-4 (2012) CrystalGenomics, Inc. 2D 3D TSV
22672799 16 Potent and selective inhibitors of PI3Kd: obtaining isoform selectivity from the affinity pocket and tryptophan shelf.EBI Bioorg Med Chem Lett 22: 4296-302 (2012) Genentech 2D 3D TSV
22668600 200 Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV.EBI Bioorg Med Chem 21: 1564-9 (2013) Universit£ degli Studi di Firenze 2D 3D TSV
22664127 19 Antagonists of 5-HT6 receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.EBI Bioorg Med Chem Lett 22: 4273-80 (2012) Chemical Diversity Research Institute 2D 3D TSV
22663155 2 Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain.EBI J Nat Prod 75: 1108-16 (2012) China Pharmaceutical University 2D 3D TSV
22662288 11 HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis.EBI ACS Med Chem Lett 3: 402-406 (2012) TBA 2D 3D TSV
22662287 116 Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia.EBI ACS Med Chem Lett 3: 129-134 (2012) TBA 2D 3D TSV
22659092 2 Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.EBI Drug Metab Dispos 40: 1736-43 (2012) Gdansk University of Technology 2D 3D TSV
22658862 41 Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.EBI Bioorg Med Chem Lett 22: 4341-7 (2012) Advinus Therapeutics Ltd 2D 3D TSV
22658558 10 Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter.EBI Bioorg Med Chem Lett 22: 4303-6 (2012) Beijing Normal University 2D 3D TSV
22658537 76 Natural products as a gold mine for selective matrix metalloproteinases inhibitors.EBI Bioorg Med Chem 20: 4164-71 (2012) East China University of Science and Technology 2D 3D TSV
22652255 50 C-Aryl 5a-carba-ß-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.EBI Bioorg Med Chem 20: 4117-27 (2012) Chugai Pharmaceutical Co. Ltd 2D 3D TSV
22652254 21 Beta-carboline alkaloids derived from the ascidian Synoicum sp.EBI Bioorg Med Chem 20: 4082-7 (2012) Seoul National University 2D 3D TSV
22652225 27 A novel class of small-molecule caspase-3 inhibitors prepared by multicomponent reactions.EBI Eur J Med Chem 54: 232-8 (2012) Southern Medical University 2D 3D TSV
22652053 6 Syntheses and biological activities of sulfoximine-based acyclic triaryl olefins.EBI Bioorg Med Chem Lett 22: 4307-9 (2012) RWTH Aachen University 2D 3D TSV
22651858 74 Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.EBI J Med Chem 55: 5774-83 (2012) Universit£ Catholique de Louvain 2D 3D TSV
22651823 57 Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases.EBI J Med Chem 55: 5088-109 (2012) Pfizer Inc 2D 3D TSV
22650618 4 Rediocide A, an Insecticide, induces G-protein-coupled receptor desensitization via activation of conventional protein kinase C.EBI J Nat Prod 75: 1058-62 (2012) Chinese Academy of Sciences 2D 3D TSV
22650325 39 Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.EBI J Med Chem 55: 6645-68 (2012) University of Southern California 2D 3D TSV
22650305 64 Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.EBI J Med Chem 55: 6162-75 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22650177 12 Design and synthesis of a novel series of bicyclic heterocycles as potent¿-secretase modulators.EBI J Med Chem 55: 9089-106 (2012) Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. 2D 3D TSV
22647881 2 Substrate analog studies of the ?-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.EBI Bioorg Med Chem 20: 4064-81 (2012) University of California San Francisco 2D 3D TSV
22647721 19 Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹?F-PET imaging agents for ?-amyloid plaques.EBI Bioorg Med Chem Lett 22: 4332-7 (2012) AstraZeneca 2D 3D TSV
22647219 1 Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors.EBI Eur J Med Chem 54: 264-71 (2012) Universidade Federal do Rio de Janeiro 2D 3D TSV
22647217 57 Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.EBI Eur J Med Chem 54: 188-96 (2012) East China University of Science and Technology 2D 3D TSV
22646221 11 Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.EBI J Med Chem 55: 5734-48 (2012) National Center for Advancing Translation Sciences 2D 3D TSV
22645149 12 Novel Anti-inflammatory Activity of Epoxyazadiradione against Macrophage Migration Inhibitory Factor: INHIBITION OF TAUTOMERASE AND PROINFLAMMATORY ACTIVITIES OF MACROPHAGE MIGRATION INHIBITORY FACTOR.BDB J Biol Chem 287: 24844-61 (2012) Council of Scientific and Industrial Research (CSIR) Indian Institute of Chemical Biology 2D 3D TSV
22645092 15 Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.EBI Drug Metab Dispos 40: 1686-97 (2012) Pfizer Inc 2D 3D TSV
22642587 2 Langkolide, a 32-membered macrolactone antibiotic produced by Streptomyces sp. Acta 3062.EBI J Nat Prod 75: 1018-24 (2012) Technische Universit£t Berlin 2D 3D TSV
22642365 62 Structure-activity relationship study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterizatioEBI J Med Chem 55: 5826-40 (2012) Wayne State University 2D 3D TSV
22642319 1 Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.EBI J Med Chem 55: 5933-41 (2012) University of Illinois at Chicago 2D 3D TSV
22642300 160 Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.EBI J Med Chem 55: 5760-73 (2012) Kyoto Prefectural University of Medicine 2D 3D TSV
22642259 22 Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.EBI J Med Chem 55: 5922-32 (2012) Eisai Inc. 2D 3D TSV
22633833 5 Rational design, synthesis, and pharmacological properties of pyranochalcone derivatives as potent anti-inflammatory agents.EBI Eur J Med Chem 54: 272-80 (2012) Sichuan University 2D 3D TSV
22633692 51 Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease.EBI Bioorg Med Chem Lett 22: 4404-9 (2012) Arena Pharmaceuticals 2D 3D TSV
22633691 42 Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.EBI Bioorg Med Chem Lett 22: 4462-6 (2012) Sun Yat-sen University 2D 3D TSV
22633688 30 Small molecule tertiary amines as agonists of the nuclear hormone receptor Rev-erba.EBI Bioorg Med Chem Lett 22: 4413-7 (2012) The Scripps Research Institute 2D 3D TSV
22633008 4 Biochemical and pharmacological evaluation of 4-hydroxychromen-2-ones bearing polar C-3 substituents as anticoagulants.EBI Eur J Med Chem 54: 144-58 (2012) University of Kragujevac 2D 3D TSV
22632936 42 Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors.EBI Bioorg Med Chem Lett 22: 4377-85 (2012) Myrexis Inc 2D 3D TSV
22632934 8 Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular efflux.EBI Bioorg Med Chem Lett 22: 4410-2 (2012) Purdue University 2D 3D TSV
22632933 65 Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90.EBI Bioorg Med Chem Lett 22: 4396-403 (2012) Merck Serono 2D 3D TSV
22632094 26 Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.EBI J Med Chem 55: 6689-99 (2012) National Institute on Drug Abuse-Intramural Research Program 2D 3D TSV
22630076 38 Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds.BDB J Enzyme Inhib Med Chem 28: 816-23 (2013) University of Life Sciences 2D 3D TSV
22630073 12 Susceptibility of cord blood antioxidant enzymes glutathione reductase, glutathione peroxidase and glutathione S-transferase to different antibiotics: in vitro approach.BDB J Enzyme Inhib Med Chem 28: 824-9 (2013) Ondokuz Mayis University 2D 3D TSV
22626654 7 Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles.EBI Eur J Med Chem 54: 95-102 (2012) University of Namur (FUNDP) 2D 3D TSV
22626552 2 Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²¿ channel blockers with analgesic activity.EBI Bioorg Med Chem 20: 4128-39 (2012) Abbott Laboratories 2D 3D TSV
22626259 59 Discovery of novel PI3-kinased specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition.EBI J Med Chem 55: 5887-900 (2012) Genentech 2D 3D TSV
22625994 28 Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.EBI J Med Chem 55: 5614-26 (2012) Kyoto University 2D 3D TSV
22624960 1 AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development.EBI J Med Chem 55: 4934-5 (2012) University of Michigan Comprehensive Cancer Center 2D 3D TSV
22624880 16 Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo.EBI J Med Chem 55: 5231-42 (2012) Universit£t Regensburg 2D 3D TSV
22621689 1 Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.EBI J Med Chem 55: 5784-96 (2012) National Hellenic Research Foundation 2D 3D TSV
22621623 44 Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts.EBI J Med Chem 55: 5591-600 (2012) University of Manchester 2D 3D TSV
22621422 2 ¹²5I-radiolabeled morpholine-containing arginine-glycine-aspartate (RGD) ligand ofavß3 integrin as a molecular imaging probe for angiogenesis.EBI J Med Chem 55: 5024-33 (2012) University of Florence 2D 3D TSV
22621397 39 Irreversible protein kinase inhibitors: balancing the benefits and risks.EBI J Med Chem 55: 6243-62 (2012) Covalution Pharma BV 2D 3D TSV
22621375 17 Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases.EBI J Med Chem 55: 5841-50 (2012) University of Leeds 2D 3D TSV
22617492 56 Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.EBI Bioorg Med Chem Lett 22: 3890-4 (2012) Scripps Florida 2D 3D TSV
22617490 23 Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.EBI Bioorg Med Chem Lett 22: 4198-202 (2012) Cephalon Inc 2D 3D TSV
22616902 165 Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.EBI J Med Chem 55: 5270-90 (2012) Ludwig Center for Cancer Research of the University of Lausanne 2D 3D TSV
22613176 1 Covalent modification and time-dependent inhibition of human CYP2E1 by the meta-isomer of acetaminophen.EBI Drug Metab Dispos 40: 1460-5 (2012) Pacific University Oregon 2D 3D TSV
22613098 3 Novel Cruzain Inhibitors for the Treatment of Chagas' Disease.BDB Chem Biol Drug Des 80: 398-405 (2012) University of California San Diego 2D 3D TSV
22612866 123 Protein-ligand crystal structures can guide the design of selective inhibitors of the FGFR tyrosine kinase.EBI J Med Chem 55: 5003-12 (2012) AstraZeneca 2D 3D TSV
22612268 12 Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect.EBI J Med Chem 55: 6094-110 (2012) Philipps University Marburg 2D 3D TSV
22608965 186 The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38a MAP kinase inhibitor for the treatment of inflammatory diseases.EBI Bioorg Med Chem Lett 22: 3879-83 (2012) AstraZeneca 2D 3D TSV
22608963 109 The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.EBI Bioorg Med Chem Lett 22: 3895-9 (2012) AstraZeneca 2D 3D TSV
22608962 59 Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes.EBI Bioorg Med Chem Lett 22: 3873-8 (2012) AstraZeneca 2D 3D TSV
22608961 46 Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists.EBI Bioorg Med Chem Lett 22: 3946-50 (2012) Bristol-Myers Squibb Research 2D 3D TSV
22608920 4 Synthesis and evaluation of 11ß-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.EBI Bioorg Med Chem 20: 3768-80 (2012) Northeastern University 2D 3D TSV
22608919 3 5-(5-(6-[(11)C]methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)pyridin-2-yl)-1H-indole as a potential PET radioligand for imaging cerebrala7-nAChR in mice.EBI Bioorg Med Chem 20: 3698-702 (2012) The Johns Hopkins University School of Medicine 2D 3D TSV
22608762 25 Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.EBI Eur J Med Chem 54: 123-36 (2012) Shanghai Institute of Pharmaceutical Industry 2D 3D TSV
22608393 64 Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists.EBI Bioorg Med Chem Lett 22: 3951-6 (2012) Bristol-Myers Squibb Research 2D 3D TSV
22608391 12 Towards a KCC2 blocker pharmacophore model.EBI Bioorg Med Chem Lett 22: 3978-82 (2012) UCB Pharma SA 2D 3D TSV
22607880 54 Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP).EBI Bioorg Med Chem 20: 3728-41 (2012) Gazi University 2D 3D TSV
22607877 38 Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.EBI Bioorg Med Chem 20: 3807-15 (2012) Shandong University 2D 3D TSV
22607697 1 Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.BDB Biochemistry 51: 4868-79 (2012) The University of Auckland 2D 3D TSV
22607684 50 7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s2) receptor ligands.EBI Bioorg Med Chem Lett 22: 4059-63 (2012) The University of Sydney 2D 3D TSV
22607683 19 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.EBI Bioorg Med Chem Lett 22: 4038-43 (2012) University of Texas Medical Branch 2D 3D TSV
22607682 47 Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor.EBI Bioorg Med Chem Lett 22: 4163-8 (2012) AstraZeneca 2D 3D TSV
22607677 8 Identification of chalcones as potent and selective PDE5A1 inhibitors.EBI Bioorg Med Chem Lett 22: 3983-7 (2012) Youai Co., Ltd 2D 3D TSV
22607676 47 Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists.EBI Bioorg Med Chem Lett 22: 3916-20 (2012) The Scripps Research Institute 2D 3D TSV
22607675 28 Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.EBI Bioorg Med Chem Lett 22: 3988-92 (2012) University of Lille 2D 3D TSV
22607673 34 Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.EBI Bioorg Med Chem Lett 22: 3921-5 (2012) Vanderbilt University Medical Center 2D 3D TSV
22607672 28 MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats.EBI Bioorg Med Chem Lett 22: 3941-5 (2012) Merck Research Laboratories 2D 3D TSV
22607670 34 Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.EBI Bioorg Med Chem Lett 22: 3967-72 (2012) University of Belgrade 2D 3D TSV
22607669 45 Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.EBI Bioorg Med Chem Lett 22: 4033-7 (2012) Biogen Idec Inc 2D 3D TSV
22607668 66 N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration.EBI Bioorg Med Chem Lett 22: 3884-9 (2012) AstraZeneca 2D 3D TSV
22607231 1 Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.EBI J Nat Prod 75: 1051-7 (2012) University of Southampton Faculty of Medicine 2D 3D TSV
22607152 7 Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.EBI J Med Chem 55: 6669-86 (2012) Universit£ degli Studi di Napoli Federico II 2D 3D TSV
22607122 38 Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy.EBI J Med Chem 55: 5483-96 (2012) Taiho Pharmaceutical Co., Ltd 2D 3D TSV
22606365 5 Non-iminosugar glucocerebrosidase small molecule chaperones.EBI Medchemcomm 3: 56-60 (2012) National Human Genome Research Institute 2D 3D TSV
22595177 14 Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening.EBI Bioorg Med Chem Lett 22: 4004-9 (2012) East China University of Science and Technology 2D 3D TSV
22595176 31 Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors.EBI Bioorg Med Chem Lett 22: 4089-93 (2012) Amgen Inc 2D 3D TSV
22595175 18 N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases.EBI Bioorg Med Chem Lett 22: 3993-7 (2012) University of Lisbon 2D 3D TSV
22595174 9 Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptase.EBI Bioorg Med Chem Lett 22: 4064-7 (2012) Yale University 2D 3D TSV
22595173 68 The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).EBI Bioorg Med Chem Lett 22: 3935-40 (2012) Pharmaxis Ltd. 2D 3D TSV
22594690 80 A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779.EBI J Med Chem 55: 5243-54 (2012) Cephalon Inc 2D 3D TSV
22594609 30 Structure-activity relationship study of selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101) and absolute configurational assignment using infrared and vibrational circEBI J Med Chem 55: 5403-12 (2012) University of Copenhagen 2D 3D TSV
22593037 8 Potent inhibition of human sulfotransferase 1A1 by 17a-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.EBI Drug Metab Dispos 40: 1588-95 (2012) University of Alabama at Birmingham 2D 3D TSV
22591730 22 Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening.EBI Bioorg Med Chem Lett 22: 4023-7 (2012) S*BIO Pte Ltd 2D 3D TSV
22591648 78 Evaluation of synthetic acridones and 4-quinolinones as potent inhibitors of cathepsins L and V.EBI Eur J Med Chem 54: 10-21 (2012) Universidade Federal de S£o Carlos 2D 3D TSV
22591441 29 Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling.EBI J Med Chem 55: 5536-45 (2012) Genentech 2D 3D TSV
22591402 127 Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors.EBI J Med Chem 55: 5901-21 (2012) Argenta Discovery Ltd 2D 3D TSV
22591317 5 Impacts of some antibiotics on human serum paraoxonase 1 activity.BDB J Enzyme Inhib Med Chem 28: 758-64 (2013) Atatürk University 2D 3D TSV
22591063 12 Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711).EBI J Med Chem 55: 4605-18 (2012) University of Berne 2D 3D TSV
22589534 28 Discovery of a Novel Allosteric Modulator of 5-HT3 Receptors: INHIBITION AND POTENTIATION OF CYS-LOOP RECEPTOR SIGNALING THROUGH A CONSERVED TRANSMEMBRANE INTERSUBUNIT SITE.BDB J Biol Chem 287: 25241-54 (2012) University of Copenhagen 2D 3D TSV
22587986 26 The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery.EBI Drug Metab Dispos 40: 1641-8 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22587443 55 Synthesis and structure-activity relationships of pyrazolo[1,5-a]pyridine derivatives: potent and orally active antagonists of corticotropin-releasing factor 1 receptor.EBI J Med Chem 55: 5255-69 (2012) Eisai Co., Ltd 2D 3D TSV
22583779 6 Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors.EBI Eur J Med Chem 53: 346-55 (2012) Universidad Aut£noma del Estado de Morelos 2D 3D TSV
22583669 1 Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors.EBI Bioorg Med Chem 20: 3746-55 (2012) Nanjing University 2D 3D TSV
22583618 8 Kappa agonist CovX-Bodies.EBI Bioorg Med Chem Lett 22: 4173-8 (2012) Pfizer Inc 2D 3D TSV
22583617 12 E297G mutated bile salt export pump (BSEP) function enhancers derived from GW4064: structural development study and separation from farnesoid X receptor-agonistic activity.EBI Bioorg Med Chem Lett 22: 3962-6 (2012) The University of Tokyo 2D 3D TSV
22583616 67 Identification of benzoxazole analogs as novel, S1P(3) sparing S1P(1) agonists.EBI Bioorg Med Chem Lett 22: 3973-7 (2012) GlaxoSmithKline 2D 3D TSV
22583019 6 Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.EBI J Med Chem 55: 5582-90 (2012) Technical University of Denmark 2D 3D TSV
22582973 21 Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds.EBI J Med Chem 55: 4978-89 (2012) Trinity College 2D 3D TSV
22582136 8 Hydrophobic Interactions Improve Selectivity to ERa for Ben-zothiophene SERMs.EBI ACS Med Chem Lett 3: 207-210 (2012) TBA 2D 3D TSV
22579620 36 Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.EBI Bioorg Med Chem 20: 3816-27 (2012) Peking University 2D 3D TSV
22579615 19 Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C.EBI Bioorg Med Chem 20: 3915-24 (2012) Universit£ de Li£ge 2D 3D TSV
22579487 53 Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors.EBI Bioorg Med Chem Lett 22: 4044-8 (2012) Korea Research Institute of Chemical Technology 2D 3D TSV
22579486 80 Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.EBI Bioorg Med Chem Lett 22: 4028-32 (2012) GlaxoSmithKline 2D 3D TSV
22579484 6 Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells.EBI Bioorg Med Chem Lett 22: 4094-9 (2012) Korea University 2D 3D TSV
22579422 31 Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.EBI Bioorg Med Chem Lett 22: 4153-8 (2012) Zalicus Pharmaceuticals Ltd 2D 3D TSV
22579420 45 Total synthesis and dual PPARa/¿ agonist effects of amorphastilbol and its synthetic derivatives.EBI Bioorg Med Chem Lett 22: 4122-6 (2012) Korea Institute of Science and Technology 2D 3D TSV
22579419 23 Depigmenting activities of kojic acid derivatives without tyrosinase inhibitory activities.EBI Bioorg Med Chem Lett 22: 4159-62 (2012) Hanyang University 2D 3D TSV
22578786 40 Microwave assisted synthesis of spirocyclic pyrrolidines -s1 receptor ligands with modified benzene-N-distance.EBI Eur J Med Chem 53: 327-36 (2012) Institut f£r Pharmazeutische und Medizinische Chemie 2D 3D TSV
22578490 35 Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.EBI Bioorg Med Chem 20: 3880-6 (2012) Cephalon Inc 2D 3D TSV
22578460 4 Identification of blapsins A and B as potent small-molecule 14-3-3 inhibitors from the insect Blaps japanensis.EBI Bioorg Med Chem Lett 22: 4179-81 (2012) Chinese Academy of Sciences 2D 3D TSV
22578458 84 Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors.EBI Bioorg Med Chem Lett 22: 4133-8 (2012) Merck Research Laboratories 2D 3D TSV
22575869 61 Structure-activity relationship of a series of non peptidic RGD integrin antagonists targetinga5ß1: part 1.EBI Bioorg Med Chem Lett 22: 4111-6 (2012) AstraZeneca 2D 3D TSV
22575532 2 Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors.EBI Eur J Med Chem 53: 229-34 (2012) Fudan University 2D 3D TSV
22575050 40 Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.EBI J Med Chem 55: 5337-49 (2012) Korea Advanced Institute of Science and Technology (KAIST) 2D 3D TSV
22575017 1 Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.EBI J Med Chem 55: 5121-9 (2012) University of Minnesota Health Sciences Center 2D 3D TSV
22574973 36 Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK1/NK3 antagonists.EBI J Med Chem 55: 5061-76 (2012) F. Hoffmann-La Roche Inc 2D 3D TSV
22572583 49 Structure guided P1' modifications of HEA derivedß-secretase inhibitors for the treatment of Alzheimer's disease.EBI Bioorg Med Chem Lett 22: 3607-11 (2012) Envoy Therapeutics 2D 3D TSV
22572580 26 Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents.EBI Bioorg Med Chem Lett 22: 3589-93 (2012) Nanjing University 2D 3D TSV
22572579 38 Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists.EBI Bioorg Med Chem Lett 22: 4148-52 (2012) Corning Inc. 2D 3D TSV
22572578 124 Structure-activity relationship of a series of non peptidic RGD integrin antagonists targetinga5ß1: part 2.EBI Bioorg Med Chem Lett 22: 4117-21 (2012) AstraZeneca 2D 3D TSV
22571451 46 Indole-2-carboxamides as allosteric modulators of the cannabinoid CB1 receptor.EBI J Med Chem 55: 5627-31 (2012) Sapienza University of Rome 2D 3D TSV
22570300 3 Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.BDB Chembiochem 13: 1291-6 (2012) Frederick National Laboratory for Cancer Research 2D 3D TSV
22568637 158 Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists.EBI J Med Chem 55: 5380-90 (2012) Universit£ di Ferrara 2D 3D TSV
22564381 27 Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists.EBI Bioorg Med Chem 20: 3429-45 (2012) Universit£ di Perugia 2D 3D TSV
22564380 624 Activity landscape modeling of PPAR ligands with dual-activity difference maps.EBI Bioorg Med Chem 20: 3523-32 (2012) Universidad Nacional Aut£noma de M£xico 2D 3D TSV
22564207 44 Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase.EBI J Med Chem 55: 4580-93 (2012) Cephalon Inc 2D 3D TSV
22563729 80 Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.EBI J Med Chem 55: 4640-51 (2012) University of Wisconsin-Milwaukee 2D 3D TSV
22563707 27 A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.EBI J Med Chem 55: 5311-25 (2012) Radboud University Nijmegen Medical Centre 2D 3D TSV
22560838 7 Radiosynthesis of a¹8F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.EBI Bioorg Med Chem 20: 3410-21 (2012) Helmholtz-Zentrum Dresden-Rossendorf 2D 3D TSV
22560627 70 2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines.EBI Eur J Med Chem 53: 254-63 (2012) Technische Universit£t Braunschweig 2D 3D TSV
22560585 16 Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.EBI Bioorg Med Chem Lett 22: 3639-42 (2012) Ajinomoto Pharmaceuticals Co. Ltd 2D 3D TSV
22560583 48 Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.EBI Bioorg Med Chem Lett 22: 3643-7 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22560567 82 Discovery of XL413, a potent and selective CDC7 inhibitor.EBI Bioorg Med Chem Lett 22: 3727-31 (2012) Exelixis Inc 2D 3D TSV
22560473 16 Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.EBI Bioorg Med Chem Lett 22: 3693-8 (2012) Vertex Pharmaceuticals Inc 2D 3D TSV
22560471 10 Use of libraries to access new chemical space: applications to CRTH2.EBI Bioorg Med Chem Lett 22: 3682-7 (2012) Pfizer Inc 2D 3D TSV
22560469 25 Synthesis and SAR of tetrahydroisoquinolines as Rev-erba agonists.EBI Bioorg Med Chem Lett 22: 3739-42 (2012) The Scripps Research Institute 2D 3D TSV
22559926 6 Preparation of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET kinase inhibitors.EBI J Med Chem 55: 4872-6 (2012) University of Gothenburg 2D 3D TSV
22559880 52 Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.EBI J Med Chem 55: 4847-60 (2012) National Institute of Diabetes and Digestive and Kidney Diseases 2D 3D TSV
22554495 10 Synthesis and in vitro characterization of trans- and cis-[(18)F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-D-aspartate receptor.EBI Eur J Med Chem 53: 408-15 (2012) Institute of Biomedical Imaging (I2BM) 2D 3D TSV
22554206 33 Discovery of pyrroloaminopyrazoles as novel PAK inhibitors.EBI J Med Chem 55: 4728-39 (2012) Pfizer Inc 2D 3D TSV
22552196 17 Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives.EBI Bioorg Med Chem Lett 22: 3800-6 (2012) Syngenta Crop Protection Muenchwilen AG 2D 3D TSV
22552195 34 Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.EBI Bioorg Med Chem Lett 22: 3688-92 (2012) Chosun University 2D 3D TSV
22552008 7 Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.BDB Leukemia 26: 2326-35 (2012) Celgene 2D 3D TSV
22551631 18 Automated generation of turn mimetics: proof of concept study for the MC4 receptor.EBI Bioorg Med Chem 20: 3565-74 (2012) Neurocrine Biosciences Inc 2D 3D TSV
22551629 72 Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.EBI Bioorg Med Chem 20: 3575-83 (2012) ZAFES/LiFF/OSF Goethe-University Frankfurt 2D 3D TSV
22551018 68 Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas.EBI J Med Chem 55: 5130-42 (2012) AstraZeneca 2D 3D TSV
22548457 60 Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists.EBI J Med Chem 55: 5391-402 (2012) Universit£ degli Studi di Siena 2D 3D TSV
22548439 9 Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer.EBI J Med Chem 55: 4776-87 (2012) Amgen Inc 2D 3D TSV
22548365 293 Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases.EBI J Med Chem 55: 5188-219 (2012) Amgen Inc 2D 3D TSV
22548342 210 Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase¿ inhibitors.EBI J Med Chem 55: 5467-82 (2012) Exelixis Inc 2D 3D TSV
22546675 24 Wake promoting agents: search for next generation modafinil, lessons learned: part III.EBI Bioorg Med Chem Lett 22: 3751-3 (2012) Cephalon Inc 2D 3D TSV
22546671 9 Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.EBI Bioorg Med Chem Lett 22: 3795-9 (2012) Pfizer Inc 2D 3D TSV
22546668 30 Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism.EBI Bioorg Med Chem Lett 22: 3656-60 (2012) Seoul National University 2D 3D TSV
22546206 162 Synthesis and evaluation of¿-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists.EBI Bioorg Med Chem 20: 3502-22 (2012) Minase Research Institute 2D 3D TSV
22546204 9 Recent developments and biological activities of thiazolidinone derivatives: a review.EBI Bioorg Med Chem 20: 3378-95 (2012) Dr. Hari Singh Gour University 2D 3D TSV
22545941 14 Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.BDB J Enzyme Inhib Med Chem 28: 717-26 (2013) Shandong University 2D 3D TSV
22545939 5 Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors.BDB J Enzyme Inhib Med Chem 28: 747-52 (2013) East China University of Science and Technology 2D 3D TSV
22545924 44 Targeting GSK3 from Ustilago maydis: Type-II Kinase Inhibitors as Potential Antifungals.BDB ACS Chem Biol 7: 1257-67 (2012) Technische Universität Dortmund 2D 3D TSV
22545772 100 Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.EBI J Med Chem 55: 5361-79 (2012) AstraZeneca 2D 3D TSV
22543028 39 Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.EBI Bioorg Med Chem Lett 22: 3671-5 (2012) Eli Lilly and Company 2D 3D TSV
22543026 6 Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives.EBI Bioorg Med Chem Lett 22: 3807-9 (2012) Clermont Universit£ 2D 3D TSV
22542283 2 Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.EBI Bioorg Med Chem 20: 3658-65 (2012) Kobe Pharmaceutical University 2D 3D TSV
22542282 25 Discovery of novel indane derivatives as liver-selective thyroid hormone receptorß (TRß) agonists for the treatment of dyslipidemia.EBI Bioorg Med Chem 20: 3622-34 (2012) Kissei Pharmaceutical Co., Ltd 2D 3D TSV
22542194 22 Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring.EBI Bioorg Med Chem Lett 22: 3392-7 (2012) Pfizer Inc 2D 3D TSV
22542107 14 Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease.EBI Eur J Med Chem 53: 13-21 (2012) University of KwaZulu-Natal 2D 3D TSV
22542019 44 Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards theß-exosite.EBI Bioorg Med Chem Lett 22: 3754-7 (2012) Fox Chase Chemical Diversity Center 2D 3D TSV
22542012 155 The design, synthesis, and biological evaluation of PIM kinase inhibitors.EBI Bioorg Med Chem Lett 22: 3732-8 (2012) Exelixis Inc 2D 3D TSV
22542010 31 Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.EBI Bioorg Med Chem Lett 22: 3781-5 (2012) Amgen Inc 2D 3D TSV
22542009 102 Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11ß-HSD1 inhibitors.EBI Bioorg Med Chem Lett 22: 3786-90 (2012) Amgen Inc 2D 3D TSV
22541394 30 Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors.EBI Eur J Med Chem 53: 390-7 (2012) Guru Ghasidas University 2D 3D TSV
22541393 1 A variant peptide of buffalo colostrumß-lactoglobulin inhibits angiotensin I-converting enzyme activity.EBI Eur J Med Chem 53: 211-9 (2012) University of Mysore 2D 3D TSV
22541068 73 Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.EBI J Med Chem 55: 4740-63 (2012) Uppsala University 2D 3D TSV
22541041 84 Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor.EBI J Med Chem 55: 4955-67 (2012) Eli Lilly and Company 2D 3D TSV
22540974 67 A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.EBI J Med Chem 55: 4714-27 (2012) University Hospital M£nster 2D 3D TSV
22540945 19 Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.EBI J Med Chem 55: 5151-64 (2012) The University of Tokyo 2D 3D TSV
22537682 6 Inverse Virtual Screening allows the discovery of the biological activity of natural compounds.EBI Bioorg Med Chem 20: 3596-602 (2012) Universit£ di Salerno 2D 3D TSV
22537678 8 3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate.EBI Bioorg Med Chem 20: 3173-9 (2012) Institute for Advanced Chemistry of Catalonia 2D 3D TSV
22537450 54 Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.EBI Bioorg Med Chem Lett 22: 3437-40 (2012) Gedeon Richter Plc 2D 3D TSV
22537178 5 Charting, navigating, and populating natural product chemical space for drug discovery.EBI J Med Chem 55: 5989-6001 (2012) Max Planck Institute of Molecular Physiology 2D 3D TSV
22537153 10 Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers.EBI J Med Chem 55: 5704-19 (2012) University of North Carolina at Chapel Hill 2D 3D TSV
22537109 25 Identification of a novel family of BRAF(V600E) inhibitors.EBI J Med Chem 55: 5220-30 (2012) University of Pennsylvania 2D 3D TSV
22536986 12 Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.EBI J Med Chem 55: 4189-204 (2012) Epichem Pty Ltd 2D 3D TSV
22536944 91 Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.EBI J Med Chem 55: 4457-78 (2012) Purdue University 2D 3D TSV
22534450 36 The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase.EBI Bioorg Med Chem Lett 22: 3387-91 (2012) Array BioPharma, Inc. 2D 3D TSV
22534184 87 Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptord agonists as potent anti-obesity agents in vivo.EBI Eur J Med Chem 53: 190-202 (2012) Seoul National University 2D 3D TSV
22533986 181 Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors.EBI J Med Chem 55: 5291-310 (2012) ArQule Inc 2D 3D TSV
22533905 2 Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1).EBI J Med Chem 55: 4683-99 (2012) The State University of New York 2D 3D TSV
22533875 11 Mitigating heterocycle metabolism in drug discovery.EBI J Med Chem 55: 6002-20 (2012) Amgen Inc 2D 3D TSV
22533818 84 Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3a.EBI J Med Chem 55: 4407-24 (2012) Technische Universit£t Darmstadt 2D 3D TSV
22533316 10 Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.EBI J Med Chem 55: 4990-5002 (2012) Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) 2D 3D TSV
22531045 2 In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.EBI Drug Metab Dispos 40: 1263-7 (2012) Amgen Inc 2D 3D TSV
22525315 1 Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata.EBI Bioorg Med Chem Lett 22: 3398-401 (2012) Griffith University 2D 3D TSV
22525314 159 Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.EBI Bioorg Med Chem Lett 22: 3412-7 (2012) University of Antwerp (UA) 2D 3D TSV
22525313 30 Tetrahydro-naphthols as orally available TRPV1 inhibitors.EBI Bioorg Med Chem Lett 22: 3408-11 (2012) Bayer Yakuhin, Ltd 2D 3D TSV
22524677 6 Interaction of superoxide dismutase with the glycine zipper regions of ß-amyloid peptides: is there an implication towards Alzheimer's disease and oxidative stress?BDB J Enzyme Inhib Med Chem 28: 727-33 (2013) Rhodes University 2D 3D TSV
22524676 8 The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors.BDB J Enzyme Inhib Med Chem 28: 741-6 (2013) East China University of Science and Technology 2D 3D TSV
22524527 13 Structure-based design of novel inhibitors of the MDM2-p53 interaction.EBI J Med Chem 55: 4936-54 (2012) Amgen Inc 2D 3D TSV
22524450 24 Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.EBI J Med Chem 55: 4142-58 (2012) Universit£ di Napoli Federico II 2D 3D TSV
22524426 281 Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kß inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers.EBI J Med Chem 55: 4788-805 (2012) Sanofi Research & Development 2D 3D TSV
22524250 12 Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.EBI J Med Chem 55: 4244-73 (2012) Genomics Institute of the Novartis Research Foundation 2D 3D TSV
22523618 16 Synthesis and Evaluation of Metabotropic Glutamate Receptor Subtype 5 Antagonists Based on Fenobam().EBI ACS Med Chem Lett 2: 882-884 (2011) TBA 2D 3D TSV
22522748 1 Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.EBI Drug Metab Dispos 40: 1441-8 (2012) Pfizer Inc 2D 3D TSV
22522007 102 Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.EBI Bioorg Med Chem 20: 3255-62 (2012) Colorado State University 2D 3D TSV
22521647 56 Conjugates of 5-isoquinolinesulfonylamides and oligo-D-arginine possess high affinity and selectivity towards Rho kinase (ROCK).EBI Bioorg Med Chem Lett 22: 3425-30 (2012) University of Tartu 2D 3D TSV
22521646 38 Novel triazolopyridylbenzamides as potent and selective p38a inhibitors.EBI Bioorg Med Chem Lett 22: 3431-6 (2012) Rhône-Poulenc Rorer 2D 3D TSV
22520630 21 Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.EBI Bioorg Med Chem 20: 3359-67 (2012) Nanjing University 2D 3D TSV
22520259 65 Identification of ETP-46321, a potent and orally bioavailable PI3Ka,d inhibitor.EBI Bioorg Med Chem Lett 22: 3460-6 (2012) Spanish National Cancer Research Centre (CNIO) 2D 3D TSV
22520153 135 Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants.EBI Eur J Med Chem 53: 124-32 (2012) Florida A&M University 2D 3D TSV
22519963 80 Discovery of a potent and selective GPR120 agonist.EBI J Med Chem 55: 4511-5 (2012) University of Southern Denmark 2D 3D TSV
22517972 40 Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme.EBI Drug Metab Dispos 40: 1429-40 (2012) Amgen Inc 2D 3D TSV
22516672 47 Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.EBI Bioorg Med Chem 20: 3306-16 (2012) University of Mansoura 2D 3D TSV
22516424 7 The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease.EBI Eur J Med Chem 53: 374-9 (2012) University of Belgrade 2D 3D TSV
22516282 23 Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells.EBI Bioorg Med Chem Lett 22: 3567-70 (2012) The University of Arizona 2D 3D TSV
22516281 10 Practical access to four stereoisomers of naftidrofuryl and their binding affinity towards 5-hydroxytryptamine 2A receptor.EBI Bioorg Med Chem Lett 22: 3441-4 (2012) China Pharmaceutical University 2D 3D TSV
22515405 39 Thiophene bioisosteres of spirocyclics receptor ligands: relationships between substitution pattern ands receptor affinity.EBI J Med Chem 55: 5350-60 (2012) Institut f£r Pharmazeutische und Medizinische Chemie der Universit£t M£nster 2D 3D TSV
22515328 17 N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.EBI J Med Chem 55: 4824-36 (2012) Universit£ degli Studi di Urbino Carlo Bo 2D 3D TSV
22512908 6 Synthesis,s1,s2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes.EBI Bioorg Med Chem 20: 3323-31 (2012) National and Kapodistrian University of Athens 2D 3D TSV
22512907 49 Discovery of potent and orally bioavailable 17ß-hydroxysteroid dehydrogenase type 3 inhibitors.EBI Bioorg Med Chem 20: 3242-54 (2012) Sumitomo Chemical Co., Ltd 2D 3D TSV
22512727 20 Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives.BDB J Enzyme Inhib Med Chem 28: 299-304 (2013) Inonu University 2D 3D TSV
22512696 61 Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.EBI J Med Chem 55: 4479-88 (2012) Institut de Qu£mica Avan£ada de Catalunya (IQAC-CSIC) 2D 3D TSV
22512543 72 Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors.EBI J Med Chem 55: 4309-21 (2012) China Pharmaceutical University 2D 3D TSV
22512505 3 Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.EBI J Med Chem 55: 4373-81 (2012) Showa Pharmaceutical University 2D 3D TSV
22512468 13 Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia.EBI J Med Chem 55: 5649-75 (2012) Zydus Research Centre 2D 3D TSV
22511346 1 Interaction of lapatinib with cytochrome P450 3A5.EBI Drug Metab Dispos 40: 1414-22 (2012) National University of Singapore 2D 3D TSV
22507964 17 Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer.EBI Bioorg Med Chem Lett 22: 3492-7 (2012) Perelman School of Medicine University of Pennsylvania 2D 3D TSV
22507963 73 Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.EBI Bioorg Med Chem Lett 22: 3467-72 (2012) Vanderbilt University Medical Center 2D 3D TSV
22507962 4 The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.EBI Bioorg Med Chem Lett 22: 3498-502 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22507960 26 Synthesis and acrosin inhibitory activity of methyl 5-substituted-1H-benzo[d]imidazol-2-yl carbamate derivatives.EBI Bioorg Med Chem Lett 22: 3554-9 (2012) Second Military Medical University 2D 3D TSV
22507206 21 Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus.EBI Bioorg Med Chem 20: 3263-79 (2012) Astellas Pharma Inc 2D 3D TSV
22506594 20 Selective inhibition of human type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.EBI J Nat Prod 75: 716-21 (2012) Gifu Pharmaceutical University 2D 3D TSV
22506561 68 Novel steroid inhibitors of glucose 6-phosphate dehydrogenase.EBI J Med Chem 55: 4431-45 (2012) University of Manchester 2D 3D TSV
22506516 29 Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions.EBI J Med Chem 55: 4594-604 (2012) Argenta Discovery Ltd 2D 3D TSV
22506484 6 Structural modifications that alter the P-glycoprotein efflux properties of compounds.EBI J Med Chem 55: 4877-95 (2012) Envoy Therapeutics 2D 3D TSV
22506091 151 Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure.EBI ACS Med Chem Lett 3: 294-298 (2012) TBA 2D 3D TSV
22503460 37 Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR)¿ Agonists.EBI Bioorg Med Chem 20: 3332-58 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22503453 59 The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement.EBI Bioorg Med Chem Lett 22: 3531-4 (2012) GlaxoSmithKline 2D 3D TSV
22503362 35 New description of protein-ligand interactions using a spherical self-organizing map.EBI Bioorg Med Chem 20: 5410-5 (2012) Chugai Pharmaceutical Company 2D 3D TSV
22503250 128 Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity.EBI Bioorg Med Chem Lett 22: 3544-9 (2012) AMRI 2D 3D TSV
22503249 149 Modulation of thermo-transient receptor potential (thermo-TRP) channels by thymol-based compounds.EBI Bioorg Med Chem Lett 22: 3535-9 (2012) Sapienza University of Rome 2D 3D TSV
22503248 61 Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition.EBI Bioorg Med Chem Lett 22: 3560-3 (2012) GlaxoSmithKline 2D 3D TSV
22503246 32 Long-acting peptidomimetics based DPP-IV inhibitors.EBI Bioorg Med Chem Lett 22: 3516-21 (2012) Zydus Research Centre 2D 3D TSV
22503231 66 Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.EBI Eur J Med Chem 52: 251-62 (2012) Laboratorio de Radicales Libres y Qu�mica Computacional (IQOG, CSIC) 2D 3D TSV
22500977 30 De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.EBI J Med Chem 55: 4159-68 (2012) Princeton University 2D 3D TSV
22500954 99 Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).EBI J Med Chem 55: 4286-96 (2012) GlaxoSmithKline 2D 3D TSV
22497764 3 Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities.EBI Bioorg Med Chem Lett 22: 3067-71 (2012) LG Life Sciences R & D Center 2D 3D TSV
22497763 120 Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.EBI Bioorg Med Chem Lett 22: 3163-7 (2012) Dr. Reddy's Laboratories Ltd 2D 3D TSV
22497762 35 Triazoloamides as potent¿-secretase modulators with reduced hERG liability.EBI Bioorg Med Chem Lett 22: 3140-6 (2012) Merck Research Laboratories 2D 3D TSV
22497761 59 Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors.EBI Bioorg Med Chem Lett 22: 3056-62 (2012) Eli Lilly and Company 2D 3D TSV
22497760 144 Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases.EBI Bioorg Med Chem Lett 22: 3050-5 (2012) AstraZeneca 2D 3D TSV
22497444 55 Discovery and characterization of an inhibitor of glucosylceramide synthase.EBI J Med Chem 55: 4322-35 (2012) Exelixis Inc 2D 3D TSV
22496391 40 Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition/induction profile of saxagliptin in human.EBI Drug Metab Dispos 40: 1345-56 (2012) Bristol-Myers Squibb Research 2D 3D TSV
22494842 18 The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.EBI Bioorg Med Chem 20: 2845-9 (2012) Merck Research Laboratories 2D 3D TSV
22494098 8 Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).EBI J Med Chem 55: 3934-44 (2012) Caprotec Bioanalytics GmbH 2D 3D TSV
22490229 7 Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.EBI Drug Metab Dispos 40: 1328-35 (2012) University of Michigan 2D 3D TSV
22490067 69 Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent.EBI J Med Chem 55: 3960-74 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22490048 59 Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.EBI J Med Chem 55: 4336-51 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22490010 8 A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1a,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3.EBI J Med Chem 55: 4352-66 (2012) University of Wisconsin-Madison 2D 3D TSV
22489952 38 Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein.EBI J Med Chem 55: 4506-10 (2012) Universit£ di Salerno 2D 3D TSV
22489897 41 Discovery of novel potent and highly selective glycogen synthase kinase-3ß (GSK3ß) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines.EBI J Med Chem 55: 9107-19 (2012) AstraZeneca 2D 3D TSV
22487182 102 Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists.EBI Bioorg Med Chem Lett 22: 3157-62 (2012) Dr. Reddy's Laboratories Ltd 2D 3D TSV
22487179 50 Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists.EBI Bioorg Med Chem Lett 22: 3083-8 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22487176 109 Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins.EBI Bioorg Med Chem Lett 22: 3063-6 (2012) Universit£ degli Studi di Cagliari 2D 3D TSV
22487174 36 Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation.EBI Bioorg Med Chem Lett 22: 3223-8 (2012) Glenmark Pharmaceuticals Limited 2D 3D TSV
22486710 3 Head-to-head prenyl tranferases: anti-infective drug targets.EBI J Med Chem 55: 4367-72 (2012) University of Illinois at Urbana-Champaign 2D 3D TSV
22486652 44 Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.EBI J Med Chem 55: 4297-308 (2012) National Institute of Diabetes and Digestive and Kidney Diseases 2D 3D TSV
22483967 38 Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.EBI Eur J Med Chem 52: 284-94 (2012) Universit£ di Pisa 2D 3D TSV
22483635 1 Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.EBI Eur J Med Chem 52: 275-83 (2012) CNRS 2D 3D TSV
22483609 52 Lead optimization of 4,4-biaryl piperidine amides as ?-secretase inhibitors.EBI Bioorg Med Chem Lett 22: 3203-7 (2012) Merck Research Laboratories 2D 3D TSV
22483608 2 Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents.EBI Bioorg Med Chem Lett 22: 3122-5 (2012) Sichuan University 2D 3D TSV
22483591 12 Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits.EBI Bioorg Med Chem 20: 2930-9 (2012) Piramal Healthcare Limited 2D 3D TSV
22483590 5 Radiofluorinated histamine H3 receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation.EBI Bioorg Med Chem 20: 2889-96 (2012) ETH Zurich (Swiss Federal Institute of Technology) 2D 3D TSV
22483586 10 Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.EBI Bioorg Med Chem Lett 22: 3261-4 (2012) Sun Yat-sen University 2D 3D TSV
22483585 28 Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.EBI Bioorg Med Chem Lett 22: 3095-9 (2012) Gedeon Richter Plc 2D 3D TSV
22483584 3 Development of rationally designed DNA N6 adenine methyltransferase inhibitors.EBI Bioorg Med Chem Lett 22: 3079-82 (2012) University of Southampton 2D 3D TSV
22483582 3 Discovery of small molecule HIV-1 integrase dimerization inhibitors.EBI Bioorg Med Chem Lett 22: 3109-14 (2012) University of Siena 2D 3D TSV
22483390 8 An approach for differentiating isozymes. Construction of libraries containing short aromatic peptides as part of a method to design selective inhibitors against lipases.EBI Bioorg Med Chem Lett 22: 3147-51 (2012) Seoul National University 2D 3D TSV
22483089 2 Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.EBI Eur J Med Chem 52: 70-81 (2012) Sichuan University 2D 3D TSV
22482720 8 Pentachlorophenol hydroxylase, a poorly functioning enzyme required for degradation of pentachlorophenol by Sphingobium chlorophenolicum.BDB Biochemistry 51: 3848-60 (2012) University of Colorado Boulder 2D 3D TSV
22480851 6 Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinasea (PI3Ka) inhibitors.EBI Bioorg Med Chem 20: 2837-44 (2012) Zhejiang University 2D 3D TSV
22480850 4 Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.EBI Bioorg Med Chem 20: 3119-27 (2012) YB Chavan College of Pharmacy 2D 3D TSV
22475926 39 Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.EBI Bioorg Med Chem 20: 2912-22 (2012) University of Hacettepe 2D 3D TSV
22475866 19 Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.EBI Eur J Med Chem 52: 205-12 (2012) Chinese Academy of Sciences 2D 3D TSV
22475561 42 Synthesis and inhibitory effect of piperine derivates on monoamine oxidase.EBI Bioorg Med Chem Lett 22: 3343-8 (2012) General Hospital of PLA 2D 3D TSV
22475558 82 Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone.EBI Bioorg Med Chem Lett 22: 3311-6 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22475557 75 Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potentß isoform selective phosphatidylinositol 3-kinase inhibitors.EBI Bioorg Med Chem Lett 22: 3198-202 (2012) GlaxoSmithKline 2D 3D TSV
22475308 3 Bis-spirolabdane diterpenoids from Leonotis nepetaefolia.EBI J Nat Prod 75: 728-34 (2012) University of Mississippi 2D 3D TSV
22475216 13 New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.EBI J Med Chem 55: 3992-4002 (2012) University of Coimbra 2D 3D TSV
22472693 17 Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques.EBI Bioorg Med Chem Lett 22: 3181-7 (2012) China Pharmaceutical University 2D 3D TSV
22472167 11 Studies on gambogic acid (IV): Exploring structure-activity relationship with I¿B kinase-beta (IKKß).EBI Eur J Med Chem 51: 110-23 (2012) China Pharmaceutical University 2D 3D TSV
22472046 40 Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.EBI Bioorg Med Chem 20: 3038-48 (2012) Sun Yat-sen University 2D 3D TSV
22469703 32 Isoquinoline derivatives as potent CRTH2 receptor antagonists: synthesis and SAR.EBI Bioorg Med Chem Lett 22: 3305-10 (2012) Taisho Pharmaceutical Co., Ltd 2D 3D TSV
22469702 36 Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis.EBI Bioorg Med Chem Lett 22: 3349-53 (2012) MRC Technology 2D 3D TSV
22468999 20 Discovery and optimization of a novel spiropyrrolidine inhibitor ofß-secretase (BACE1) through fragment-based drug design.EBI J Med Chem 55: 9069-88 (2012) Pfizer Inc 2D 3D TSV
22468970 2 Development of a novel class of glucose transporter inhibitors.EBI J Med Chem 55: 3827-36 (2012) The Ohio State University 2D 3D TSV
22468936 49 Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789).EBI J Med Chem 55: 4806-23 (2012) Siena Biotech SpA 2D 3D TSV
22468757 171 Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications.EBI J Med Chem 55: 5676-703 (2012) Universit£ di Ferrara 2D 3D TSV
22468751 2 Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor.BDB J Enzyme Inhib Med Chem 28: 661-70 (2013) Federal University of São Paulo 2D 3D TSV
22468750 3 Tyrosinase inhibitory activities of the compounds isolated from Neolitsea aciculata (Blume) Koidz.BDB J Enzyme Inhib Med Chem 28: 685-9 (2013) Jeju National University 2D 3D TSV
22468746 10 (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors.BDB J Enzyme Inhib Med Chem 28: 402-6 (2013) Atatürk University 2D 3D TSV
22468684 76 Design and synthesis of potent, orally efficacious hydroxyethylamine derivedß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors.EBI J Med Chem 55: 9025-44 (2012) Amgen Inc 2D 3D TSV
22468639 26 Design and preparation of a potent series of hydroxyethylamine containingß-secretase inhibitors that demonstrate robust reduction of centralß-amyloid.EBI J Med Chem 55: 9009-24 (2012) Amgen Inc 2D 3D TSV
22465637 48 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators.EBI Bioorg Med Chem Lett 22: 3235-9 (2012) Lundbeck Research USA, Inc. 2D 3D TSV
22465636 125 Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).EBI Bioorg Med Chem Lett 22: 3291-5 (2012) Merck Research Laboratories 2D 3D TSV
22465635 95 Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.EBI Bioorg Med Chem Lett 22: 3208-12 (2012) Abbott Laboratories 2D 3D TSV
22465091 28 A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study.EBI Eur J Med Chem 52: 111-22 (2012) Dalian University of Technology 2D 3D TSV
22464687 44 Discovery of novel tricyclic compounds as squalene synthase inhibitors.EBI Bioorg Med Chem 20: 3072-93 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22464684 85 Semisynthetic neoclerodanes as kappa opioid receptor probes.EBI Bioorg Med Chem 20: 3100-10 (2012) The University of Kansas 2D 3D TSV
22464458 8 Novel acridinedione derivatives: design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies.EBI Bioorg Med Chem Lett 22: 3256-60 (2012) Birla Institute of Technology 2D 3D TSV
22464456 27 X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase.EBI Bioorg Med Chem Lett 22: 3296-300 (2012) Sanofi US 2D 3D TSV
22464134 1 Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors.EBI Bioorg Med Chem Lett 22: 3248-55 (2012) CiVentiChem (India) Private Limited 2D 3D TSV
22464133 5 Penicacids A-C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07.EBI Bioorg Med Chem Lett 22: 3332-5 (2012) Chinese Academy of Sciences 2D 3D TSV
22464132 8 Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.EBI Bioorg Med Chem Lett 22: 3244-7 (2012) University of Virginia 2D 3D TSV
22464131 1 Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors.EBI Bioorg Med Chem Lett 22: 3284-6 (2012) Beijing Institute of Biotechnology 2D 3D TSV
22464130 27 Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists.EBI Bioorg Med Chem Lett 22: 3354-7 (2012) Merck Research Laboratories 2D 3D TSV
22460951 7 Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.EBI Nature 485: 62-68 (2012) The Scripps Research Institute 2D 3D TSV
22460033 85 Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.EBI Bioorg Med Chem Lett 22: 3327-31 (2012) Cylene Pharmaceuticals 2D 3D TSV
22460029 21 Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.EBI Bioorg Med Chem Lett 22: 3366-9 (2012) GlaxoSmithKline 2D 3D TSV
22460026 39 Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.EBI Bioorg Med Chem Lett 22: 2775-9 (2012) Kitasato University 2D 3D TSV
22460025 12 The chemical synthesis of metabolically stabilized 2-OMe-LPA analogues and preliminary studies of their inhibitory activity toward autotaxin.EBI Bioorg Med Chem Lett 22: 2698-700 (2012) Technical University of Lodz 2D 3D TSV
22459213 29 Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators.EBI Bioorg Med Chem 20: 2982-91 (2012) Chinese Academy of Sciences 2D 3D TSV
22459212 12 Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.EBI Bioorg Med Chem 20: 2992-9 (2012) Chinese Academy of Medical Sciences & Peking Union Medical College 2D 3D TSV
22458611 16 Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres.EBI J Med Chem 55: 3900-10 (2012) University of Trieste 2D 3D TSV
22458568 37 Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction.EBI J Med Chem 55: 3837-51 (2012) Amgen Inc 2D 3D TSV
22458531 58 Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.EBI J Med Chem 55: 3804-13 (2012) Progen Pharmaceuticals Limited 2D 3D TSV
22455789 32 Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.EBI Bioorg Med Chem 20: 2506-19 (2012) University of Bath 2D 3D TSV
22455444 93 Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.EBI J Med Chem 55: 4114-22 (2012) Max Planck Institute of Psychiatry 2D 3D TSV
22455398 122 Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.EBI J Med Chem 55: 4123-31 (2012) Max Planck Institute of Psychiatry 2D 3D TSV
22455383 16 Computational design and discovery of"minimally structured" hERG blockers.EBI J Med Chem 55: 4010-4 (2012) University of Bologna 2D 3D TSV
22455312 43 Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.EBI J Med Chem 55: 3101-12 (2012) National Center for Advancing Translational Sciences 2D 3D TSV
22452568 2 Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases.EBI J Med Chem 55: 3814-26 (2012) University of Michigan 2D 3D TSV
22452518 22 Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo.EBI J Med Chem 55: 3852-66 (2012) Sichuan University 2D 3D TSV
22452412 31 Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.EBI J Med Chem 55: 3261-73 (2012) University of Vienna 2D 3D TSV
22450133 64 Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists.EBI Bioorg Med Chem Lett 22: 2807-10 (2012) Cephalon Inc 2D 3D TSV
22450131 8 A new pancreatic lipase inhibitor from Broussonetia kanzinoki.EBI Bioorg Med Chem Lett 22: 2760-3 (2012) Chungbuk National University 2D 3D TSV
22450130 87 Design and synthesis of potent, isoxazole-containing renin inhibitors.EBI Bioorg Med Chem Lett 22: 2670-4 (2012) Merck Frosst Centre for Therapeutic Research 2D 3D TSV
22450128 38 Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.EBI Bioorg Med Chem Lett 22: 2837-42 (2012) Korea Research Institute of Chemical Technology 2D 3D TSV
22450127 64 Pyrazolopyrimidines as dual Akt/p70S6K inhibitors.EBI Bioorg Med Chem Lett 22: 2693-7 (2012) Exelixis Inc 2D 3D TSV
22449023 9 Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).EBI J Med Chem 55: 3792-803 (2012) Johann Wolfgang Goethe University 2D 3D TSV
22449016 6 Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.EBI J Med Chem 55: 3193-200 (2012) BMSSI UMR 5086 CNRS/Universit£ Lyon 1 2D 3D TSV
22448988 77 Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.EBI J Med Chem 55: 4664-82 (2012) University of Michigan 2D 3D TSV
22448770 1 Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors.EBI J Med Chem 55: 3135-43 (2012) Chinese Academy of Sciences 2D 3D TSV
22446520 1 Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver.EBI Drug Metab Dispos 40: 1080-4 (2012) Kanazawa University 2D 3D TSV
22445674 43 Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits.EBI Bioorg Med Chem 20: 2595-602 (2012) Graduate School of Gyeongsang National University 2D 3D TSV
22445286 19 Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor.EBI Bioorg Med Chem Lett 22: 2738-43 (2012) Pfizer Inc 2D 3D TSV
22445285 26 Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.EBI Bioorg Med Chem Lett 22: 2689-92 (2012) Kitasato University 2D 3D TSV
22444876 34 Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.EBI Bioorg Med Chem 20: 2527-34 (2012) Sun Yat-sen University 2D 3D TSV
22444875 25 Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.EBI Bioorg Med Chem 20: 2603-13 (2012) Northern Kentucky University 2D 3D TSV
22444685 45 A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes.EBI Bioorg Med Chem Lett 22: 2818-22 (2012) Merck Research Laboratories 2D 3D TSV
22444684 9 Bromophenols as inhibitors of protein tyrosine phosphatase 1B with antidiabetic properties.EBI Bioorg Med Chem Lett 22: 2827-32 (2012) Chinese Academy of Sciences 2D 3D TSV
22444683 68 A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation.EBI Bioorg Med Chem Lett 22: 2811-7 (2012) Merck Research Laboratories 2D 3D TSV
22444679 2 Radioiodinated sunitinib as a potential radiotracer for imaging angiogenesis-radiosynthesis and first radiopharmacological evaluation of 5-[125I]Iodo-sunitinib.EBI Bioorg Med Chem Lett 22: 2850-5 (2012) Helmholtz-Zentrum Dresden-Rossendorf eV 2D 3D TSV
22444677 45 Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent.EBI Bioorg Med Chem Lett 22: 2803-6 (2012) Shionogi & Co., Ltd 2D 3D TSV
22444026 103 Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies.EBI Eur J Med Chem 52: 1-13 (2012) Universidad de Navarra 2D 3D TSV
22443141 115 Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors.EBI J Med Chem 55: 3891-9 (2012) Universit£ di Messina 2D 3D TSV
22443115 4 In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.EBI J Med Chem 55: 4231-43 (2012) Universidad de Granada 2D 3D TSV
22442751 45 Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A.EBI Medchemcomm 2: 1217-1222 (2011) University of Kansas 2D 3D TSV
22440859 176 Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.EBI Eur J Med Chem 51: 259-70 (2012) Vilnius University 2D 3D TSV
22440625 44 Synthesis and evaluation of piperidine urea derivatives as efficacious 11ß-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice.EBI Bioorg Med Chem Lett 22: 2748-52 (2012) Chinese Academy of Sciences 2D 3D TSV
22439974 79 Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders.EBI J Med Chem 55: 3975-91 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22439881 157 Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.EBI J Med Chem 55: 3878-90 (2012) Harvard Medical School 2D 3D TSV
22439863 21 Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo.EBI J Med Chem 55: 3777-91 (2012) Taipei Medical University 2D 3D TSV
22439843 32 Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.EBI J Med Chem 55: 3578-82 (2012) Imperial College 2D 3D TSV
22437830 8 Selective inhibition of biotin protein ligase from Staphylococcus aureus.BDB J Biol Chem 287: 17823-32 (2012) University of Adelaide 2D 3D TSV
22437117 47 Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.EBI Bioorg Med Chem Lett 22: 2730-3 (2012) GlaxoSmithKline 2D 3D TSV
22437115 66 Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).EBI Bioorg Med Chem Lett 22: 2968-72 (2012) GlaxoSmithKline 2D 3D TSV
22437111 34 CB 1/2 dual agonists with 3-carbamoyl 2-pyridone derivatives as antipruritics: reduction of CNS side effects by introducing polar functional groups.EBI Bioorg Med Chem Lett 22: 2894-7 (2012) Shionogi & Co., Ltd 2D 3D TSV
22437109 31 2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1.EBI Bioorg Med Chem Lett 22: 2880-4 (2012) S*BIO Pte Ltd 2D 3D TSV
22436396 30 Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step.EBI Eur J Med Chem 51: 216-26 (2012) Universit£ di Salerno 2D 3D TSV
22436387 4 Synthesis and evaluation of [¹8F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).EBI Bioorg Med Chem 20: 3065-71 (2012) Karolinska Institutet 2D 3D TSV
22435740 43 (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.EBI J Med Chem 55: 3644-66 (2012) Arena Pharmaceuticals 2D 3D TSV
22435669 16 Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead.EBI J Med Chem 55: 3066-75 (2012) Nankai University 2D 3D TSV
22435599 4 Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.EBI J Med Chem 55: 4205-19 (2012) St. Jude Children's Research Hospital 2D 3D TSV
22432713 64 Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.EBI J Med Chem 55: 3521-34 (2012) Monash University 2D 3D TSV
22432682 2 Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.EBI J Med Chem 55: 3568-72 (2012) Universit£ degli Studi di Perugia 2D 3D TSV
22429471 64 Calcitonin gene-related peptide (CGRP) receptor antagonists: novel aspartates and succinates.EBI Bioorg Med Chem Lett 22: 2912-6 (2012) Bristol-Myers Squibb Research & Development 2D 3D TSV
22429470 75 Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group.EBI Bioorg Med Chem Lett 22: 2917-21 (2012) Bristol-Myers Squibb Research & Development 2D 3D TSV
22429469 2 Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active¿-secretase modulators.EBI Bioorg Med Chem Lett 22: 2906-11 (2012) Pfizer Inc 2D 3D TSV
22429468 60 Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists.EBI Bioorg Med Chem Lett 22: 2794-7 (2012) GlaxoSmithKline 2D 3D TSV
22429467 2 Medicinal chemistry approaches to avoid aldehyde oxidase metabolism.EBI Bioorg Med Chem Lett 22: 2856-60 (2012) Pfizer Inc 2D 3D TSV
22428944 61 Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes.EBI J Med Chem 55: 3756-76 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22425563 16 Prospective acetylcholinesterase inhibitory activity of indole and its analogs.EBI Bioorg Med Chem Lett 22: 2885-8 (2012) Naresuan University 2D 3D TSV
22425453 43 Pyrazine-based Syk kinase inhibitors.EBI Bioorg Med Chem Lett 22: 2784-8 (2012) Rhône-Poulenc Rorer 2D 3D TSV
22425346 28 Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors.EBI Bioorg Med Chem 20: 2721-38 (2012) Emory University 2D 3D TSV
22425031 1 Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction.EBI Eur J Med Chem 51: 286-93 (2012) Universit£ de Rennes1 2D 3D TSV
22424979 10 Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.EBI Bioorg Med Chem Lett 22: 2866-71 (2012) Bristol-Myers Squibb 2D 3D TSV
22424978 23 Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.EBI Bioorg Med Chem Lett 22: 2843-9 (2012) Advinus Therapeutics Ltd 2D 3D TSV
22424975 4 Sesquiterpene lactones from Tithonia diversifolia act as peroxisome proliferator-activated receptor agonists.EBI Bioorg Med Chem Lett 22: 2954-8 (2012) National Kaohsiung Normal University 2D 3D TSV
22424974 35 Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists.EBI Bioorg Med Chem Lett 22: 2943-7 (2012) Pfizer Inc 2D 3D TSV
22424612 29 Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.EBI Eur J Med Chem 51: 184-92 (2012) VU University Amsterdam 2D 3D TSV
22424300 3 Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma.EBI J Nat Prod 75: 784-8 (2012) Korea University 2D 3D TSV
22424239 42 Molecular cloning, characterization, and inhibition studies of aß-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.EBI J Med Chem 55: 3513-20 (2012) Union Life Sciences Ltd. 2D 3D TSV
22421276 1 Tyrosine modified analogues of thea4ß7 integrin inhibitor biotin-R8ERY prepared via Click Chemistry: synthesis and biological evaluation.EBI Bioorg Med Chem 20: 2638-44 (2012) University of Auckland 2D 3D TSV
22421020 9 Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain.EBI Bioorg Med Chem Lett 22: 2932-7 (2012) Merck Research Laboratories 2D 3D TSV
22421019 62 Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent.EBI Bioorg Med Chem Lett 22: 2898-901 (2012) Shionogi & Co., Ltd 2D 3D TSV
22421018 34 The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.EBI Bioorg Med Chem Lett 22: 2922-6 (2012) Janssen Pharmaceutica NV 2D 3D TSV
22420884 21 Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active ?-secretase inhibitor.EBI J Med Chem 55: 3414-24 (2012) Pfizer Inc. 2D 3D TSV
22420844 86 First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.EBI J Med Chem 55: 3488-501 (2012) NeurAxon Inc 2D 3D TSV
22420827 14 Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases.EBI J Med Chem 55: 3588-92 (2012) Huazhong University of Science and Technology 2D 3D TSV
22420626 4 Design of ?-amyloid aggregation inhibitors from a predicted structural motif.EBI J Med Chem 55: 3002-10 (2012) Stanford University 2D 3D TSV
22418280 5 Development of clickable active site-directed photoaffinity probes for ?-secretase.EBI Bioorg Med Chem Lett 22: 2997-3000 (2012) Memorial Sloan-Kettering Cancer Center 2D 3D TSV
22417091 73 Design and synthesis of novel lactate dehydrogenase a inhibitors by fragment-based lead generation.BDB J Med Chem 55: 3285-306 (2012) AstraZeneca 2D 3D TSV
22414679 12 Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity.EBI Bioorg Med Chem 20: 2624-37 (2012) King Abdulaziz University 2D 3D TSV
22414613 6 Synthesis and biological evaluation of novel small non-peptidic HIV-1 PIs: the benzothiophene ring as an effective moiety.EBI Bioorg Med Chem Lett 22: 2948-50 (2012) Universit£ degli Studi della Basilicata 2D 3D TSV
22413863 21 Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).EBI J Med Chem 55: 4101-13 (2012) Genentech 2D 3D TSV
22413845 17 A new strategy for detection and development of tractable telomerase inhibitors.EBI J Med Chem 55: 3678-86 (2012) University of California 2D 3D TSV
22410247 2 Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.EBI Bioorg Med Chem 20: 2739-46 (2012) Hokkaido University 2D 3D TSV
22410083 17 Consequences of linker length alteration of thea7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333.EBI Bioorg Med Chem Lett 22: 2380-4 (2012) The University of Sydney 2D 3D TSV
22409666 4 Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.EBI J Med Chem 55: 4527-38 (2012) Eli Lilly and Company 2D 3D TSV
22409629 15 Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitor.EBI J Med Chem 55: 3036-48 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22409598 28 Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.EBI J Med Chem 55: 4896-933 (2012) Pfizer Inc 2D 3D TSV
22408719 21 The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.EBI Medchemcomm 2: 1016-1020 (2011) NIH Chemical Genomics Center 2D 3D TSV
22408714 23 Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor.EBI ACS Med Chem Lett 3: 232-237 (2012) TBA 2D 3D TSV
22406152 6 Structure aided design of chimeric antibiotics.EBI Bioorg Med Chem Lett 22: 2428-33 (2012) University of Queensland 2D 3D TSV
22406151 21 Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy.EBI Bioorg Med Chem Lett 22: 2411-4 (2012) Takeda California Inc 2D 3D TSV
22406116 4 Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screening.EBI Bioorg Med Chem Lett 22: 2388-92 (2012) Zhejiang Gongshang University 2D 3D TSV
22406115 18 Discovery of a new binding mode for a series of liver X receptor agonists.EBI Bioorg Med Chem Lett 22: 2407-10 (2012) Amgen Inc 2D 3D TSV
22405919 3 Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT6 receptor antagonists.EBI Bioorg Med Chem 20: 2707-12 (2012) Ewha Womans University 2D 3D TSV
22405833 52 Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1.EBI Bioorg Med Chem Lett 22: 2497-502 (2012) Sanofi-Aventis R&D 2D 3D TSV
22405832 24 Discovery of nor-seco himbacine analogs as thrombin receptor antagonists.EBI Bioorg Med Chem Lett 22: 2544-9 (2012) Pfizer Inc 2D 3D TSV
22405649 5 Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.EBI Eur J Med Chem 51: 277-85 (2012) University of Strasburg 2D 3D TSV
22405648 7 Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.EBI Eur J Med Chem 51: 294-9 (2012) Anhui Medical University 2D 3D TSV
22405291 11 Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.EBI Eur J Med Chem 51: 92-8 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22405288 5 Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.EBI Eur J Med Chem 51: 60-6 (2012) Shandong University 2D 3D TSV
22405286 10 Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.EBI Eur J Med Chem 51: 17-34 (2012) Torrey Pines Institute for Molecular Studies 2D 3D TSV
22404847 24 Synthesis and Biological Evaluation of N-aryl-4-aryl-1,3-Thiazole-2-Amine Derivatives as Direct 5-Lipoxygenase Inhibitors.BDB Chem Biol Drug Des 80: 89-98 (2012) Korea Research Institute of Chemical Technology 2D 3D TSV
22404396 16 Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity.EBI J Med Chem 55: 5143-50 (2012) Keio University 2D 3D TSV
22404346 52 Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity.EBI J Med Chem 55: 3228-41 (2012) The Institute of Cancer Research 2D 3D TSV
22404301 44 Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors.EBI J Med Chem 55: 2960-9 (2012) Taiho Pharmaceutical Co., Ltd 2D 3D TSV
22401864 61 Discovery of oxazole-based PDE4 inhibitors with picomolar potency.EBI Bioorg Med Chem Lett 22: 2594-7 (2012) Merck Research Laboratories 2D 3D TSV
22401863 30 Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.EBI Bioorg Med Chem Lett 22: 2536-43 (2012) Pfizer Inc. 2D 3D TSV
22401672 6 Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.EBI J Med Chem 55: 3387-97 (2012) Georgia State University 2D 3D TSV
22400713 39 Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.EBI J Med Chem 55: 3687-98 (2012) Gwangju Institute of Science and Technology (GIST) 2D 3D TSV
22398259 87 Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.EBI Bioorg Med Chem 20: 2762-72 (2012) TUBITAK MAM Chemistry Institute P K 21 Gebze 2D 3D TSV
22397393 5 Synthesis of a-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase.BDB J Enzyme Inhib Med Chem 28: 576-82 (2013) Institute for Advanced Studies in Basic Sciences (IASBS) 2D 3D TSV
22394120 7 The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.EBI J Med Chem 55: 3027-35 (2012) Universit£ di Chieti-Pescara G. d'Annunzio 2D 3D TSV
22394077 19 Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies.EBI J Med Chem 55: 4539-50 (2012) Hoffmann-La Roche Inc 2D 3D TSV
22391033 69 Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists.EBI Bioorg Med Chem 20: 2338-52 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22390835 80 Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor.EBI Bioorg Med Chem Lett 22: 2444-9 (2012) Merck Research Laboratories 2D 3D TSV
22390627 1 Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus.EBI J Nat Prod 75: 764-7 (2012) Biomedicinal Information Research Center (BIRC) 2D 3D TSV
22390538 2 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.EBI J Med Chem 55: 3479-87 (2012) University of Cape Town 2D 3D TSV
22390415 28 Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells.EBI J Med Chem 55: 3201-15 (2012) McGill University 2D 3D TSV
22386984 67 In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.EBI Bioorg Med Chem 20: 2323-37 (2012) Colosseum Combinatorial Chemistry Centre for Technology (C4T SCarl) 2D 3D TSV
22386983 25 Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2).EBI Bioorg Med Chem 20: 2221-6 (2012) University of Alberta 2D 3D TSV
22386981 14 Synthesis and P2Y2 receptor agonist activities of uridine 5'-phosphonate analogues.EBI Bioorg Med Chem 20: 2304-15 (2012) Ghent University 2D 3D TSV
22386980 7 Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors.EBI Bioorg Med Chem 20: 2208-13 (2012) Balikesir University 2D 3D TSV
22386979 104 Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.EBI Bioorg Med Chem 20: 2235-51 (2012) Minase Research Institute 2D 3D TSV
22386978 2 C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.EBI Bioorg Med Chem 20: 2199-207 (2012) University of Hyderabad Campus 2D 3D TSV
22386665 23 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.EBI Bioorg Med Chem Lett 22: 2514-7 (2012) Eli Lilly and Company 2D 3D TSV
22386564 43 Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.EBI Bioorg Med Chem 20: 2427-34 (2012) Purdue University 2D 3D TSV
22386529 38 From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.EBI Bioorg Med Chem Lett 22: 2963-7 (2012) GlaxoSmithKline 2D 3D TSV
22386527 23 Discovery of novel aminoquinazolin-7-yl 6,7-dihydro-indol-4-ones as potent, selective inhibitors of heat shock protein 90.EBI Bioorg Med Chem Lett 22: 2550-4 (2012) Serenex Inc. 2D 3D TSV
22386368 33 Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFa-induced nuclear factor-¿B activation inhibition.EBI Eur J Med Chem 50: 393-404 (2012) Sun Yat-sen University 2D 3D TSV
22386260 9 Use of copper(I) catalyzed azide alkyne cycloaddition (CuAAC) for the preparation of conjugated pyrrolo[2,3-a]carbazole Pim kinase inhibitors.EBI Eur J Med Chem 50: 304-10 (2012) Clermont Universit£ 2D 3D TSV
22386244 4 Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening.EBI Bioorg Med Chem Lett 22: 2450-5 (2012) Sanofi Pharmaceuticals 2D 3D TSV
22386243 83 Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor.EBI Bioorg Med Chem Lett 22: 2456-9 (2012) GlaxoSmithKline 2D 3D TSV
22386242 13 N-Caffeoyl serotonin as selective COX-2 inhibitor.EBI Bioorg Med Chem Lett 22: 2494-6 (2012) Kinki University 2D 3D TSV
22386241 46 Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.EBI Bioorg Med Chem Lett 22: 2434-9 (2012) SK Biopharmaceuticals 2D 3D TSV
22385507 20 Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.EBI J Med Chem 55: 3274-84 (2012) Instituto de Qu£mica M£dica (CSIC) 2D 3D TSV
22385498 24 Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors.EBI J Med Chem 55: 3242-9 (2012) NeuroSearch Sweden AB 2D 3D TSV
22385476 7 Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.EBI J Med Chem 55: 3353-63 (2012) University of Kansas 2D 3D TSV
22381672 20 Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with ??-adrenoceptor affinities.EBI Bioorg Med Chem 20: 2290-303 (2012) Jagiellonian University Medical College 2D 3D TSV
22381357 41 New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.EBI Eur J Med Chem 50: 332-43 (2012) University of Messina 2D 3D TSV
22381355 16 Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4'-piperidine]-2-ones as potential c-Met inhibitors.EBI Eur J Med Chem 50: 370-5 (2012) Southern Medical University 2D 3D TSV
22381334 2 In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.EBI Drug Metab Dispos 40: 1093-103 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22381116 2 The discovery of novel β-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies.BDB Chem Biol Drug Des 79: 972-80 (2012) Peking University Health Science Center 2D 3D TSV
22381048 45 Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists.EBI Bioorg Med Chem Lett 22: 2560-4 (2012) Monash University (Parkville Campus) 2D 3D TSV
22381047 30 Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.EBI Bioorg Med Chem Lett 22: 2527-33 (2012) Chungnam National University 2D 3D TSV
22380779 35 Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.BDB J Enzyme Inhib Med Chem 28: 545-51 (2013) Shandong University 2D 3D TSV
22380777 16 Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.BDB J Enzyme Inhib Med Chem 28: 113-22 (2013) Aristotle University of Thessaloniki 2D 3D TSV
22380775 28 2-(2-indolyl-)-4(3H)-quinazolines derivates as new inhibitors of AChE: design, synthesis, biological evaluation and molecular modelling.BDB J Enzyme Inhib Med Chem 28: 583-92 (2013) Sun Yat-sen University 2D 3D TSV
22380772 34 Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II.BDB J Enzyme Inhib Med Chem 28: 294-8 (2013) Ataturk University 2D 3D TSV
22380770 5 Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity.BDB J Enzyme Inhib Med Chem 28: 565-8 (2013) Yeungnam University 2D 3D TSV
22380736 90 Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index.EBI J Med Chem 55: 3250-60 (2012) Ambit Biosciences Corporation 2D 3D TSV
22380680 3 Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.EBI J Med Chem 55: 3011-20 (2012) Drexel University College of Medicine 2D 3D TSV
22380653 69 Lead optimization of 17ß-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis.EBI J Med Chem 55: 3307-18 (2012) Saarland University 2D 3D TSV
22380629 174 Discovery of cyclic sulfone hydroxyethylamines as potent and selectiveß-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloidß-peptides.EBI J Med Chem 55: 3364-86 (2012) Novartis Pharma AG 2D 3D TSV
22380603 3 Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies.EBI J Med Chem 55: 3049-57 (2012) University of Troms£ 2D 3D TSV
22380511 73 Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors.EBI J Med Chem 55: 2597-605 (2012) Peking University 2D 3D TSV
22377675 44 Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.EBI Bioorg Med Chem 20: 2282-9 (2012) Westf£lische Wilhelms-Universit£t M£nster 2D 3D TSV
22377674 80 Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.EBI Bioorg Med Chem 20: 2266-73 (2012) Universit£ degli Studi di Firenze 2D 3D TSV
22377673 4 Proteasome inhibitors for cancer therapy.EBI Bioorg Med Chem 20: 2362-8 (2012) Cephalon Inc 2D 3D TSV
22377671 6 2-Morpholinoisoflav-3-enes as flexible intermediates in the synthesis of phenoxodiol, isophenoxodiol, equol and analogues: vasorelaxant properties, estrogen receptor binding and Rho/RhoA kinase pathway inhibition.EBI Bioorg Med Chem 20: 2353-61 (2012) University of Melbourne 2D 3D TSV
22377519 23 An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors.EBI Bioorg Med Chem Lett 22: 2464-9 (2012) Prosidion Ltd 2D 3D TSV
22377517 15 Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists.EBI Bioorg Med Chem Lett 22: 2572-8 (2012) Pfizer Inc 2D 3D TSV
22377514 75 The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia.EBI Bioorg Med Chem Lett 22: 2585-9 (2012) Merck Research Laboratories 2D 3D TSV
22376008 19 Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.EBI J Med Chem 55: 2724-36 (2012) Uppsala University 2D 3D TSV
22374217 33 Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates.EBI Bioorg Med Chem Lett 22: 2609-12 (2012) Merck Research Laboratories 2D 3D TSV
22373734 42 Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.EBI Eur J Med Chem 50: 179-95 (2012) Pfizer Inc 2D 3D TSV
22372864 25 Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.EBI J Med Chem 55: 2846-57 (2012) Hanmi Research Center 2D 3D TSV
22372835 71 Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity.EBI J Med Chem 55: 2820-34 (2012) Research Triangle Institute 2D 3D TSV
22372816 3 Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.EBI J Med Chem 55: 2758-68 (2012) Universit£ de Caen Basse-Normandie 2D 3D TSV
22370341 29 Favourable involvement ofa2A-adrenoreceptor antagonism in the I2-imidazoline binding sites-mediated morphine analgesia enhancement.EBI Bioorg Med Chem 20: 2259-65 (2012) University of Camerino 2D 3D TSV
22370340 91 N¿?¿-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.EBI Bioorg Med Chem 20: 2444-54 (2012) Duquesne University 2D 3D TSV
22370338 183 Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases.EBI Bioorg Med Chem 20: 2392-404 (2012) Griffith University 2D 3D TSV
22370337 30 Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.EBI Bioorg Med Chem 20: 2435-43 (2012) Northwestern University 2D 3D TSV
22370270 30 Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).EBI Bioorg Med Chem Lett 22: 2510-3 (2012) NeurAxon Inc 2D 3D TSV
22370269 44 Discovery of P2X3 selective antagonists for the treatment of chronic pain.EBI Bioorg Med Chem Lett 22: 2565-71 (2012) AstraZeneca 2D 3D TSV
22370265 63 Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management.EBI Bioorg Med Chem Lett 22: 2604-8 (2012) Abbott Laboratories 2D 3D TSV
22369268 29 Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1.EBI J Med Chem 55: 2803-10 (2012) University of Washington 2D 3D TSV
22369198 40 From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.EBI J Med Chem 55: 2574-84 (2012) Laboratoires Fournier 2D 3D TSV
22369181 6 (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARß/d-selective ligand with inverse agonistic properties.EBI J Med Chem 55: 2858-68 (2012) Philipps University 2D 3D TSV
22368763 82 Small Molecule Inhibitors of Regulator of G Protein Signalling (RGS) Proteins.EBI ACS Med Chem Lett 3: 146-150 (2012) TBA 2D 3D TSV
22366955 11 Blind prediction of host-guest binding affinities: a new SAMPL3 challenge.BDB J Comput Aided Mol Des 26: 475-87 (2012) University of California San Diego 2D 3D TSV
22366657 39 A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.EBI Bioorg Med Chem Lett 22: 2620-3 (2012) GlaxoSmithKline 2D 3D TSV
22366656 5 Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production.EBI Bioorg Med Chem Lett 22: 2534-5 (2012) Kangwon National University 2D 3D TSV
22366654 33 2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator.EBI Bioorg Med Chem Lett 22: 2635-9 (2012) University of Louisville 2D 3D TSV
22366653 3 Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease.EBI Bioorg Med Chem Lett 22: 2629-34 (2012) Gilead Sciences Inc 2D 3D TSV
22365911 3 Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists.EBI Bioorg Med Chem 20: 2369-75 (2012) Astellas Pharma Inc 2D 3D TSV
22365762 64 Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activity.EBI Bioorg Med Chem Lett 22: 2613-9 (2012) Merck Research Laboratories 2D 3D TSV
22365761 144 New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.EBI Bioorg Med Chem Lett 22: 2182-5 (2012) Universit£ degli Studi di Firenze 2D 3D TSV
22365760 6 Pyrrolovesamicols--synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers.EBI Bioorg Med Chem Lett 22: 2163-6 (2012) Institute of Radiopharmacy 2D 3D TSV
22365758 43 Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).EBI Bioorg Med Chem Lett 22: 2287-90 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22365757 2 Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions.EBI Bioorg Med Chem Lett 22: 2146-50 (2012) PharmaDesign Inc 2D 3D TSV
22365755 42 Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors.EBI Bioorg Med Chem Lett 22: 2262-5 (2012) Amgen Inc 2D 3D TSV
22365751 45 Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.EBI Bioorg Med Chem Lett 22: 2151-3 (2012) Cephalon Inc 2D 3D TSV
22365563 29 Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors.EBI Eur J Med Chem 50: 264-73 (2012) St. John's University 2D 3D TSV
22365562 154 Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold.EBI Eur J Med Chem 50: 255-63 (2012) University of Ljubljana 2D 3D TSV
22364952 4 Synthesis and antidiabetic performance of ?-amino ketone containing nabumetone moiety.EBI Bioorg Med Chem 20: 2119-30 (2012) Southwest University 2D 3D TSV
22364812 7 Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors.EBI Bioorg Med Chem Lett 22: 2308-11 (2012) Purdue University 2D 3D TSV
22364743 8 Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts.EBI Bioorg Med Chem 20: 2180-8 (2012) University of Virginia 2D 3D TSV
22364528 412 1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia.EBI J Med Chem 55: 2945-59 (2012) Merck Research Laboratories 2D 3D TSV
22364337 38 Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.EBI J Med Chem 55: 2388-405 (2012) Janssen-Cilag S.A. 2D 3D TSV
22361686 3 Design, synthesis and biological evaluation of novel (E)-?-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors.EBI Eur J Med Chem 50: 288-95 (2012) Nanjing University 2D 3D TSV
22361685 123 Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach.EBI Eur J Med Chem 50: 216-29 (2012) Universit£ degli Studi Magna Grecia di Catanzaro 2D 3D TSV
22361272 74 Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.EBI Bioorg Med Chem 20: 2010-8 (2012) Nanjing University 2D 3D TSV
22361135 29 Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists.EBI Bioorg Med Chem Lett 22: 2167-71 (2012) Lundbeck Research USA 2D 3D TSV
22361134 26 N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation.EBI Bioorg Med Chem Lett 22: 2154-9 (2012) University of Alberta 2D 3D TSV
22361133 148 Synthesis and structure-activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors.EBI Bioorg Med Chem Lett 22: 2230-4 (2012) GlaxoSmithKline 2D 3D TSV
22360639 12 Cycloartane and friedelane triterpenoids from the leaves of Caloncoba glauca and their evaluation for inhibition of 11ß-hydroxysteroid dehydrogenases.EBI J Nat Prod 75: 599-604 (2012) Chinese Academy of Sciences 2D 3D TSV
22360587 1 Symplocin A, a linear peptide from the Bahamian cyanobacterium Symploca sp. Configurational analysis of N,N-dimethylamino acids by chiral-phase HPLC of naphthacyl esters.EBI J Nat Prod 75: 425-31 (2012) University of California 2D 3D TSV
22360565 20 Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease.EBI J Med Chem 55: 2737-45 (2012) University of British Columbia 2D 3D TSV
22357342 8 SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives asµ opioid ligands.EBI Bioorg Med Chem Lett 22: 2200-3 (2012) Pfizer Inc 2D 3D TSV
22356915 27 Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and Implications for design of parasite selective inhibitors.BDB J Biol Chem 287: 11788-97 (2012) University of North Carolina 2D 3D TSV
22356319 4 Inhibition of galactosyltransferases by a novel class of donor analogues.EBI J Med Chem 55: 2015-24 (2012) University of East Anglia 2D 3D TSV
22352892 42 Synthesis, biological evaluation, and molecular modeling of natural and unnatural flavonoidal alkaloids, inhibitors of kinases.EBI J Med Chem 55: 2811-9 (2012) Institut de Chimie des Substances Naturelles (ICSN) 2D 3D TSV
22352868 8 Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres.EBI J Med Chem 55: 2746-57 (2012) Kyoto University 2D 3D TSV
22352782 17 Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.EBI J Med Chem 55: 2688-701 (2012) Janssen-Cilag S.A. 2D 3D TSV
22344701 30 Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589).EBI Drug Metab Dispos 40: 1041-50 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22342630 2 Biotransformations of 6',7'-dihydroxybergamottin and 6',7'-epoxybergamottin by the citrus-pathogenic fungi diminish cytochrome P450 3A4 inhibitory activity.EBI Bioorg Med Chem Lett 22: 2279-82 (2012) Agricultural Research Service 2D 3D TSV
22342627 36 Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.EBI Bioorg Med Chem Lett 22: 2204-8 (2012) CISI scrl 2D 3D TSV
22342626 42 Substituted azaquinazolinones as modulators of GHSr-1a for the treatment of type II diabetes and obesity.EBI Bioorg Med Chem Lett 22: 2271-8 (2012) Prosidion Ltd 2D 3D TSV
22342625 6 Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.EBI Bioorg Med Chem Lett 22: 2195-9 (2012) Sejong University 2D 3D TSV
22342624 2 Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes.EBI Bioorg Med Chem Lett 22: 2347-9 (2012) Korea University 2D 3D TSV
22342268 98 Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine.EBI Bioorg Med Chem 20: 2091-100 (2012) Menarini Ricerche 2D 3D TSV
22342267 18 Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.EBI Bioorg Med Chem 20: 2152-7 (2012) Chulalongkorn University 2D 3D TSV
22342147 55 Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors.EBI Bioorg Med Chem Lett 22: 2330-7 (2012) AstraZeneca R&D Boston 2D 3D TSV
22342144 72 Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.EBI Bioorg Med Chem Lett 22: 2242-6 (2012) PanThera Biopharma, LLC 2D 3D TSV
22342143 37 Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis.EBI Bioorg Med Chem Lett 22: 2266-70 (2012) Galapagos NV 2D 3D TSV
22342124 9 Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors.EBI Bioorg Med Chem Lett 22: 2283-6 (2012) Exelixis Inc 2D 3D TSV
22341944 29 Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.EBI Bioorg Med Chem Lett 22: 2257-61 (2012) School of Chemistry & Chemical Engineering of Guangxi Normal University 2D 3D TSV
22341942 18 Wake-promoting agents: search for next generation modafinil: part II.EBI Bioorg Med Chem Lett 22: 2315-7 (2012) Cephalon Inc 2D 3D TSV
22341941 34 Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.EBI Bioorg Med Chem Lett 22: 2235-8 (2012) University of Alberta 2D 3D TSV
22341898 7 Synthesis and inhibitory activity of ureidophosphonates, against acetylcholinesterase: pharmacological assay and molecular modeling.BDB Bioorg Chem 22-7 (2012) Institute for Advanced Studies in Basic Sciences (IASBS) 2D 3D TSV
22341895 26 Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selectiveµ-antagonist activity.EBI Eur J Med Chem 50: 44-54 (2012) National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism 2D 3D TSV
22341573 39 Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptorsa/¿ dual agonists.EBI Bioorg Med Chem 20: 2141-51 (2012) Universit£ degli Studi di Bari 'Aldo Moro' 2D 3D TSV
22341572 61 Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.EBI Bioorg Med Chem 20: 2067-81 (2012) RTI International 2D 3D TSV
22341244 103 Might the observeda(2A)-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?EBI Bioorg Med Chem 20: 2082-90 (2012) Universit£ degli Studi di Camerino 2D 3D TSV
22341243 6 Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.EBI Bioorg Med Chem 20: 2172-9 (2012) Central Drug Research Institute 2D 3D TSV
22340081 16 Solid phase synthesis of 1,5-diarylpyrazole-4-carboxamides: discovery of antagonists of the CB-1 receptor.BDB ACS Comb Sci 14: 197-204 (2012) Bristol-Myers Squibb Research and Development 2D 3D TSV
22339993 8 Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP response regulator.BDB Chem Biol Drug Des 79: 1007-17 (2012) Washington University 2D 3D TSV
22339472 148 Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthEBI J Med Chem 55: 2623-40 (2012) S BIO Pte. Ltd 2D 3D TSV
22339433 48 Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.EBI J Med Chem 55: 2899-903 (2012) Kyoto University 2D 3D TSV
22339362 20 Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors.EBI J Med Chem 55: 2970-80 (2012) Taiho Pharmaceutical Co., Ltd 2D 3D TSV
22339342 28 Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine7¿°¿ methionine7¿° mutant.EBI J Med Chem 55: 2711-23 (2012) Chinese Academy of Sciences 2D 3D TSV
22339166 14 Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation.EBI J Med Chem 55: 2649-71 (2012) University of Nebraska Medical Center 2D 3D TSV
22339127 14 Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.EBI J Med Chem 55: 2641-8 (2012) Genzyme Corp. 2D 3D TSV
22336385 4 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.EBI Eur J Med Chem 50: 129-39 (2012) Universidad de Granada 2D 3D TSV
22336247 20 Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity.EBI Bioorg Med Chem 20: 1644-58 (2012) Kyorin Pharmaceutical Co., Ltd 2D 3D TSV
22336246 7 JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.EBI Bioorg Med Chem 20: 1947-51 (2012) Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics 2D 3D TSV
22336245 72 Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.EBI Bioorg Med Chem 20: 1671-8 (2012) Florida A&M University 2D 3D TSV
22335897 2 Characterization of TAE684 as a potent LRRK2 kinase inhibitor.EBI Bioorg Med Chem Lett 22: 1864-9 (2012) University of Dundee 2D 3D TSV
22335895 41 Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors.EBI Bioorg Med Chem Lett 22: 2015-9 (2012) Harvard Medical School 2D 3D TSV
22335894 10 New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.EBI Bioorg Med Chem Lett 22: 1860-3 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22335602 93 Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selectivea-melanocyte-stimulating hormone (a-MSH) analogues.EBI J Med Chem 55: 1969-77 (2012) Novo Nordisk A/S 2D 3D TSV
22335555 43 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.EBI J Med Chem 55: 2882-93 (2012) NeurAxon Inc 2D 3D TSV
22335519 3 Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.EBI J Med Chem 55: 2869-81 (2012) Genentech 2D 3D TSV
22331994 3 Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance.EBI Drug Metab Dispos 40: 982-9 (2012) Khon Kaen University 2D 3D TSV
22330635 25 Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.EBI Bioorg Med Chem Lett 22: 1903-7 (2012) Janssen Pharmaceutica NV 2D 3D TSV
22330633 5 Depigmenting activity of new kojic acid derivative obtained as a side product in the synthesis of cinnamate of kojic acid.EBI Bioorg Med Chem Lett 22: 2004-7 (2012) Hanyang University 2D 3D TSV
22329646 3 Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.EBI J Nat Prod 75: 271-4 (2012) Korea Research Institute of Bioscience and Biotechnology 2D 3D TSV
22329602 22 Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.EBI J Med Chem 55: 2125-43 (2012) University of Strasburg 2D 3D TSV
22329561 5 Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis.EBI J Med Chem 55: 2112-24 (2012) University of Milan-Bicocca 2D 3D TSV
22329507 49 Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.EBI J Med Chem 55: 1593-611 (2012) Amgen Inc 2D 3D TSV
22328963 4 Discovery of a Potent HIV Integrase Inhibitor that Leads to a Prodrug with Significant anti-HIV Activity.EBI ACS Med Chem Lett 2: 877-881 (2011) TBA 2D 3D TSV
22328583 132 Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.EBI Drug Metab Dispos 40: 943-51 (2012) Pfizer Inc 2D 3D TSV
22326398 22 Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.EBI Bioorg Med Chem Lett 22: 1886-90 (2012) London School of Hygiene and Tropical Medicine 2D 3D TSV
22326396 32 Aminopyrimidinone cdc7 kinase inhibitors.EBI Bioorg Med Chem Lett 22: 1940-3 (2012) Abbott Laboratories 2D 3D TSV
22326168 67 Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1.EBI Bioorg Med Chem Lett 22: 2070-4 (2012) Biogen Idec Inc 2D 3D TSV
22326166 40 Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists.EBI Bioorg Med Chem Lett 22: 2075-8 (2012) Merck Research Laboratories 2D 3D TSV
22326163 63 SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.EBI Bioorg Med Chem Lett 22: 1969-75 (2012) ZAFES/LiFF/OSF Goethe-University Frankfurt 2D 3D TSV
22325951 41 Structure-activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3ß inhibitor.EBI Bioorg Med Chem Lett 22: 1891-4 (2012) CrystalGenomics, Inc. 2D 3D TSV
22325949 28 Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at thed opioid receptor. Discovery of two highly potent and selectived opioid agonists.EBI Bioorg Med Chem Lett 22: 1899-902 (2012) Clinical Research Institute of Montreal 2D 3D TSV
22325948 52 Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia.EBI Bioorg Med Chem Lett 22: 1870-3 (2012) Arena Pharmaceuticals Inc 2D 3D TSV
22325946 36 3,4-Diarylpiperidines as potent renin inhibitors.EBI Bioorg Med Chem Lett 22: 1953-7 (2012) Merck Frosst Center for Therapeutic Research 2D 3D TSV
22325945 55 Design, synthesis, and evaluation of novel 4-thiazolylimidazoles as inhibitors of transforming growth factor-ß type I receptor kinase.EBI Bioorg Med Chem Lett 22: 2024-9 (2012) Taisho Pharmaceutical Co., Ltd 2D 3D TSV
22325943 71 Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.EBI Bioorg Med Chem Lett 22: 1874-8 (2012) Spanish National Cancer Research Centre (CNIO) 2D 3D TSV
22325942 31 Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy.EBI Bioorg Med Chem Lett 22: 1854-9 (2012) AstraZeneca 2D 3D TSV
22325155 20 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.EBI Bioorg Med Chem 20: 1690-8 (2012) University of Ferrara 2D 3D TSV
22325154 25 N-(4-Substituted-benzoyl)-N'-(ß-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.EBI Bioorg Med Chem 20: 1801-16 (2012) University of Debrecen 2D 3D TSV
22324546 55 Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors.EBI J Med Chem 55: 2301-10 (2012) Institut Pasteur Korea 2D 3D TSV
22321216 2 Towards the preparation of radiolabeled 1-aryl-3-benzyl ureas: Radiosynthesis of [(11)C-carbonyl] AR-A014418 by [(11)C]CO(2) fixation.EBI Bioorg Med Chem Lett 22: 2099-101 (2012) University of Toronto 2D 3D TSV
22321215 16 Anti-tumor activity of new orally bioavailable 2-amino-5-(thiophen-2-yl)benzamide-series histone deacetylase inhibitors, possessing an aqueous soluble functional group as a surface recognition domain.EBI Bioorg Med Chem Lett 22: 1926-30 (2012) Kansai University 2D 3D TSV
22321214 42 Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors.EBI Bioorg Med Chem Lett 22: 1944-8 (2012) AstraZeneca 2D 3D TSV
22321213 16 Effect of alkyl chain length on sphingosine kinase 2 selectivity.EBI Bioorg Med Chem Lett 22: 6817-20 (2012) Virginia Tech 2D 3D TSV
22320402 4 Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.EBI J Med Chem 55: 1999-2014 (2012) The Hong Kong Polytechnic University 2D 3D TSV
22320388 116 Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.EBI J Med Chem 55: 2416-26 (2012) University of Washington 2D 3D TSV
22320343 21 Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives.EBI J Med Chem 55: 1858-67 (2012) Amgen Inc 2D 3D TSV
22320327 250 Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series.EBI J Med Chem 55: 1868-97 (2012) Amgen Inc 2D 3D TSV
22318165 85 Exploration ofa-aminophosphonate N-derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatases.EBI Eur J Med Chem 49: 354-64 (2012) Shanxi University 2D 3D TSV
22318160 12 Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo.EBI Bioorg Med Chem Lett 22: 1958-62 (2012) Massachusetts General Hospital 2D 3D TSV
22318159 36 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.EBI Bioorg Med Chem Lett 22: 1980-4 (2012) NeurAxon Inc 2D 3D TSV
22318156 128 Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists.EBI Bioorg Med Chem Lett 22: 2052-62 (2012) Amgen Inc 2D 3D TSV
22316555 12 Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.EBI Bioorg Med Chem 20: 1699-710 (2012) University of Warsaw 2D 3D TSV
22316554 22 Development of live-cell imaging probes for monitoring histone modifications.EBI Bioorg Med Chem 20: 1887-92 (2012) Japan Science and Technology Agency 2D 3D TSV
22316553 1 AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents.EBI Bioorg Med Chem 20: 1711-22 (2012) University of Hyderabad Campus 2D 3D TSV
22316010 12 Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.EBI J Med Chem 55: 2342-52 (2012) National Institute of Radiological Sciences 2D 3D TSV
22315332 1 Preclinical disposition of GDC-0973 and prospective and retrospective analysis of human dose and efficacy predictions.EBI Drug Metab Dispos 40: 919-27 (2012) Genentech 2D 3D TSV
22313242 146 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.EBI J Med Chem 55: 2452-68 (2012) Pfizer Inc 2D 3D TSV
22313227 78 Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.EBI J Med Chem 55: 2406-15 (2012) National Institute of Mental Health 2D 3D TSV
22310230 2 Methoxychalcone inhibitors of androgen receptor translocation and function.EBI Bioorg Med Chem Lett 22: 2105-9 (2012) National Cancer Institute-Bethesda 2D 3D TSV
22310229 102 Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.EBI Bioorg Med Chem Lett 22: 1985-8 (2012) Brandeis University 2D 3D TSV
22310227 89 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors.EBI Bioorg Med Chem Lett 22: 1989-94 (2012) GlaxoSmithKline 2D 3D TSV
22309913 30 Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.EBI Eur J Med Chem 49: 343-53 (2012) North-West University 2D 3D TSV
22309912 28 Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.EBI Eur J Med Chem 49: 183-90 (2012) Beijing Institute of Technology 2D 3D TSV
22309911 13 Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents.EBI Eur J Med Chem 49: 271-8 (2012) East China University of Science and Technology 2D 3D TSV
22309909 37 Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.EBI Eur J Med Chem 49: 200-10 (2012) National Medicines Institute 2D 3D TSV
22309250 3 STAT-3 inhibitory bisabolanes from Carthamus glaucus.EBI J Nat Prod 75: 453-8 (2012) Universit£ di Napoli Federico II 2D 3D TSV
22309223 70 Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines.EBI J Med Chem 55: 2353-66 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22309208 8 Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors.EBI J Med Chem 55: 2561-73 (2012) Korea Institute of Science and Technology 2D 3D TSV
22309188 2 Small peptide inhibitors of acetyl-peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation.EBI J Med Chem 55: 2102-11 (2012) Istituto di Biostrutture e Bioimmagini 2D 3D TSV
22306123 17 Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.EBI Bioorg Med Chem Lett 22: 1976-9 (2012) Chinese Academy of Sciences 2D 3D TSV
22306122 90 The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR.EBI Bioorg Med Chem Lett 22: 2033-42 (2012) Amgen Inc 2D 3D TSV
22305612 7 Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.EBI Eur J Med Chem 49: 24-40 (2012) Dongguk University-Seoul 2D 3D TSV
22305584 145 Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKe kinases.EBI Bioorg Med Chem Lett 22: 2063-9 (2012) AstraZeneca R&D Boston 2D 3D TSV
22305493 33 Discovery of a new class of ghrelin receptor antagonists.EBI Bioorg Med Chem Lett 22: 2046-51 (2012) Amgen Inc 2D 3D TSV
22305342 33 Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.EBI Eur J Med Chem 49: 379-96 (2012) Universit£ d'Orl£ans 2D 3D TSV
22304848 44 Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.EBI Bioorg Med Chem 20: 1779-93 (2012) University of St. Andrews 2D 3D TSV
22304847 1 Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies.EBI Bioorg Med Chem 20: 1760-6 (2012) Instituto Oswaldo Cruz 2D 3D TSV
22304006 1 Antiproliferative activity of trans-avicennol from Zanthoxylum chiloperone var. angustifolium against human cancer stem cells.EBI J Nat Prod 75: 257-61 (2012) Paris-Sud University 2D 3D TSV
22301214 4 Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).EBI Eur J Med Chem 49: 310-23 (2012) University of Lille 2D 3D TSV
22301213 7 Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.EBI Eur J Med Chem 49: 245-52 (2012) Pusan National University 2D 3D TSV
22300887 8 QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).EBI Bioorg Med Chem 20: 1388-95 (2012) University of Tours 2D 3D TSV
22300886 5 Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.EBI Bioorg Med Chem 20: 1373-9 (2012) Nanjing University 2D 3D TSV
22300884 9 Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases.EBI Bioorg Med Chem 20: 1740-8 (2012) Korea Research Institute of Bioscience and Biotechnology 2D 3D TSV
22300661 21 Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors.EBI Bioorg Med Chem Lett 22: 2094-8 (2012) University of Siena 2D 3D TSV
22300660 9 Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity.EBI Bioorg Med Chem Lett 22: 2110-3 (2012) AmorePacific Corporation R&D Center 2D 3D TSV
22300659 4 Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.EBI Bioorg Med Chem Lett 22: 2125-9 (2012) Loma Linda University School of Medicine 2D 3D TSV
22300657 29 Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist.EBI Bioorg Med Chem Lett 22: 2020-3 (2012) Shionogi & Co., Ltd 2D 3D TSV
22299588 33 Inhibition of the ß-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.BDB J Enzyme Inhib Med Chem 28: 392-6 (2013) Università degli Studi di Firenze 2D 3D TSV
22299586 14 Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme.BDB J Enzyme Inhib Med Chem 28: 328-36 (2013) Dumlupinar University 2D 3D TSV
22299585 46 Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes.BDB J Enzyme Inhib Med Chem 28: 412-7 (2013) Ege University 2D 3D TSV
22299583 34 Tripeptides with non-code amino acids as potential serine proteases inhibitors.BDB J Enzyme Inhib Med Chem 28: 639-43 (2013) Medical University of Bialystok 2D 3D TSV
22299579 1 Evaluation of a dithiocarbamate derivative as an inhibitor of human glutaredoxin-1.BDB J Enzyme Inhib Med Chem 28: 456-62 (2013) South Dakota State University 2D 3D TSV
22299578 74 Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.BDB J Enzyme Inhib Med Chem 28: 388-91 (2013) Università degli Studi di Firenze 2D 3D TSV
22299577 12 Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII.BDB J Enzyme Inhib Med Chem 28: 289-93 (2013) Università di Firenze 2D 3D TSV
22299576 44 Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.BDB J Enzyme Inhib Med Chem 28: 397-401 (2013) Ecole Nationale Supérieure de Chimie de Montpellier 2D 3D TSV
22299575 2 Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine.BDB J Enzyme Inhib Med Chem 28: 463-7 (2013) University Roma Tre 2D 3D TSV
22297115 37 Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.EBI Bioorg Med Chem Lett 22: 1510-9 (2012) AstraZeneca R&D Boston 2D 3D TSV
22297114 20 Dualß2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.EBI Bioorg Med Chem Lett 22: 1523-6 (2012) Sun Yat-sen University 2D 3D TSV
22297111 32 Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity.EBI Bioorg Med Chem Lett 22: 1546-9 (2012) Cephalon Inc 2D 3D TSV
22296826 4 New active HIV-1 protease inhibitors derived from 3-hexanol: conformation study of the free inhibitors in crystalline state and in complex with the enzyme.BDB Chem Biol Drug Des 79: 798-809 (2012) Technical University of Lódz 2D 3D TSV
22292590 1 Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro.BDB BMC Biochem 13: 3 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22290078 70 Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors.EBI Bioorg Med Chem Lett 22: 1727-30 (2012) Merck Research Laboratories 2D 3D TSV
22290077 3 Concise synthesis of (+)-conduritol F and inositol analogues from naturally available (+)-proto-quercitol and their glucosidase inhibitory activity.EBI Bioorg Med Chem Lett 22: 1538-40 (2012) Chulalongkorn University 2D 3D TSV
22290076 44 Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists.EBI Bioorg Med Chem Lett 22: 1494-8 (2012) AMRI 2D 3D TSV
22290075 60 4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity.EBI Bioorg Med Chem Lett 22: 1504-9 (2012) Cephalon Inc 2D 3D TSV
22289061 14 Identification of binding specificity-determining features in protein families.EBI J Med Chem 55: 1926-39 (2012) Sandia National Laboratories 2D 3D TSV
22285942 79 3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of humana4ß2 neuronal nicotinic acetylcholine receptors.EBI Bioorg Med Chem Lett 22: 1797-813 (2012) The Ohio State University 2D 3D TSV
22285571 49 QSAR studies for prediction of cross-ß sheet aggregate binding affinity and selectivity.EBI Bioorg Med Chem 20: 1434-41 (2012) The Ohio State University College of Medicine 2D 3D TSV
22285569 107 Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA).EBI Bioorg Med Chem 20: 1557-68 (2012) University of Antwerp 2D 3D TSV
22285172 124 Cloning, characterization and sulfonamide inhibition studies of ana-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.EBI Bioorg Med Chem 20: 1403-10 (2012) Slovak Academy of Sciences 2D 3D TSV
22285028 22 Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors.EBI Bioorg Med Chem 20: 1475-81 (2012) Michigan State University 2D 3D TSV
22284818 4 First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)- and (-)-govadine.EBI Bioorg Med Chem Lett 22: 1557-9 (2012) University of British Columbia 2D 3D TSV
22284817 82 ¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.EBI Bioorg Med Chem Lett 22: 1619-24 (2012) AstraZeneca R&D Montreal 2D 3D TSV
22284362 91 Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen.BDB Chem Biol 19: 155-63 (2012) Boston College 2D 3D TSV
22284361 37 Discovery of potent and selective covalent inhibitors of JNK.BDB Chem Biol 19: 140-54 (2012) Harvard Medical School 2D 3D TSV
22283377 25 Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.EBI J Med Chem 55: 2242-50 (2012) Peking University 2D 3D TSV
22283328 28 Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.EBI J Med Chem 55: 2324-41 (2012) Wuhan University 2D 3D TSV
22282722 10 Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.EBI ACS Med Chem Lett 3: 39-42 (2012) TBA 2D 3D TSV
22281190 12 Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I.EBI Bioorg Med Chem Lett 22: 1579-81 (2012) The University of Sydney 2D 3D TSV
22281189 63 SAR ofa7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore.EBI Bioorg Med Chem Lett 22: 1633-8 (2012) Abbott Laboratories 2D 3D TSV
22281185 3 Fluorinated ?F508-CFTR correctors and potentiators for PET imaging.EBI Bioorg Med Chem Lett 22: 1602-5 (2012) University of California Davis 2D 3D TSV
22280820 53 Novel inhibitors of nitric oxide synthase with antioxidant properties.EBI Eur J Med Chem 49: 118-26 (2012) Universit£ degli Studi di Catania 2D 3D TSV
22280816 1 Recent advances in antitubercular natural products.EBI Eur J Med Chem 49: 1-23 (2012) Universidad Aut£noma de Nuevo Le£n 2D 3D TSV
22280453 19 Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.EBI J Med Chem 55: 2251-64 (2012) Universit£ degli Studi di Parma 2D 3D TSV
22280402 12 "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer.EBI J Med Chem 55: 1635-44 (2012) Trinity College 2D 3D TSV
22280363 104 Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.EBI J Med Chem 55: 1731-50 (2012) Imperial College 2D 3D TSV
22277589 72 Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.EBI Bioorg Med Chem 20: 1545-56 (2012) Jagiellonian University Medical College 2D 3D TSV
22277588 25 Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.EBI Bioorg Med Chem 20: 1411-6 (2012) Nanjing University 2D 3D TSV
22277279 9 Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.EBI Bioorg Med Chem Lett 22: 1560-4 (2012) Istituto di Biostrutture e Bioimmagini-CNR 2D 3D TSV
22277094 59 Optimization of hydroxybenzothiazoles as novel potent and selective inhibitors of 17ß-HSD1.EBI J Med Chem 55: 2469-73 (2012) Saarland University 2D 3D TSV
22277057 11 Highly potent and selective fluorescent antagonists of the human adenosine A3 receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.EBI J Med Chem 55: 1771-82 (2012) University of Nottingham 2D 3D TSV
22276953 63 A new strategy for the development of highly potent and selective plasmin inhibitors.EBI J Med Chem 55: 1171-80 (2012) Philipps University Marburg 2D 3D TSV
22276851 4 Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.EBI J Nat Prod 75: 262-6 (2012) University of Montana 2D 3D TSV
22276693 5 Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72.EBI J Nat Prod 75: 285-9 (2012) Biomedicinal Information Research Center (BIRC) 2D 3D TSV
22276570 112 Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.EBI J Med Chem 55: 1721-30 (2012) Universit£ degli Studi di Firenze 2D 3D TSV
22272748 46 Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors.EBI J Med Chem 55: 2474-8 (2012) H. Lee Moffitt Cancer Center and Research Institute 2D 3D TSV
22269278 50 Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation.EBI Bioorg Med Chem 20: 1442-60 (2012) Chugai Pharmaceutical Co. Ltd 2D 3D TSV
22269276 3 Synthesis and evaluation of malonate-based inhibitors of phosphosugar-metabolizing enzymes: class II fructose-1,6-bis-phosphate aldolases, type I phosphomannose isomerase, and phosphoglucose isomerase.EBI Bioorg Med Chem 20: 1511-20 (2012) Univ Paris-Sud 2D 3D TSV
22268551 42 Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity.EBI J Med Chem 55: 1559-71 (2012) Universit£ degli Studi di Siena 2D 3D TSV
22268448 34 New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.EBI J Med Chem 55: 1572-82 (2012) University of Li£ge 2D 3D TSV
22267981 30 CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway.EBI ACS Med Chem Lett 2: 818-823 (2011) TBA 2D 3D TSV
22266039 119 Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.EBI Bioorg Med Chem Lett 22: 1591-7 (2012) Spanish National Cancer Research Centre (CNIO) 2D 3D TSV
22266038 55 Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis.EBI Bioorg Med Chem Lett 22: 1655-9 (2012) AstraZeneca 2D 3D TSV
22266037 2 New inhibitor of 3-phosphoinositide dependent protein kinase-1 identified from virtual screening.EBI Bioorg Med Chem Lett 22: 1629-32 (2012) Central China Normal University 2D 3D TSV
22266036 116 Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.EBI Bioorg Med Chem Lett 22: 1575-8 (2012) Merck Research Laboratories 2D 3D TSV
22264754 36 17ß-Arylsulfonamides of 17ß-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase.EBI Bioorg Med Chem 20: 1535-44 (2012) University of Waterloo 2D 3D TSV
22264488 58 Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitors.EBI Bioorg Med Chem Lett 22: 1550-6 (2012) Merck Research Laboratories 2D 3D TSV
22264487 5 Aß-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity.EBI Bioorg Med Chem Lett 22: 1606-10 (2012) Sanofi Pharmaceuticals 2D 3D TSV
22264486 62 Imidazopyridines as selective CYP3A4 inhibitors.EBI Bioorg Med Chem Lett 22: 1611-4 (2012) The Scripps Research Institute 2D 3D TSV
22264485 64 Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.EBI Bioorg Med Chem Lett 22: 1788-92 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22264484 28 Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.EBI Bioorg Med Chem Lett 22: 1649-54 (2012) Kyung Hee University 2D 3D TSV
22264481 58 Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile.EBI Bioorg Med Chem Lett 22: 1750-5 (2012) Arena Pharmaceuticals 2D 3D TSV
22264479 56 Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors.EBI Bioorg Med Chem Lett 22: 1678-81 (2012) Novartis Institutes for Biomedical Research 2D 3D TSV
22264478 36 Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists.EBI Bioorg Med Chem Lett 22: 1686-9 (2012) Amgen Inc 2D 3D TSV
22264476 60 Discovery of aminopiperidine-based Smac mimetics as IAP antagonists.EBI Bioorg Med Chem Lett 22: 1690-4 (2012) AstraZeneca R&D Boston 2D 3D TSV
22264475 10 Wake-promoting agents: search for next generation modafinil: part I.EBI Bioorg Med Chem Lett 22: 2312-4 (2012) Cephalon Inc 2D 3D TSV
22264472 30 Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.EBI Bioorg Med Chem Lett 22: 1701-4 (2012) University of Mississippi 2D 3D TSV
22264170 38 Pinophilins A and B, inhibitors of mammalian A-, B-, and Y-family DNA polymerases and human cancer cell proliferation.EBI J Nat Prod 75: 135-41 (2012) Science University of Tokyo 2D 3D TSV
22264115 19 Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities.EBI J Nat Prod 75: 267-70 (2012) Korean Institute of Oriental Medicine (KIOM) 2D 3D TSV
22264015 29 N-phosphonocarbonylpyrrolidine derivatives of guanine: a new class of bi-substrate inhibitors of human purine nucleoside phosphorylase.EBI J Med Chem 55: 1612-21 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22263962 6 Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase.EBI J Med Chem 55: 2173-84 (2012) University of Oxford 2D 3D TSV
22263917 77 Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors.EBI J Med Chem 55: 1698-705 (2012) Amgen Inc 2D 3D TSV
22263894 23 Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.EBI J Med Chem 55: 2287-300 (2012) Vanderbilt Institute of Chemical Biology 2D 3D TSV
22263872 15 Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1.EBI J Med Chem 55: 1751-7 (2012) Abbott Laboratories 2D 3D TSV
22263837 262 Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.EBI J Med Chem 55: 2311-23 (2012) University of Pennsylvania 2D 3D TSV
22261024 21 Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.EBI Bioorg Med Chem 20: 1251-8 (2012) King's College London 2D 3D TSV
22261023 14 Quinolone derivatives containing strained spirocycle as orally active glycogen synthase kinase 3ß (GSK-3ß) inhibitors for type 2 diabetics.EBI Bioorg Med Chem 20: 1188-200 (2012) Kyorin Pharmaceutical Co., Ltd 2D 3D TSV
22261021 33 Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist.EBI Bioorg Med Chem 20: 1201-12 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22260770 12 Synthesis and antihormonal properties of novel 11ß-benzoxazole-substituted steroids.EBI Bioorg Med Chem Lett 22: 1705-8 (2012) Research Triangle Institute 2D 3D TSV
22260203 73 [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding.EBI J Med Chem 55: 1127-36 (2012) Novartis Institutes for BioMedical Research 2D 3D TSV
22260166 17 Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.EBI J Med Chem 55: 1465-77 (2012) Georgia Institute of Technology 2D 3D TSV
22260081 12 Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.EBI J Med Chem 55: 4027-61 (2012) Universit£ Lille Nord de France 2D 3D TSV
22257893 22 Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors.EBI Bioorg Med Chem Lett 22: 1739-42 (2012) Wenzhou Medical College 2D 3D TSV
22257892 60 Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.EBI Bioorg Med Chem Lett 22: 1674-7 (2012) Sapienza University of Rome 2D 3D TSV
22257889 52 Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups.EBI Bioorg Med Chem Lett 22: 1779-83 (2012) Amgen Inc 2D 3D TSV
22257528 5 A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.EBI Bioorg Med Chem 20: 1175-80 (2012) Punjabi University 2D 3D TSV
22257213 98 Discovery and development of spleen tyrosine kinase (SYK) inhibitors.EBI J Med Chem 55: 3614-43 (2012) Rigel, Inc. 2D 3D TSV
22257165 50 Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.EBI J Med Chem 55: 1662-70 (2012) Pfizer Inc. 2D 3D TSV
22257095 65 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists.EBI J Med Chem 55: 1490-9 (2012) Universit£ di Pisa 2D 3D TSV
22257026 31 5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3.EBI J Med Chem 55: 1645-61 (2012) Instituto de Qu£mica M£dica-CSIC 2D 3D TSV
22257012 21 Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.EBI J Med Chem 55: 1671-81 (2012) The University of Melbourne 2D 3D TSV
22250781 16 Identification of novel adenosine A(2A) receptor antagonists by virtual screening.EBI J Med Chem 55: 1904-9 (2012) Heptares Therapeutics Limited 2D 3D TSV
22249123 2 Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents.EBI Bioorg Med Chem 20: 1222-30 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22249122 9 Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging.EBI Bioorg Med Chem 20: 1337-45 (2012) Lehigh University 2D 3D TSV
22248857 39 Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine.EBI Bioorg Med Chem Lett 22: 1774-8 (2012) Merck Research Laboratories 2D 3D TSV
22248361 24 Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.EBI J Med Chem 55: 2154-62 (2012) Trinity College 2D 3D TSV
22248356 20 A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A.BDB ACS Chem Biol 7: 698-706 (2012) Moffitt Cancer Center 2D 3D TSV
22248345 6 Contribution of phosphates and adenine to the potency of adenophostins at the IP3 receptor: synthesis of all possible bisphosphates of adenophostin A.EBI J Med Chem 55: 1706-20 (2012) University of Bath 2D 3D TSV
22248262 101 Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activity.EBI J Med Chem 55: 1511-25 (2012) The Beatson Institute for Cancer Research 2D 3D TSV
22248236 24 Diverse heterocyclic scaffolds as allosteric inhibitors of AKT.EBI J Med Chem 55: 1261-73 (2012) AstraZeneca 2D 3D TSV
22247788 40 Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.EBI ACS Med Chem Lett 2: 907-912 (2011) TBA 2D 3D TSV
22245230 128 Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.EBI Bioorg Med Chem 20: 1291-7 (2012) Florida A&M University 2D 3D TSV
22245049 14 New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold.EBI Eur J Med Chem 49: 102-9 (2012) Universit£ degli Studi di Torino 2D 3D TSV
22245047 135 Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.EBI Eur J Med Chem 49: 68-73 (2012) Ondokuz Mayis University 2D 3D TSV
22244939 31 [¹¿?¿F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).EBI Bioorg Med Chem Lett 22: 1308-13 (2012) GE Healthcare 2D 3D TSV
22244937 44 Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.EBI Bioorg Med Chem Lett 22: 1433-8 (2012) Celgene Corporation 2D 3D TSV
22244072 43 Inhibition of the pore-forming protein perforin by a series of aryl-substituted isobenzofuran-1(3H)-ones.EBI Bioorg Med Chem 20: 1319-36 (2012) University of Auckland 2D 3D TSV
22243962 17 Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.EBI Bioorg Med Chem Lett 22: 1340-3 (2012) Stanford University School of Medicine 2D 3D TSV
22243960 88 Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.EBI Bioorg Med Chem Lett 22: 1448-54 (2012) VU University Amsterdam 2D 3D TSV
22243698 66 Homobivalent ligands of the atypical antipsychotic clozapine: design, synthesis, and pharmacological evaluation.EBI J Med Chem 55: 1622-34 (2012) Monash University (Parkville Campus) 2D 3D TSV
22243648 112 New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, andß-amyloid-reducing properties.EBI J Med Chem 55: 1303-17 (2012) Instituto de Qu£mica M£dica 2D 3D TSV
22243528 12 Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier.EBI J Med Chem 55: 1758-70 (2012) Duquesne University 2D 3D TSV
22243489 75 1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.EBI J Med Chem 55: 1783-7 (2012) Universit£ di Camerino 2D 3D TSV
22243413 7 Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation.EBI J Med Chem 55: 852-70 (2012) Scripps Florida 2D 3D TSV
22242551 76 Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists.EBI J Med Chem 55: 1538-52 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22239545 287 Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19.EBI J Med Chem 55: 1205-14 (2012) Amgen Inc 2D 3D TSV
22239465 26 Design and characterization of optimized adenosine A2A/A1 receptor antagonists for the treatment of Parkinson's disease.EBI J Med Chem 55: 1402-17 (2012) Janssen Research and Development LLC 2D 3D TSV
22239408 31 Toll-like receptor (TLR)-7 and -8 modulatory activities of dimeric imidazoquinolines.EBI J Med Chem 55: 1106-16 (2012) University of Kansas 2D 3D TSV
22239250 59 Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.EBI J Med Chem 55: 783-96 (2012) GlaxoSmithKline 2D 3D TSV
22239221 3 Rational approaches to improving selectivity in drug design.EBI J Med Chem 55: 1424-44 (2012) University of Cambridge 2D 3D TSV
22237251 4 Synthesis and interaction with midkine of biotinylated chondroitin sulfate tetrasaccharides.EBI Bioorg Med Chem Lett 22: 1371-4 (2012) Tottori University 2D 3D TSV
22236472 51 Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.EBI Eur J Med Chem 48: 321-9 (2012) Gifu Pharmaceutical University 2D 3D TSV
22236250 16 Exploring activity cliffs in medicinal chemistry.EBI J Med Chem 55: 2932-42 (2012) Rheinische Friedrich-Wilhelms-Universit£t 2D 3D TSV
22236086 3 Synthesis and evaluation of ¹?F-labeled styryltriazole and resveratrol derivatives for ?-amyloid plaque imaging.EBI J Med Chem 55: 883-92 (2012) Sungkyunkwan University School of Medicine 2D 3D TSV
22233543 70 New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis.BDB J Enzyme Inhib Med Chem 28: 163-71 (2013) Centre de Recherche de Gif 2D 3D TSV
22233540 7 Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol.BDB J Enzyme Inhib Med Chem 28: 137-42 (2013) Baylor University 2D 3D TSV
22233539 90 Nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.BDB J Enzyme Inhib Med Chem 27: 628-40 (2012) Shandong University 2D 3D TSV
22233320 19 Structural basis of selective inhibition of human tankyrases.EBI J Med Chem 55: 1360-7 (2012) Abo Akademi University 2D 3D TSV
22230199 12 Unbiased binding assays for discovering small-molecule probes and drugs.EBI Bioorg Med Chem 20: 1979-89 (2012) Broad Institute of Harvard and MIT 2D 3D TSV
22230050 82 Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives.EBI Bioorg Med Chem Lett 22: 1352-7 (2012) Artvin£oruh University 2D 3D TSV
22229710 18 Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.EBI J Med Chem 55: 1287-95 (2012) Universit£ de Lyon 2D 3D TSV
22229669 130 Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.EBI J Med Chem 55: 1189-204 (2012) University of Lille 2D 3D TSV
22229647 20 Design, synthesis, and biological evaluation of new diaminoquinazolines as ?-catenin/Tcf4 pathway inhibitors.EBI J Med Chem 55: 1346-59 (2012) State University of New York 2D 3D TSV
22227463 90 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions.EBI Bioorg Med Chem 20: 1310-8 (2012) Shenyang Pharmaceutical University 2D 3D TSV
22227462 2 Chemical modulators working at pharmacological interface of target proteins.EBI Bioorg Med Chem 20: 1893-901 (2012) Korea University College of Pharmacy Sejong-ro 2D 3D TSV
22227214 22 Discovery of novel selective inhibitors for EGFR-T790M/L858R.EBI Bioorg Med Chem Lett 22: 1365-70 (2012) Dalian University of Technology 2D 3D TSV
22227212 58 Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound.EBI Bioorg Med Chem Lett 22: 1335-9 (2012) Merck Research Laboratories 2D 3D TSV
22227210 74 Anion inhibition studies of ana-carbonic anhydrase from the living fossil Astrosclera willeyana.EBI Bioorg Med Chem Lett 22: 1314-6 (2012) Slovak Academy of Sciences 2D 3D TSV
22226656 75 Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.EBI Bioorg Med Chem Lett 22: 1421-6 (2012) Cephalon Inc 2D 3D TSV
22226655 88 Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.EBI Bioorg Med Chem Lett 22: 1427-32 (2012) Celgene Corporation 2D 3D TSV
22225917 44 Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802).EBI Bioorg Med Chem 20: 1271-80 (2012) Chugai Pharmaceutical Co. Ltd 2D 3D TSV
22225641 13 Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPAR¿ partial agonists.EBI Bioorg Med Chem Lett 22: 1348-51 (2012) Daiichi Sankyo Co., Ltd 2D 3D TSV
22225639 29 Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).EBI Bioorg Med Chem Lett 22: 1384-7 (2012) Bristol-Myers Squibb Co. 2D 3D TSV
22225638 18 A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.EBI Bioorg Med Chem Lett 22: 1380-3 (2012) Northeast Ohio Medical University 2D 3D TSV
22225636 11 The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not aß-secretase inhibitor.EBI Bioorg Med Chem Lett 22: 1408-14 (2012) Beijing Institute of Pharmacology and Toxicology 2D 3D TSV
22225635 5 Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents.EBI Bioorg Med Chem Lett 22: 1317-21 (2012) University of Nottingham 2D 3D TSV
22225633 96 Design and synthesis of boronic acid inhibitors of endothelial lipase.EBI Bioorg Med Chem Lett 22: 1397-401 (2012) Tufts University School of Medicine 2D 3D TSV
22225576 11 Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.BDB J Enzyme Inhib Med Chem 28: 172-82 (2013) Umeå University 2D 3D TSV
22224710 44 Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive properties.EBI J Med Chem 55: 1181-8 (2012) Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) 2D 3D TSV
22224640 53 Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.EBI J Med Chem 55: 2915-31 (2012) Oxagen Ltd. 2D 3D TSV
22224594 346 Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.EBI J Med Chem 55: 1021-46 (2012) Evotec (UK) Ltd 2D 3D TSV
22222157 55 Structure-activity relationships for naturally occurring coumarins asß-secretase inhibitor.EBI Bioorg Med Chem 20: 784-8 (2012) Kinki University 2D 3D TSV
22222138 40 Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain.EBI Eur J Med Chem 48: 214-30 (2012) Universit£ degli Studi di Parma 2D 3D TSV
22222137 13 Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.EBI Eur J Med Chem 48: 284-95 (2012) Universit£ degli Studi Magna Gr£cia di Catanzaro 2D 3D TSV
22222037 77 Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.EBI Bioorg Med Chem Lett 22: 797-800 (2012) Janssen Pharmaceutica NV 2D 3D TSV
22222036 9 Small molecule inhibitors of BRAF in clinical trials.EBI Bioorg Med Chem Lett 22: 789-92 (2012) The Institute of Cancer Research 2D 3D TSV
22222034 35 The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.EBI Bioorg Med Chem Lett 22: 1019-22 (2012) Merck Research Laboratories 2D 3D TSV
22222032 3 Synthesis and binding affinity ata4ß2 anda7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.EBI Bioorg Med Chem Lett 22: 829-32 (2012) Universit£ degli Studi di Milano 2D 3D TSV
22221201 32 VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia.EBI J Med Chem 55: 725-34 (2012) University of Kentucky 2D 3D TSV
22220592 27 Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.EBI J Med Chem 55: 1898-903 (2012) Heptares Therapeutics Limited 2D 3D TSV
22217933 6 STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells.EBI Bioorg Med Chem 20: 750-8 (2012) Massachusetts General Hospital 2D 3D TSV
22217876 21 AMG 837: a potent, orally bioavailable GPR40 agonist.EBI Bioorg Med Chem Lett 22: 1267-70 (2012) Amgen Inc 2D 3D TSV
22217874 49 Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability.EBI Bioorg Med Chem Lett 22: 824-8 (2012) Prosidion Ltd 2D 3D TSV
22217871 6 Enzymatic transformation of caffeic acid with enhanced cyclooxygenase-2 inhibitory activity.EBI Bioorg Med Chem Lett 22: 793-6 (2012) Kyungpook National University 2D 3D TSV
22217870 51 Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).EBI Bioorg Med Chem Lett 22: 868-71 (2012) ActivX Biosciences Inc 2D 3D TSV
22216892 66 The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.EBI J Med Chem 55: 1147-60 (2012) University of Regensburg 2D 3D TSV
22214395 14 Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ?F508 cystic fibrosis transmembrane conductance regulator protein.EBI J Med Chem 55: 1242-51 (2012) University of California Davis 2D 3D TSV
22214363 78 Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists.EBI J Med Chem 55: 1368-81 (2012) Exelixis Inc 2D 3D TSV
22214210 32 Synthesis and binding study of certain 6-arylalkanamides as molecular probes for cannabinoid receptor subtypes.BDB J Enzyme Inhib Med Chem 28: 436-9 (2013) Cairo University 2D 3D TSV
22214209 33 Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three ß-class carbonic anhydrases from Mycobacterium tuberculosis.BDB J Enzyme Inhib Med Chem 28: 384-7 (2013) Università degli Studi di Firenze 2D 3D TSV
22211528 85 Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.EBI ACS Chem Biol 7: 526-34 (2012) University of Tennessee Health Science Center 2D 3D TSV
22209731 81 Antidiabetogenic oligostilbenoids and 3-ethyl-4-phenyl-3,4-dihydroisocoumarins from the bark of Shorea roxburghii.EBI Bioorg Med Chem 20: 832-40 (2012) Kinki University 2D 3D TSV
22209730 73 A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR)¿ agonists: design and synthesis of benzylpyrazole acylsulfonamides.EBI Bioorg Med Chem 20: 714-33 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22209462 16 Pyrazolopyridine inhibitors of B-Raf(V600E). Part 3: an increase in aqueous solubility via the disruption of crystal packing.EBI Bioorg Med Chem Lett 22: 912-5 (2012) Array BioPharma 2D 3D TSV
22209458 114 Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.EBI Bioorg Med Chem Lett 22: 901-6 (2012) Vernalis (R&D) Ltd 2D 3D TSV
22209457 47 SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist.EBI Bioorg Med Chem Lett 22: 854-8 (2012) Merck Research Laboratory 2D 3D TSV
22209418 5 A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation.EBI Eur J Med Chem 48: 206-13 (2012) Statistical and Biological Physics Sector, SISSA-ISAS, Via Bonomea 265, 34136 Trieste, Italy. 2D 3D TSV
22209272 10 Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E2 synthase-1.EBI Eur J Med Chem 48: 153-63 (2012) University of M£nster 2D 3D TSV
22209206 35 Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.EBI Bioorg Med Chem Lett 22: 980-4 (2012) Merck Frosst Centre for Therapeutic Research 2D 3D TSV
22209205 38 Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists.EBI Bioorg Med Chem Lett 22: 1055-60 (2012) Amgen Inc 2D 3D TSV
22207054 5 Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse.EBI Drug Metab Dispos 40: 671-9 (2012) Kanazawa University 2D 3D TSV
22206607 9 Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.EBI Bioorg Med Chem Lett 22: 850-3 (2012) Central South University 2D 3D TSV
22206546 42 Nonquaternary reactivators for organophosphate-inhibited cholinesterases.EBI J Med Chem 55: 465-74 (2012) Human BioMolecular Research Institute 2D 3D TSV
22206487 17 Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.EBI J Med Chem 55: 367-77 (2012) Purdue University 2D 3D TSV
22205779 11 Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro.EBI Drug Metab Dispos 40: 655-61 (2012) University of Oslo 2D 3D TSV
22204912 6 Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthase.EBI Bioorg Med Chem Lett 22: 907-11 (2012) University of Canterbury 2D 3D TSV
22204910 17 Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.EBI Bioorg Med Chem Lett 22: 1023-6 (2012) Harvard Medical School 2D 3D TSV
22204908 22 New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.EBI Bioorg Med Chem Lett 22: 1282-6 (2012) University of Karachi 2D 3D TSV
22204907 4 Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid.EBI Bioorg Med Chem Lett 22: 1036-9 (2012) China Pharmaceutical University 2D 3D TSV
22204903 6 Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.EBI Eur J Med Chem 48: 97-107 (2012) Quimique C£a. Ltd 2D 3D TSV
22204902 9 Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases.EBI Eur J Med Chem 48: 143-52 (2012) Institute of the Sir Mortimer Jewish General Hospital 2D 3D TSV
22204741 46 N¿?¿-Aryl-6-substitutedphenylmethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as receptor tyrosine kinase inhibitors.EBI Bioorg Med Chem 20: 910-4 (2012) Duquesne University 2D 3D TSV
22204740 135 Synthesis and evaluation of novel modified¿-lactam prostanoids as EP4 subtype-selective agonists.EBI Bioorg Med Chem 20: 702-13 (2012) Minase Research Institute 2D 3D TSV
22204739 136 Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.EBI Bioorg Med Chem 20: 1046-59 (2012) Universit£ di Ferrara 2D 3D TSV
22204607 15 Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds.EBI J Med Chem 55: 1274-86 (2012) University of Lille 2D 3D TSV
22202172 17 6-Position optimization of tricyclic 4-quinolone-based inhibitors of glycogen synthase kinase-3ß: discovery of nitrile derivatives with picomolar potency.EBI Bioorg Med Chem Lett 22: 1005-8 (2012) ActivX Biosciences Inc 2D 3D TSV
22200597 33 Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase.EBI Bioorg Med Chem Lett 22: 942-4 (2012) University of the Punjab 2D 3D TSV
22200345 7 An integrated computational workflow for efficient and quantitative modeling of renin inhibitors.EBI Bioorg Med Chem 20: 851-8 (2012) Sanofi US 2D 3D TSV
22197670 51 Synthesis of quinolinomorphinan-4-ol derivatives asd opioid receptor agonists.EBI Bioorg Med Chem 20: 949-61 (2012) Kitasato University 2D 3D TSV
22197396 57 Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor¿ selective agonists with protein-tyrosine phosphatase 1B inhibition.EBI Bioorg Med Chem 20: 1060-75 (2012) Kyoto Pharmaceutical Industries 2D 3D TSV
22197391 44 Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).EBI Bioorg Med Chem Lett 22: 1086-90 (2012) Merck Research Laboratories 2D 3D TSV
22197390 94 The discovery of potent antagonists of NPBWR1 (GPR7).EBI Bioorg Med Chem Lett 22: 1014-8 (2012) Merck & Co. 2D 3D TSV
22197144 2 Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.EBI Bioorg Med Chem Lett 22: 929-32 (2012) Novartis Institutes of BioMedical Research 2D 3D TSV
22197143 17 Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors.EBI Bioorg Med Chem Lett 22: 1009-13 (2012) S*BIO Pte Ltd 2D 3D TSV
22197142 42 Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012.EBI Bioorg Med Chem Lett 22: 1044-8 (2012) Vanderbilt University Medical Center 2D 3D TSV
22197141 64 Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.EBI Bioorg Med Chem Lett 22: 1061-7 (2012) Amgen Inc 2D 3D TSV
22197140 15 Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer.EBI Bioorg Med Chem Lett 22: 1230-6 (2012) Pfizer Inc 2D 3D TSV
22197139 42 Multiparameter exploration of piperazine derivatives asd-opioid receptor agonists for CNS indications.EBI Bioorg Med Chem Lett 22: 1169-73 (2012) AstraZeneca Pharmaceuticals 2D 3D TSV
22197137 61 4-Piperidin-4-ylidenemethyl-benzamides asd-opioid receptor agonists for CNS indications: identifying clinical candidates.EBI Bioorg Med Chem Lett 22: 1174-8 (2012) AstraZeneca Pharmaceuticals 2D 3D TSV
22197136 29 Synthesis and structure-activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H(3) receptor inverse agonists.EBI Bioorg Med Chem Lett 22: 1073-7 (2012) Cephalon Inc 2D 3D TSV
22196621 17 Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.EBI J Med Chem 55: 1318-33 (2012) Pfizer Inc 2D 3D TSV
22196515 14 Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.EBI Bioorg Med Chem 20: 1100-12 (2012) Max Planck Institute of Molecular Physiology 2D 3D TSV
22196514 70 Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF¿?) receptor antagonists.EBI Bioorg Med Chem 20: 1122-38 (2012) Minase Research Institute 2D 3D TSV
22196124 48 Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.EBI Bioorg Med Chem Lett 22: 1165-8 (2012) Array BioPharma, Inc. 2D 3D TSV
22196123 23 Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors.EBI Bioorg Med Chem Lett 22: 1027-30 (2012) Sejong University 2D 3D TSV
22196117 48 Identification of triazolopyridazinones as potent p38a inhibitors.EBI Bioorg Med Chem Lett 22: 1226-9 (2012) Amgen Inc 2D 3D TSV
22192591 17 Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors.EBI Bioorg Med Chem Lett 22: 1136-41 (2012) Chugai Pharmaceutical Co. Ltd 2D 3D TSV
22192588 9 Structure-based library design and the discovery of a potent and selective mast cellß-tryptase inhibitor as an oral therapeutic agent.EBI Bioorg Med Chem Lett 22: 1049-54 (2012) Sanofi Pharmaceuticals 2D 3D TSV
22191686 4 Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.EBI J Med Chem 55: 1418-22 (2012) Universit£ degli Studi di Bari"Aldo Moro" 2D 3D TSV
22191331 6 ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.EBI J Med Chem 55: 515-27 (2012) Northwestern University 2D 3D TSV
22189275 26 Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction.EBI Bioorg Med Chem 20: 962-77 (2012) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22189274 1 Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N¿?¿,5'-bis-ureido- and 5'-carbamoyl-N¿?¿-ureidoadenosine derivatives.EBI Bioorg Med Chem 20: 1008-19 (2012) Brigham Young University 2D 3D TSV
22189141 2 In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase.EBI Bioorg Med Chem Lett 22: 1219-23 (2012) Martin-Luther-University Halle-Wittenberg 2D 3D TSV
22189138 62 Synthesis of novel histamine H4 receptor antagonists.EBI Bioorg Med Chem Lett 22: 1156-9 (2012) Pfizer Inc 2D 3D TSV
22189137 2 Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation.EBI Bioorg Med Chem Lett 22: 1125-9 (2012) University of Genoa 2D 3D TSV
22189136 25 Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.EBI Bioorg Med Chem Lett 22: 1111-7 (2012) M.S. University of Baroda 2D 3D TSV
22189135 15 High-affinity fluorescent ligands for the 5-HT(3) receptor.EBI Bioorg Med Chem Lett 22: 1151-5 (2012) University of Bern 2D 3D TSV
22188522 45 Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.BDB J Enzyme Inhib Med Chem 27: 818-24 (2012) Ataturk University 2D 3D TSV
22185670 73 Oxadiazoles in medicinal chemistry.EBI J Med Chem 55: 1817-30 (2012) AstraZeneca 2D 3D TSV
22185640 15 Tailoring of integrin ligands: probing the charge capability of the metal ion-dependent adhesion site.EBI J Med Chem 55: 871-82 (2012) Technische Universit£t M£nchen 2D 3D TSV
22185619 50 Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.EBI J Med Chem 55: 661-9 (2012) Universitat de Barcelona 2D 3D TSV
22185522 159 Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors.EBI J Med Chem 55: 824-36 (2012) Universidad Complutense de Madrid 2D 3D TSV
22185476 3 Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.EBI J Med Chem 55: 1056-71 (2012) Tokyo University of Pharmacy and Life Sciences 2D 3D TSV
22185282 32 Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases.EBI J Med Chem 55: 961-5 (2012) Islamic University of Gaza 2D 3D TSV
22185225 2 Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.EBI J Med Chem 55: 893-902 (2012) The University of Tokyo 2D 3D TSV
22182581 36 Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors.EBI Bioorg Med Chem 20: 877-85 (2012) East China University of Science and Technology 2D 3D TSV
22182579 110 Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases.EBI Bioorg Med Chem 20: 985-95 (2012) University of Applied Sciences 2D 3D TSV
22182578 13 Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the humanß2-adrenoceptor.EBI Bioorg Med Chem 20: 933-41 (2012) Instituto Polit£cnico Nacional (IPN) 2D 3D TSV
22182575 1 Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A¿? adenosine receptor.EBI Bioorg Med Chem 20: 996-1007 (2012) Universit£ di Ferrara 2D 3D TSV
22182499 20 Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.EBI Bioorg Med Chem Lett 22: 1068-72 (2012) Merck Research Laboratories 2D 3D TSV
22182498 71 Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.EBI Bioorg Med Chem Lett 22: 1237-41 (2012) Afraxis 2D 3D TSV
22180837 7 Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.EBI Medchemcomm 2: 424-429 (2011) Centre National de la Recherche Scientifique 2D 3D TSV
22180836 5 Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist.EBI Medchemcomm 2: 325-330 (2011) University of Virginia 2D 3D TSV
22178554 29 Discovery of novel and potent CRTH2 antagonists.EBI Bioorg Med Chem Lett 22: 1194-7 (2012) Astellas Pharma Inc 2D 3D TSV
22178553 10 Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.EBI Bioorg Med Chem Lett 22: 1130-5 (2012) Kobe Gakuin University 2D 3D TSV
22178551 46 A multivalent approach to the discovery of long-actingß(2)-adrenoceptor agonists for the treatment of asthma and COPD.EBI Bioorg Med Chem Lett 22: 1213-8 (2012) Theravance, Inc. 2D 3D TSV
22178188 19 Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.EBI Bioorg Med Chem 20: 1076-89 (2012) Academy of Sciences of the Czech Republic 2D 3D TSV
22177784 2 In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor.EBI Bioorg Med Chem Lett 22: 1198-201 (2012) Kyung Hee University 2D 3D TSV
22177783 122 Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.EBI Bioorg Med Chem Lett 22: 1464-8 (2012) Argenta Discovery Ltd 2D 3D TSV
22177408 25 Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.EBI Bioorg Med Chem 20: 34-41 (2011) Astellas Pharma Inc 2D 3D TSV
22177407 104 Novel pyrazolo[1,5-a]pyridines as p110a-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR.EBI Bioorg Med Chem 20: 58-68 (2011) University of Auckland 2D 3D TSV
22177405 104 Discovery of pyrazolo[1,5-a]pyridines as p110a-selective PI3 kinase inhibitors.EBI Bioorg Med Chem 20: 69-85 (2011) University of Auckland 2D 3D TSV
22177081 2 Discovery of novela7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.EBI Bioorg Med Chem Lett 22: 1179-86 (2012) Targacept Inc 2D 3D TSV
22175825 19 Potent inhibitors of LpxC for the treatment of Gram-negative infections.EBI J Med Chem 55: 914-23 (2012) Pfizer Inc 2D 3D TSV
22175799 22 Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.EBI J Med Chem 55: 709-16 (2012) Alantos Pharmaceuticals AG 2D 3D TSV
22175766 45 Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.EBI J Med Chem 55: 943-55 (2012) NeurAxon Inc 2D 3D TSV
22172704 106 Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway.EBI Bioorg Med Chem Lett 22: 76-81 (2011) The Broad Institute Probe Development Center 2D 3D TSV
22172701 40 Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.EBI Bioorg Med Chem Lett 22: 39-44 (2011) Second Military Medical University 2D 3D TSV
22172700 6 The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives.EBI Bioorg Med Chem Lett 22: 53-6 (2011) Shenyang Pharmaceutical University 2D 3D TSV
22172695 28 Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916).EBI Bioorg Med Chem Lett 22: 71-5 (2011) Arena Pharmaceuticals 2D 3D TSV
22172310 47 Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.EBI Bioorg Med Chem 20: 521-30 (2011) Punjabi University 2D 3D TSV
22172309 12 Novel bioactive metabolites of dipyrone (metamizol).EBI Bioorg Med Chem 20: 101-7 (2011) Philipps-Universit£t 2D 3D TSV
22172308 26 Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.EBI Bioorg Med Chem 20: 108-16 (2011) Medical University of Gdansk 2D 3D TSV
22172029 29 Design, synthesis, and anaplastic lymphoma kinase (ALK) inhibitory activity for a novel series of 2,4,8,22-tetraazatetracyclo[14.3.1.1³,¿?¿.1¿?¿,¹³]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles.EBI J Med Chem 55: 449-64 (2012) Cephalon Inc 2D 3D TSV
22171543 22 Chemistry and behavioral studies identify chiral cyclopropanes as selectivea4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.EBI J Med Chem 55: 717-24 (2012) University of Illinois at Chicago 2D 3D TSV
22170047 24 Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine α4β2 receptors: unique role of halogen bonding revealed.BDB J Biol Chem 287: 4248-59 (2012) University of Copenhagen 2D 3D TSV
22169633 47 N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.EBI Bioorg Med Chem 20: 215-24 (2011) Seoul National University 2D 3D TSV
22169601 16 Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.EBI Bioorg Med Chem 20: 125-36 (2011) University of Regensburg 2D 3D TSV
22169600 6 Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.EBI Bioorg Med Chem 20: 47-57 (2012) National Cancer Institute 2D 3D TSV
22169265 22 Activation of human RNase L by 2'- and 5'-O-methylphosphonate-modified oligoadenylates.EBI Bioorg Med Chem Lett 22: 181-5 (2011) Academy of Sciences of the Czech Republic 2D 3D TSV
22169263 73 Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases.EBI Bioorg Med Chem Lett 22: 133-7 (2011) Cephalon Inc 2D 3D TSV
22169262 26 Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase.EBI Bioorg Med Chem Lett 22: 110-4 (2011) Shenyang Pharmaceutical University 2D 3D TSV
22169261 38 Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.EBI Bioorg Med Chem Lett 22: 45-8 (2012) Cylene Pharmaceuticals Inc. 2D 3D TSV
22169260 36 A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors.EBI Bioorg Med Chem Lett 22: 65-70 (2011) Merck Research Laboratories 2D 3D TSV
22168898 10 Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.EBI J Med Chem 55: 1789-808 (2012) Merck Research Laboratories 2D 3D TSV
22168824 4 Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.EBI J Med Chem 55: 956-60 (2012) Amgen Inc 2D 3D TSV
22168802 12 Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry.BDB J Enzyme Inhib Med Chem 27: 886-91 (2012) Laboratoire Synthèse et Réactivité des Substances Naturelles 2D 3D TSV
22168797 2 Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor.EBI J Med Chem 55: 735-42 (2012) National Institute of Diabetes and Digestive and Kidney Diseases 2D 3D TSV
22168626 32 Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E.EBI J Med Chem 55: 1082-105 (2012) Ambit Biosciences 2D 3D TSV
22168126 43 Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.BDB J Enzyme Inhib Med Chem 28: 283-8 (2013) Ondokuz Mayis University 2D 3D TSV
22165973 5 2-Arylbenzofuran, flavonoid, and tyrosinase inhibitory constituents of Morus yunnanensis.EBI J Nat Prod 75: 82-7 (2012) Fudan University 2D 3D TSV
22165909 48 Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.EBI J Med Chem 55: 639-51 (2012) University of Illinois at Chicago 2D 3D TSV
22165858 8 Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein.EBI J Med Chem 55: 966-70 (2012) CNRS/Universit£ Lyon 1 2D 3D TSV
22165820 22 Fragment based drug discovery: practical implementation based on¹¿F NMR spectroscopy.EBI J Med Chem 55: 678-87 (2012) Amgen Inc 2D 3D TSV
22154891 19 Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38a.EBI Eur J Med Chem 48: 1-15 (2012) Chemical Genomics Centre of the Max Planck Society 2D 3D TSV
22154762 15 Design and synthesis of novel ?-diketo derivatives as HIV-1 integrase inhibitors.EBI Bioorg Med Chem 20: 177-82 (2012) Beijing University of Technology 2D 3D TSV
22154664 7 Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.EBI Bioorg Med Chem Lett 22: 168-71 (2011) The Second Military Medical University 2D 3D TSV
22154558 22 Structure-based redesign of an edema toxin inhibitor.EBI Bioorg Med Chem 20: 368-76 (2012) UTMB 2D 3D TSV
22154351 48 Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1).EBI Bioorg Med Chem Lett 22: 90-5 (2011) Xenon Pharmaceuticals Inc 2D 3D TSV
22154349 123 5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors.EBI Bioorg Med Chem Lett 22: 96-101 (2011) Nerviano Medical Sciences srl 2D 3D TSV
22153942 50 5-HT2c receptor selectivity and structure-activity relationship of N-methyl-N-(1-methylpiperidin-4-yl)benzenesulfonamide analogs.EBI Bioorg Med Chem Lett 22: 347-52 (2011) Korea Institute of Science and Technology 2D 3D TSV
22153941 140 Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.EBI Bioorg Med Chem Lett 22: 271-7 (2011) AstraZeneca 2D 3D TSV
22153937 52 Novel brain penetrant benzofuropiperidine 5-HT6 receptor antagonists.EBI Bioorg Med Chem Lett 22: 120-3 (2011) Cephalon Inc 2D 3D TSV
22153936 26 Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold.EBI Bioorg Med Chem Lett 22: 144-8 (2011) Ono Pharmaceutical Co., Ltd 2D 3D TSV
22153663 59 Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics.EBI Bioorg Med Chem Lett 22: 461-7 (2011) Griffin Discoveries BV 2D 3D TSV
22153662 137 Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases.EBI Bioorg Med Chem Lett 22: 262-6 (2011) AstraZeneca 2D 3D TSV
22153347 111 Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H¿?-antihistamines for insomnia.EBI Bioorg Med Chem Lett 22: 421-6 (2011) Neurocrine Biosciences Inc 2D 3D TSV
22153342 60 Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.EBI Bioorg Med Chem Lett 22: 186-9 (2011) Cephalon Inc 2D 3D TSV
22153340 37 Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).EBI Bioorg Med Chem Lett 22: 138-43 (2011) Pfizer Inc 2D 3D TSV
22153339 27 Novel poly(ADP-ribose) polymerase-1 inhibitors.EBI Bioorg Med Chem Lett 22: 222-4 (2011) Cephalon Inc 2D 3D TSV
22148957 8 Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase.EBI J Med Chem 55: 754-65 (2012) Merck Research Laboratories 2D 3D TSV
22148921 48 Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-cEBI J Med Chem 55: 903-13 (2012) Cephalon Inc 2D 3D TSV
22148859 190 Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A2B adenosine receptor antagonists.EBI J Med Chem 55: 797-811 (2012) University of Ferrara 2D 3D TSV
22148838 125 Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.EBI J Med Chem 55: 106-14 (2012) University of Michigan 2D 3D TSV
22148754 26 Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.EBI J Med Chem 55: 140-52 (2012) University of Dundee 2D 3D TSV
22148748 23 Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.EBI J Med Chem 55: 1445-64 (2012) Vanderbilt University Medical Center 2D 3D TSV
22148584 30 Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.EBI J Med Chem 55: 1047-55 (2012) University of Toronto 2D 3D TSV
22148391 2 Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).EBI J Med Chem 55: 312-26 (2012) University of Auckland 2D 3D TSV
22148349 7 Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities.EBI J Nat Prod 75: 111-4 (2012) The University of Tokyo 2D 3D TSV
22148323 53 Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase.EBI J Med Chem 55: 935-42 (2012) Pfizer Inc 2D 3D TSV
22148278 132 Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinaseEBI J Med Chem 55: 169-96 (2012) S BIO Pte. Ltd 2D 3D TSV
22148253 12 Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs.EBI J Med Chem 55: 688-96 (2012) University of Alberta 2D 3D TSV
22148241 3 Cyclopeptide Alkaloids from Ziziphus apetala.EBI J Nat Prod 74: 2571-5 (2011) Kunming Institute of Botany 2D 3D TSV
22148193 6 Secondary metabolites from the roots of Neolitsea daibuensis and their anti-inflammatory activity.EBI J Nat Prod 74: 2489-96 (2011) Kaohsiung Medical University 2D 3D TSV
22148173 2 Identification of novela4ß2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.EBI J Med Chem 55: 812-23 (2012) University of Illinois at Chicago 2D 3D TSV
22145694 64 Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity.BDB J Enzyme Inhib Med Chem 27: 880-5 (2012) Agri Ibrahim Cecen University 2D 3D TSV
22145674 18 Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules.BDB J Enzyme Inhib Med Chem 28: 316-9 (2013) Kirklareli University 2D 3D TSV
22145629 68 Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergica1- and serotonine 5-HT1A receptors.EBI J Med Chem 55: 23-36 (2012) Universit£ degli Studi di Modena e Reggio Emilia 2D 3D TSV
22142613 15 Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.EBI Bioorg Med Chem 20: 283-95 (2011) Purdue University 2D 3D TSV
22142546 16 AChE inhibitor: a regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxy spiro[5.3']-oxindole-spiro-[6.3¿]-2,3-dihydro-1H-inden-1¿-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole.EBI Bioorg Med Chem Lett 22: 508-11 (2011) Universiti Sains Malaysia 2D 3D TSV
22142545 96 Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia.EBI Bioorg Med Chem Lett 22: 235-9 (2011) Merck Research Laboratories 2D 3D TSV
22142542 73 4,5-dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists.EBI Bioorg Med Chem Lett 22: 194-8 (2011) Cephalon Inc 2D 3D TSV
22142541 24 SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors.EBI Bioorg Med Chem Lett 22: 199-203 (2011) Merck Sharp & Dohme Corp 2D 3D TSV
22142540 27 Synthesis of bivalent lactosides and their activity as sensors for differences between lectins in inter- and intrafamily comparisons.EBI Bioorg Med Chem Lett 22: 313-8 (2011) Ludwig-Maximilians-University Munich 2D 3D TSV
22142423 27 Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A2A and A3 adenosine receptor ligands.EBI J Med Chem 55: 342-56 (2012) Ewha Womans University 2D 3D TSV
22141460 12 2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors.BDB J Enzyme Inhib Med Chem 28: 305-10 (2013) Gazi University 2D 3D TSV
22141319 56 Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors.EBI J Med Chem 55: 115-25 (2012) Cephalon Inc 2D 3D TSV
22138308 18 Identification of new aminoacid amides containing the imidazo[2,1-b]benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling.EBI Eur J Med Chem 47: 239-54 (2012) University of the Mediterranean 2D 3D TSV
22137934 9 Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.EBI Bioorg Med Chem 20: 234-42 (2012) University of Oslo 2D 3D TSV
22137933 6 Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.EBI Bioorg Med Chem 20: 1878-86 (2012) University of Oxford 2D 3D TSV
22137932 17 Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.EBI Bioorg Med Chem 20: 183-94 (2011) Virginia Tech 2D 3D TSV
22137790 33 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).EBI Bioorg Med Chem Lett 22: 427-30 (2011) Korea Research Institute of Chemical Technology 2D 3D TSV
22137788 3 Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.EBI Bioorg Med Chem Lett 22: 323-6 (2011) Korea Research Institute of Bioscience and Biotechnology 2D 3D TSV
22137787 22 Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E2 synthase-1 inhibitors.EBI Bioorg Med Chem Lett 22: 285-8 (2011) Dainippon Sumitomo Pharma Co., Ltd 2D 3D TSV
22137786 9 Hydroxycoumarins as selective MAO-B inhibitors.EBI Bioorg Med Chem Lett 22: 258-61 (2011) Universit£ degli Studi di Cagliari 2D 3D TSV
22137785 6 Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.EBI Bioorg Med Chem Lett 22: 231-4 (2011) Institute of Microbial Chemistry 2D 3D TSV
22137598 15 Stereochemical diversity of AI-2 analogs modulates quorum sensing in Vibrio harveyi and Escherichia coli.EBI Bioorg Med Chem 20: 249-56 (2011) Instituto de Tecnologia Qu£mica e Biol£gica 2D 3D TSV
22137457 3 Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.EBI Eur J Med Chem 47: 493-500 (2012) VU University Amsterdam 2D 3D TSV
22137345 36 5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.EBI Bioorg Med Chem Lett 22: 267-70 (2011) Universit£ degli Studi di Firenze 2D 3D TSV
22137342 26 Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors.EBI Bioorg Med Chem Lett 22: 747-52 (2011) Celgene Corporation 2D 3D TSV
22137341 10 Identification of oxazolidinediones and thiazolidinediones as potent 17ß-hydroxysteroid dehydrogenase type 3 inhibitors.EBI Bioorg Med Chem Lett 22: 504-7 (2011) Sumitomo Chemical Co., Ltd 2D 3D TSV
22137339 23 Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.EBI Bioorg Med Chem Lett 22: 278-84 (2011) University of Leeds 2D 3D TSV
22136765 31 Synthesis, radiofluorination and pharmacological evaluation of a fluoromethyl spirocyclic PET tracer for centrals1 receptors and comparison with fluoroalkyl homologs.EBI Bioorg Med Chem 20: 257-69 (2011) Institute of Radiopharmacy 2D 3D TSV
22136469 148 Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.EBI J Med Chem 55: 587-96 (2012) GlaxoSmithKline 2D 3D TSV
22136433 67 7,8-dichloro-1-oxo-ß-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.EBI J Med Chem 55: 403-13 (2012) Ludwig-Maximilians University of Munich 2D 3D TSV
22136404 9 Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.EBI J Med Chem 55: 576-86 (2012) GlaxoSmithKline 2D 3D TSV
22136336 55 Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB).EBI J Med Chem 55: 390-402 (2012) Universidade Federal de Santa Catarina 2D 3D TSV
22133902 9 Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.EBI Bioorg Med Chem 20: 1940-6 (2012) Indiana University 2D 3D TSV
22133631 76 Discovery of cyclic amine-substituted benzoic acids as PPARa agonists.EBI Bioorg Med Chem Lett 22: 334-8 (2011) Kyorin Pharmaceutical Co., Ltd 2D 3D TSV
22133459 56 New potent 5-HT(2A) receptor ligands containing an N'-cyanopicolinamidine nucleus: Synthesis and in vitro pharmacological evaluation.EBI Eur J Med Chem 47: 520-9 (2012) Universit£ di Napoli"Federico II" 2D 3D TSV
22130420 49 Quantitative structure-activity relationships of 1,3,4-thiadiazol-2(3H)-ones and 1,3,4-oxadiazol-2(3H)-ones as human protoporphyrinogen oxidase inhibitors.EBI Bioorg Med Chem 20: 296-304 (2011) Central China Normal University 2D 3D TSV
22130135 55 Discovery of potent and specific CXCR3 antagonists.EBI Bioorg Med Chem Lett 22: 357-62 (2011) Amgen Inc 2D 3D TSV
22130134 58 5-sulfonyl-benzimidazoles as selective CB2 agonists-part 2.EBI Bioorg Med Chem Lett 22: 547-52 (2011) Janssen Pharmaceutica NV 2D 3D TSV
22130133 9 Discovery and bioactivity of 4-(2-arylpyrido[3',2':3,4]pyrrolo[1,2-f][1,2,4]triazin-4-yl) morpholine derivatives as novel PI3K inhibitors.EBI Bioorg Med Chem Lett 22: 339-42 (2011) Chinese Academy of Sciences 2D 3D TSV
22130130 19 Discovery of pyrrolidine-basedß-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency.EBI Bioorg Med Chem Lett 22: 240-4 (2011) Merck Research Laboratories 2D 3D TSV
22128851 3 (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent¿-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.EBI J Med Chem 55: 357-66 (2012) Northwestern University 2D 3D TSV
22128783 2 Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.EBI J Med Chem 55: 558-62 (2012) Boston University 2D 3D TSV
22125663 11 Structure-activity analysis and cell-based optimization of human galactokinase inhibitors.EBI ACS Med Chem Lett 2: 667-672 (2011) TBA 2D 3D TSV
22125662 11 CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist.EBI ACS Med Chem Lett 2: 620-625 (2011) TBA 2D 3D TSV
22125025 4 Inactivation of glucosamine-6-phosphate synthase by N3-oxoacyl derivatives of L-2,3-diaminopropanoic acid.BDB Chembiochem 13: 85-96 (2012) Gda£?sk University of Technology 2D 3D TSV
22123324 36 Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2.EBI Bioorg Med Chem Lett 22: 363-6 (2011) Amgen Inc 2D 3D TSV
22122563 34 Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptorß-selective ligands.EBI J Med Chem 55: 528-37 (2012) University of Illinois 2D 3D TSV
22119475 19 Fused thiophene derivatives as MEK inhibitors.EBI Bioorg Med Chem Lett 22: 472-5 (2012) UCB Pharma 2D 3D TSV
22119474 46 Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism.EBI Bioorg Med Chem Lett 22: 367-70 (2011) Amgen Inc 2D 3D TSV
22119472 35 One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities.EBI Bioorg Med Chem Lett 22: 410-4 (2011) Birla Institute of Technology 2D 3D TSV
22119471 64 Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.EBI Bioorg Med Chem Lett 22: 396-401 (2011) Minase Research Institute 2D 3D TSV
22119469 107 Novel and selective spiroindoline-based inhibitors of Sky kinase.EBI Bioorg Med Chem Lett 22: 190-3 (2011) Pfizer Inc 2D 3D TSV
22119468 1 (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).EBI Bioorg Med Chem Lett 22: 523-6 (2011) Duquesne University 2D 3D TSV
22119466 38 A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity.EBI Bioorg Med Chem Lett 22: 415-20 (2011) Pfizer Inc 2D 3D TSV
22119465 18 Structure-based design of PDK1 inhibitors.EBI Bioorg Med Chem Lett 22: 305-7 (2011) S BIO Pte. Ltd 2D 3D TSV
22119462 73 Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series.EBI Bioorg Med Chem Lett 22: 613-8 (2011) Merck Research Laboratories 2D 3D TSV
22119461 31 Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists.EBI Bioorg Med Chem Lett 22: 537-42 (2011) The Scripps Research Institute 2D 3D TSV
22119341 10 Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold.EBI Bioorg Med Chem Lett 22: 553-7 (2011) Institute of Pharmacology & Toxicology 2D 3D TSV
22119153 64 Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.EBI Eur J Med Chem 47: 111-24 (2012) Alexander Technological Education Institute of Thessaloniki 2D 3D TSV
22119130 11 Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.EBI Eur J Med Chem 47: 473-8 (2012) Nanjing University 2D 3D TSV
22118829 13 Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors.EBI Eur J Med Chem 47: 351-9 (2012) University of Hyderabad 2D 3D TSV
22118188 50 A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.EBI J Med Chem 55: 223-32 (2012) University Hospital M£nster 2D 3D TSV
22115839 42 Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.EBI Bioorg Med Chem 20: 510-20 (2011) Purdue University 2D 3D TSV
22115618 13 Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents.EBI Eur J Med Chem 47: 97-103 (2012) National Cheng Kung University 2D 3D TSV
22115617 64 CK2a and CK2a' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.EBI Eur J Med Chem 47: 345-50 (2012) The John Paul II Catholic University of Lublin 2D 3D TSV
22115595 8 3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-?-lactamase inhibitors.EBI Bioorg Med Chem Lett 22: 380-6 (2012) The University of Queensland 2D 3D TSV
22115592 1 A small molecule inhibitor of p53-inducible protein phosphatase PPM1D.EBI Bioorg Med Chem Lett 22: 729-32 (2011) Hokkaido University 2D 3D TSV
22113110 6 Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX.EBI Bioorg Med Chem Lett 22: 482-4 (2011) North-West University 2D 3D TSV
22112542 1 Molecular docking studies of a phlorotannin, dieckol isolated from Ecklonia cava with tyrosinase inhibitory activity.EBI Bioorg Med Chem 20: 311-6 (2011) Jeju National University 2D 3D TSV
22112541 11 Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.EBI Bioorg Med Chem 20: 317-23 (2011) Soochow University 2D 3D TSV
22112540 70 Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.EBI Bioorg Med Chem 20: 346-55 (2011) University of Bonn 2D 3D TSV
22112539 8 Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads.EBI Bioorg Med Chem 20: 377-400 (2011) University of Jordan 2D 3D TSV
22112538 22 Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.EBI Bioorg Med Chem 20: 1354-63 (2012) Macquarie University 2D 3D TSV
22112208 98 Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein.EBI J Med Chem 55: 424-36 (2012) Universit£ degli Studi di Bari"Aldo Moro" 2D 3D TSV
22111927 65 Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing.EBI J Med Chem 54: 8328-42 (2011) The Institute of Cancer Research 2D 3D TSV
22111545 80 Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.EBI J Med Chem 55: 327-41 (2012) University of Bristol 2D 3D TSV
22107736 8 Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.BDB Chem Biol Drug Des 79: 157-65 (2012) National Institutes of Health 2D 3D TSV
22107038 32 Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.EBI J Med Chem 55: 437-48 (2012) Bar-Ilan University 2D 3D TSV
22107017 47 Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.EBI J Med Chem 55: 414-23 (2012) Cephalon Inc 2D 3D TSV
22106937 83 Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.EBI J Med Chem 54: 8305-20 (2011) Tranzyme Pharma Inc. 2D 3D TSV
22106171 9 Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals.EBI Drug Metab Dispos 40: 426-35 (2012) University of Washington 2D 3D TSV
22104971 3 Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.EBI Eur J Med Chem 47: 299-311 (2012) Sun Yat-sen University 2D 3D TSV
22104435 54 Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.EBI Bioorg Med Chem 20: 356-67 (2011) University of Toyama 2D 3D TSV
22104149 1 Potent adjuvantic activity of a CCR1-agonistic bis-quinoline.EBI Bioorg Med Chem Lett 22: 293-5 (2011) University of Kansas 2D 3D TSV
22104147 29 Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly.EBI Bioorg Med Chem Lett 22: 591-6 (2011) Carna Biosciences, Inc 2D 3D TSV
22104145 6 Synthesis and evaluation of potential inhibitors of human and Escherichia coli histidine triad nucleotide binding proteins.EBI Bioorg Med Chem Lett 22: 558-60 (2011) University of Minnesota 2D 3D TSV
22104144 37 Quinolinone-based agonists of S1P¿?: use of a N-scan SAR strategy to optimize in vitro and in vivo activity.EBI Bioorg Med Chem Lett 22: 527-31 (2011) Amgen 2D 3D TSV
22104142 9 Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8.EBI Bioorg Med Chem Lett 22: 723-8 (2011) Pfizer Inc 2D 3D TSV
22104008 64 Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A2A adenosine receptor.EBI J Med Chem 55: 538-52 (2012) National Institute of Diabetes and Digestive and Kidney Diseases 2D 3D TSV
22103243 81 Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.EBI J Med Chem 55: 250-67 (2012) The National Center for Drug Screening 2D 3D TSV
22102940 3 Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A.EBI ACS Med Chem Lett 2: 396-401 (2011) U.S. Army Medical Research Institute for Infectious Diseases 2D 3D TSV
22101134 9 LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line.EBI Bioorg Med Chem Lett 22: 586-90 (2011) Universit£ catholique de Louvain (UCL) 2D 3D TSV
22101133 26 Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.EBI Bioorg Med Chem Lett 22: 623-7 (2011) Merck Frosst Centre for Therapeutic Research 2D 3D TSV
22101132 41 Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases.EBI Bioorg Med Chem Lett 22: 456-60 (2011) Shionogi & Co., Ltd 2D 3D TSV
22100314 38 Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P¿? agonists with in vivo lymphocyte-depleting activity.EBI Bioorg Med Chem Lett 22: 628-33 (2011) Amgen Inc 2D 3D TSV
22100312 70 Indole RSK inhibitors. Part 1: discovery and initial SAR.EBI Bioorg Med Chem Lett 22: 733-7 (2011) Boehringer Ingelheim Pharmaceuticals Inc 2D 3D TSV
22100261 12 Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.EBI Bioorg Med Chem 20: 446-54 (2011) Saitama University 2D 3D TSV
22100260 30 The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics.EBI Bioorg Med Chem 20: 498-509 (2011) Pfizer Inc 2D 3D TSV
22100258 124 Bivalent molecular probes for dopamine D2-like receptors.EBI Bioorg Med Chem 20: 455-66 (2011) Friedrich-Alexander University 2D 3D TSV
22100142 41 Monoamine oxidase inhibition by C4-substituted phthalonitriles.BDB Bioorg Chem 40: 114-24 (2012) North-West University 2D 3D TSV
22100140 10 Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.EBI Eur J Med Chem 47: 270-7 (2012) University of Eastern Finland 2D 3D TSV
22100138 4 Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.EBI Eur J Med Chem 47: 175-85 (2012) Instituto de Qu£mica M£dica (CSIC) 2D 3D TSV
22100137 6 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.EBI Eur J Med Chem 47: 337-44 (2012) University of Groningen 2D 3D TSV
22098589 47 Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors.EBI J Med Chem 55: 68-83 (2012) University of Lille 2D 3D TSV
22098494 4 Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious¿-secretase modulators in vivo.EBI J Med Chem 55: 489-502 (2012) Schering-Plough Research Institute 2D 3D TSV
22094280 3 Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.EBI Bioorg Med Chem 19: 7318-37 (2011) University of Heidelberg 2D 3D TSV
22094279 75 Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists.EBI Bioorg Med Chem 20: 422-34 (2011) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22094028 31 Lead optimisation of pyrazoles as novel FPR1 antagonists.EBI Bioorg Med Chem Lett 22: 532-6 (2011) AstraZeneca 2D 3D TSV
22091869 6 Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.EBI J Med Chem 54: 8555-62 (2011) Faculdade de Ci�ncias e Tecnologia-UNL 2D 3D TSV
22088955 33 Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.EBI Eur J Med Chem 47: 143-52 (2012) Universit£ di Napoli Federico II Via D. Montesano 49 2D 3D TSV
22088753 44 Chromenones as potent bradykinin B1 antagonists.EBI Bioorg Med Chem Lett 22: 619-22 (2011) Amgen Inc 2D 3D TSV
22088307 10 Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.EBI Bioorg Med Chem 19: 7365-73 (2011) Institute of Chemical Biology 2D 3D TSV
22087750 145 Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors.EBI J Med Chem 54: 8440-50 (2011) Amgen Inc 2D 3D TSV
22087650 9 Delineation of the Pasteurellaceae-specific GbpA-family of glutathione-binding proteins.BDB BMC Biochem 12: 59 (2011) Ghent University 2D 3D TSV
22087535 20 Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.EBI J Med Chem 55: 280-90 (2012) Washington State University 2D 3D TSV
22085405 54 Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.EBI J Med Chem 54: 8574-81 (2011) Academia Sinica 2D 3D TSV
22085339 16 Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.EBI J Med Chem 54: 8421-39 (2011) Hokkaido University 2D 3D TSV
22083916 65 Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B).BDB Chem Biodivers 8: 2035-44 (2011) East China University of Science and Technology 2D 3D TSV
22082667 67 Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.EBI Bioorg Med Chem 19: 7338-48 (2011) Microbiotix Inc 2D 3D TSV
22082562 3 Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase.EBI Bioorg Med Chem Lett 22: 610-2 (2011) University of Karachi 2D 3D TSV
22082561 9 Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.EBI Bioorg Med Chem Lett 22: 679-82 (2011) Johannes Gutenberg University 2D 3D TSV
22081932 32 Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity.EBI J Med Chem 55: 37-54 (2012) Istituto Tumori"Giovanni Paolo II" 2D 3D TSV
22079761 84 The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors.EBI Bioorg Med Chem Lett 22: 658-65 (2011) Merck Research Laboratories 2D 3D TSV
22079757 13 Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).EBI Bioorg Med Chem Lett 22: 718-22 (2011) McMaster University 2D 3D TSV
22079756 219 From libraries to candidate: the discovery of new ultra long-acting dibasicß2-adrenoceptor agonists.EBI Bioorg Med Chem Lett 22: 689-95 (2011) AstraZeneca 2D 3D TSV
22079754 72 Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.EBI Bioorg Med Chem Lett 22: 601-5 (2011) Columbia University 2D 3D TSV
22079253 16 Discovery of selective glucocorticoid receptor modulator MK-5932.EBI Bioorg Med Chem 19: 7374-86 (2011) Merck Research Laboratories 2D 3D TSV
22079027 8 Conformationally restricted analog and biotin-labeled probe based on beauveriolide III.EBI Bioorg Med Chem Lett 22: 696-9 (2011) Tohoku University 2D 3D TSV
22078413 8 Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes.EBI Bioorg Med Chem 19: 7698-710 (2011) Instituto Tecnol£gico e Nuclear 2D 3D TSV
22078412 4 Disulfide and amide-bridged cyclic peptide analogues of the VEGF8¿?¿9¿? fragment: synthesis, conformational analysis and biological evaluation.EBI Bioorg Med Chem 19: 7526-33 (2011) Instituto de Qu£mica M£dica 2D 3D TSV
22078410 31 Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines.EBI Bioorg Med Chem 19: 7482-92 (2011) West Virginia University 2D 3D TSV
22078216 146 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.EBI Bioorg Med Chem Lett 21: 7367-72 (2011) Novartis Institutes for BioMedical Research 2D 3D TSV
22078215 25 Biaryl analogues of teriflunomide as potent DHODH inhibitors.EBI Bioorg Med Chem Lett 21: 7268-72 (2011) Rhône-Poulenc Rorer 2D 3D TSV
22078214 29 Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.EBI Bioorg Med Chem Lett 21: 7287-90 (2011) Merck Research Laboratories 2D 3D TSV
22077416 30 Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability.EBI J Med Chem 54: 8353-61 (2011) Universit£ de Li£ge 2D 3D TSV
22077347 44 Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.EBI J Med Chem 54: 8271-7 (2011) Ecole Nationale Sup£rieure de Chimie de Montpellier 2D 3D TSV
22075234 35 Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities ass¿? receptor ligands.EBI Bioorg Med Chem 19: 7612-22 (2011) Universit£ degli Studi di Bari 2D 3D TSV
22075233 16 New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.EBI Bioorg Med Chem 19: 7453-63 (2011) The University of Adelaide 2D 3D TSV
22074142 89 Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.EBI J Med Chem 54: 8616-31 (2011) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22071527 2 Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin ? 20-sulfate analogues.EBI Bioorg Med Chem 19: 7541-50 (2011) Nagasaki University 2D 3D TSV
22071524 7 Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO.EBI Bioorg Med Chem 19: 7416-24 (2011) Federal University of Rio de Janeiro 2D 3D TSV
22071522 6 Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents.EBI Bioorg Med Chem 19: 7635-42 (2011) University of Lisbon 2D 3D TSV
22071521 1 Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction.EBI Bioorg Med Chem 19: 7690-7 (2011) Tokyo University of Science 2D 3D TSV
22071305 24 Rational design and synthesis of aminopiperazinones asß-secretase (BACE) inhibitors.EBI Bioorg Med Chem Lett 21: 7255-60 (2011) Research Informatics & Integrative Genomics 2D 3D TSV
22071301 115 Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.EBI Bioorg Med Chem Lett 21: 7399-404 (2011) Merck Frosst Centre for Therapeutic Research 2D 3D TSV
22071300 7 Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase.EBI Bioorg Med Chem Lett 21: 7344-50 (2011) Merck Research Labs. 2D 3D TSV
22071299 6 Inhibitory activity of novel kojic acid derivative containing trolox moiety on melanogenesis.EBI Bioorg Med Chem Lett 21: 7466-9 (2011) Kyung Hee University Skin Biotechnology Center 2D 3D TSV
22070629 61 Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905).EBI J Med Chem 55: 197-208 (2012) Millennium Pharmaceuticals Inc 2D 3D TSV
22070604 150 Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor¿ (PPAR¿) modulators.EBI J Med Chem 54: 8541-54 (2011) Merck Research Laboratories 2D 3D TSV
22066525 65 Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.EBI J Med Chem 54: 8592-604 (2011) Universit£ degli Studi di Ferrara 2D 3D TSV
22061826 19 Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.EBI Bioorg Med Chem 19: 7603-11 (2011) Ghent University 2D 3D TSV
22061645 68 Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group.EBI Bioorg Med Chem Lett 21: 7261-4 (2011) Cephalon Inc 2D 3D TSV
22061644 10 Investigation of the diastereomerism of dihydrobenzoxathiin SERMs for ER alpha by molecular modeling.EBI Bioorg Med Chem Lett 21: 7298-305 (2011) Zhejiang University 2D 3D TSV
22061641 49 The discovery of novel cyclohexylamide CCR2 antagonists.EBI Bioorg Med Chem Lett 21: 7496-501 (2011) Johnson & Johnson Pharmaceutical Research and Development LLC 2D 3D TSV
22061640 5 Discovery of 4-aminomethylphenylacetic acids as¿-secretase modulators via a scaffold design approach.EBI Bioorg Med Chem Lett 21: 7277-80 (2011) Biogen Idec Inc 2D 3D TSV
22061639 54 Discovery, optimisation and in vivo evaluation of novel GPR119 agonists.EBI Bioorg Med Chem Lett 21: 7310-6 (2011) AstraZeneca UK 2D 3D TSV
22061638 2 Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary.EBI Bioorg Med Chem Lett 21: 7505-8 (2011) Toray Industries Inc 2D 3D TSV
22060139 21 Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.EBI J Med Chem 54: 8681-92 (2011) The Ohio State University 2D 3D TSV
22059882 206 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor.EBI J Med Chem 54: 8013-29 (2011) Amira Pharmaceuticals 2D 3D TSV
22056747 23 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor.EBI Bioorg Med Chem Lett 21: 7405-11 (2011) Northeast Ohio Medical University 2D 3D TSV
22056746 53 Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity.EBI Bioorg Med Chem Lett 22: 738-42 (2011) Boehringer Ingelheim Pharmaceuticals Inc 2D 3D TSV
22056744 16 Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone.EBI Bioorg Med Chem Lett 21: 7321-4 (2011) Universit£ Catholique de Louvain 2D 3D TSV
22055716 45 Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters.EBI Bioorg Med Chem 19: 7551-8 (2011) University of New Orleans 2D 3D TSV
22055714 9 Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.EBI Bioorg Med Chem 19: 7435-40 (2011) University of Wisconsin School of Medicine and Public Health 2D 3D TSV
22055712 33 Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase.EBI Bioorg Med Chem 19: 7507-18 (2011) North-West University 2D 3D TSV
22055408 12 Conformationally restricted analogs of the direct thrombin inhibitor FM 19.EBI Bioorg Med Chem 19: 7425-34 (2011) University of Michigan 2D 3D TSV
22054058 22 Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.EBI J Med Chem 54: 8299-304 (2011) University of Bologna 2D 3D TSV
22051063 6 Synthesis and kinetic testing of new inhibitors for a metallo-?-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa.EBI Eur J Med Chem 46: 6075-82 (2011) Helwan University 2D 3D TSV
22051054 18 Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516.EBI Bioorg Med Chem 19: 6982-8 (2011) University of Oslo 2D 3D TSV
22050606 36 a-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters.BDB J Enzyme Inhib Med Chem 27: 148-54 (2012) Dumlupinar University 2D 3D TSV
22050263 3 Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities.EBI J Med Chem 54: 8461-70 (2011) Instituto de Quimica Medica-CSIC 2D 3D TSV
22050212 12 Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.EBI J Med Chem 54: 8702-6 (2011) Universit£ di Messina 2D 3D TSV
22047802 8 The arginine mimickingß-amino acidß³hPhe(3-H2N-CH2) as S1 ligand in cyclotheonamide-basedß-tryptase inhibitors.EBI Bioorg Med Chem 19: 7236-43 (2011) Universit£t Bielefeld 2D 3D TSV
22047797 16 Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs.EBI Bioorg Med Chem 19: 6977-81 (2011) Medical University of Lodz 2D 3D TSV
22047696 17 Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.EBI Bioorg Med Chem Lett 21: 7295-7 (2011) Sepuluh Nopember Institute of Technology 2D 3D TSV
22047692 50 Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy.EBI Bioorg Med Chem Lett 21: 7281-6 (2011) Merck Frosst Centre for Therapeutic Research 2D 3D TSV
22047691 76 The discovery of AZD9164, a novel muscarinic M3 antagonist.EBI Bioorg Med Chem Lett 21: 7440-6 (2011) AstraZeneca 2D 3D TSV
22047689 18 Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases.EBI Bioorg Med Chem Lett 21: 7489-95 (2011) GlaxoSmithKline 2D 3D TSV
22047688 51 CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole blood.EBI Bioorg Med Chem Lett 21: 7291-4 (2011) GlaxoSmithKline 2D 3D TSV
22047606 29 Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.EBI J Med Chem 54: 8563-73 (2011) University of British Columbia 2D 3D TSV
22046493 15 Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design.EBI ACS Med Chem Lett 2: 764-767 (2011) TBA 2D 3D TSV
22044621 4 ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.EBI Bioorg Med Chem Lett 21: 7474-8 (2011) University of North Carolina 2D 3D TSV
22044620 36 Orally active zwitterionic factor Xa inhibitors with long duration of action.EBI Bioorg Med Chem Lett 21: 7337-43 (2011) Daiichi Sankyo Co., Ltd 2D 3D TSV
22044245 4 Cucurbitane glucosides from the root of Machilus yaoshansis.EBI J Nat Prod 74: 2431-7 (2011) State Key Laboratory of Bioactive Substance and Function of Natural Medicines, and Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine 2D 3D TSV
22044209 56 Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.EBI J Med Chem 54: 8278-88 (2011) Universit£ degli Studi di Siena 2D 3D TSV
22044119 84 Design, synthesis, and qualitative structure-activity evaluations of novelß-secretase inhibitors as potential Alzheimer's drug leads.EBI J Med Chem 54: 8373-85 (2011) University of Sharjah 2D 3D TSV
22041175 74 Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.EBI Bioorg Med Chem 19: 6989-99 (2011) Genkyotex S.A. 2D 3D TSV
22041172 41 Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.EBI Bioorg Med Chem 19: 7228-35 (2011) Guangzhou Institute of Biomedicine and Health 2D 3D TSV
22041171 44 Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors.EBI Bioorg Med Chem 19: 7003-7 (2011) Universit£ di Messina 2D 3D TSV
22041060 33 2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation.EBI Bioorg Med Chem Lett 21: 7325-30 (2011) Cephalon Inc 2D 3D TSV
22041058 44 Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.EBI Bioorg Med Chem Lett 21: 7516-21 (2011) Bristol-Myers Squibb Co. 2D 3D TSV
22041057 14 Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.EBI Bioorg Med Chem Lett 21: 7416-20 (2011) AstraZeneca R&D Boston 2D 3D TSV
22040023 63 Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1).EBI J Med Chem 54: 8490-500 (2011) Pfizer Inc 2D 3D TSV
22039961 21 Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.EBI J Med Chem 54: 8343-52 (2011) Forschungszentrum J£lich GmbH 2D 3D TSV
22039836 188 Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141).EBI J Med Chem 54: 7860-83 (2011) Johnson & Johnson Pharmaceutical Research & Development 2D 3D TSV
22037378 31824 Comprehensive analysis of kinase inhibitor selectivity.EBI Nat Biotechnol 29: 1046-51 (2011) Ambit Biosciences 2D 3D TSV
22037253 51 Triazole ring-opening leads to the discovery of potent nonsteroidal 17ß-hydroxysteroid dehydrogenase type 2 inhibitors.EBI Eur J Med Chem 46: 5978-90 (2011) Saarland University 2D 3D TSV
22037049 62 Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.EBI Bioorg Med Chem 19: 7044-8 (2011) Research Triangle Institute 2D 3D TSV
22037047 1 (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.EBI Bioorg Med Chem 19: 7181-5 (2011) Slovak Academy of Sciences 2D 3D TSV
22036212 8 Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro.EBI Bioorg Med Chem 19: 7100-10 (2011) Jilin University 2D 3D TSV
22036211 4 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.EBI Bioorg Med Chem 19: 7262-9 (2011) Beijing Institute of Technology 2D 3D TSV
22033461 4 Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors.EBI Bioorg Med Chem Lett 21: 6964-8 (2011) Beijing National Laboratory for Molecular Sciences 2D 3D TSV
22033460 38 Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.EBI Bioorg Med Chem Lett 21: 6950-4 (2011) Genzyme Corp. 2D 3D TSV
22032632 56 Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.EBI J Med Chem 54: 8471-89 (2011) Georgia State University 2D 3D TSV
22031623 2 Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.EBI Drug Metab Dispos 40: 276-82 (2012) Astellas Pharma Inc 2D 3D TSV
22030032 8 Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases.EBI Bioorg Med Chem Lett 21: 7483-8 (2011) GlaxoSmithKline 2D 3D TSV
22030030 5 Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2.EBI Bioorg Med Chem Lett 21: 7089-93 (2011) Monash University (Parkville Campus) 2D 3D TSV
22030028 55 Discovery of N-aryl-2-acylindole human glucagon receptor antagonists.EBI Bioorg Med Chem Lett 21: 7124-30 (2011) Merck Research Laboratories 2D 3D TSV
22030027 12 Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kß) inhibitors with selectivity over PI3Ka.EBI Bioorg Med Chem Lett 21: 6977-81 (2011) Institute of Science and Technology (KAIST) 2D 3D TSV
22030026 13 Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.EBI Bioorg Med Chem Lett 21: 6955-9 (2011) Vanderbilt University Medical Center 2D 3D TSV
22029386 156 New serotonin 5-HT(1A) receptor agonists with neuroprotective effect against ischemic cell damage.EBI J Med Chem 54: 7986-99 (2011) Universidad Complutense de Madrid 2D 3D TSV
22029285 6 Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.EBI J Med Chem 54: 8161-73 (2011) Chemical Diversity Research Institute 2D 3D TSV
22028316 2 Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.EBI Drug Metab Dispos 40: 240-8 (2012) Kanazawa University 2D 3D TSV
22027102 7 Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.EBI Eur J Med Chem 46: 5949-58 (2011) Zhejiang University 2D 3D TSV
22024272 18 Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.EBI Bioorg Med Chem 19: 7120-8 (2011) Southern Research Institute 2D 3D TSV
22024030 22 Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors.EBI Bioorg Med Chem Lett 21: 6941-4 (2011) Pfizer Inc 2D 3D TSV
22023459 42 Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.EBI J Med Chem 54: 8251-70 (2011) Universitat Aut£noma de Barcelona 2D 3D TSV
22019468 15 Identification of novel CYP2A6 inhibitors by virtual screening.EBI Bioorg Med Chem 19: 7186-93 (2011) University of Eastern Finland 2D 3D TSV
22019466 13 Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors.EBI Bioorg Med Chem 19: 7129-35 (2011) National Chemical Laboratory (CSIR-NCL) 2D 3D TSV
22019465 28 Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.EBI Bioorg Med Chem 19: 7158-67 (2011) Zhejiang University 2D 3D TSV
22019296 32 Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.EBI Bioorg Med Chem Lett 21: 7001-5 (2011) Amgen Inc 2D 3D TSV
22019228 52 Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-ß aggregation.EBI Eur J Med Chem 46: 5885-93 (2011) Sun Yat-sen University 2D 3D TSV
22019188 4 Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.EBI Eur J Med Chem 46: 5970-7 (2011) Zhejiang University 2D 3D TSV
22019186 6 Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents.EBI Eur J Med Chem 46: 5763-8 (2011) Jamia Hamdard (Hamdard University) 2D 3D TSV
22019046 35 Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor.EBI Bioorg Med Chem 19: 7221-7 (2011) Sanwa Kagaku Kenkyusho Co., Ltd 2D 3D TSV
22018919 3 Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation.EBI Bioorg Med Chem 19: 7168-80 (2011) University of Innsbruck 2D 3D TSV
22018918 8 13,13-Dimethyl-des-C,D analogues of (20S)-1a,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): total synthesis, docking to the VDR, and biological evaluation.EBI Bioorg Med Chem 19: 7205-20 (2011) University of Wisconsin-Madison 2D 3D TSV
22018877 25 Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines.EBI Eur J Med Chem 46: 6002-14 (2011) Norwegian University of Science and Technology 2D 3D TSV
22018876 4 Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.EBI Eur J Med Chem 46: 6104-11 (2011) Facult£s Universitaires Notre-Dame de Paix 2D 3D TSV
22018790 9 Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.EBI Bioorg Med Chem Lett 21: 7180-4 (2011) Scripps Florida 2D 3D TSV
22018789 73 Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II).EBI Bioorg Med Chem Lett 21: 7113-8 (2011) The Scripps Research Institute 2D 3D TSV
22018787 57 Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.EBI Bioorg Med Chem Lett 21: 7210-5 (2011) The Scripps Research Institute 2D 3D TSV
22018464 4 Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.EBI Bioorg Med Chem Lett 21: 7013-6 (2011) Washington State University 2D 3D TSV
22018463 40 III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold.EBI Bioorg Med Chem Lett 21: 6982-6 (2011) Merck Research Laboratories 2D 3D TSV
22018461 41 Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).EBI Bioorg Med Chem Lett 21: 7006-12 (2011) Bristol-Myers Squibb Research and Development 2D 3D TSV
22017539 75 Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.EBI J Med Chem 54: 8174-87 (2011) Boehringer Ingelheim Pharmaceuticals Inc 2D 3D TSV
22017497 34 Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.EBI J Med Chem 54: 8228-32 (2011) Sapienza University of Rome 2D 3D TSV
22017477 35 Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.EBI J Med Chem 54: 8289-98 (2011) Instituto Superior T£cnico 2D 3D TSV
22014826 3 A small molecule that preferentially binds the closed conformation of Hsp90.EBI Bioorg Med Chem Lett 21: 7068-71 (2011) San Diego State University 2D 3D TSV
22014755 36 Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells.EBI Bioorg Med Chem 19: 6760-7 (2011) Hanyang University 2D 3D TSV
22014750 1 Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.EBI Bioorg Med Chem 19: 6779-91 (2011) University of Innsbruck 2D 3D TSV
22014558 21 New spirocyclic¿²-isoxazoline derivatives related to selective agonists ofa7 neuronal nicotinic acetylcholine receptors.EBI Eur J Med Chem 46: 5790-9 (2011) Universit£ degli Studi di Milano 2D 3D TSV
22014551 33 Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists.EBI Bioorg Med Chem Lett 21: 7076-80 (2011) Cephalon Inc 2D 3D TSV
22014550 337 Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD).EBI Bioorg Med Chem Lett 21: 7155-65 (2011) Ansaris 2D 3D TSV
22014549 4 Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.EBI Bioorg Med Chem Lett 21: 7094-8 (2011) RFS Pharma, LLC 2D 3D TSV
22014548 4 Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.EBI Bioorg Med Chem Lett 21: 7064-7 (2011) University of California 2D 3D TSV
22014547 2 Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.EBI Bioorg Med Chem Lett 21: 7041-4 (2011) University of Cagliari 2D 3D TSV
22014228 10 Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.EBI J Nat Prod 74: 2362-70 (2011) University of Thessaly 2D 3D TSV
22014094 15 Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.EBI J Med Chem 54: 7962-73 (2011) Kyoto Pharmaceutical University 2D 3D TSV
22011200 24 Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.EBI J Med Chem 54: 8078-84 (2011) H. Lee Moffitt Cancer Center & Research Institute 2D 3D TSV
22011144 13 Multidentate (18)F-polypegylated styrylpyridines as imaging agents for A? plaques in cerebral amyloid angiopathy (CAA).EBI J Med Chem 54: 8085-98 (2011) University of Pennsylvania 2D 3D TSV
22007704 1 Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.EBI J Med Chem 54: 7884-98 (2011) Academy of Sciences of the Czech Republic v.v.i. 2D 3D TSV
22007676 22 Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.EBI J Med Chem 54: 8148-60 (2011) University of Kansas 2D 3D TSV
22007643 25 Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.EBI J Med Chem 54: 8195-206 (2011) VU University Amsterdam 2D 3D TSV
22005185 25 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.EBI Eur J Med Chem 46: 5838-51 (2011) University of Santiago de Compostela 2D 3D TSV
22004849 9 Selection of cyclic-peptide inhibitors targeting Aurora kinase A: problems and solutions.EBI Bioorg Med Chem 19: 6743-9 (2011) University of Arizona 2D 3D TSV
22004719 56 Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.EBI Bioorg Med Chem Lett 21: 7072-5 (2011) The Scripps Research Institute 2D 3D TSV
22004718 58 Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I).EBI Bioorg Med Chem Lett 21: 7107-12 (2011) The Scripps Research Institute 2D 3D TSV
22003888 41 Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.EBI J Med Chem 54: 8136-47 (2011) VU University Amsterdam 2D 3D TSV
22003817 71 Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.EBI J Med Chem 54: 8030-50 (2011) Takeda Pharmaceutical Co., Ltd 2D 3D TSV
22003428 136 Identification of Inhibitors of NOD1-Induced Nuclear Factor-¿B Activation.EBI ACS Med Chem Lett 2: 780-785 (2011) TBA 2D 3D TSV
22001327 77 Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.EBI Bioorg Med Chem 19: 6750-9 (2011) Jagiellonian University Medical College 2D 3D TSV
22001326 51 Small molecule probes of the receptor binding site in the Vibrio cholerae CAI-1 quorum sensing circuit.EBI Bioorg Med Chem 19: 6906-18 (2011) Princeton University 2D 3D TSV
22001094 78 Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.EBI Bioorg Med Chem Lett 21: 7131-6 (2011) Merck Research Laboratories 2D 3D TSV
22001093 4 Synthesis of GSK3ß mimetic inhibitors of Akt featuring a novel extended dipeptide surrogate.EBI Bioorg Med Chem Lett 21: 7166-9 (2011) H. Lee Moffitt Cancer Center and Research Institute 2D 3D TSV
22001092 37 Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.EBI Bioorg Med Chem Lett 21: 7205-9 (2011) Roche Research Center 2D 3D TSV
22001090 4 Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-ß-valienamine (NOEV) and N-octyl-ß-valienamine (NOV).EBI Bioorg Med Chem Lett 21: 7189-92 (2011) Hokko Chemical Industry Co. Ltd 2D 3D TSV
22001088 6 The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.EBI Bioorg Med Chem Lett 21: 7137-41 (2011) University of Victoria 2D 3D TSV
22001085 22 Synthesis and testing of trifluoromethyl-containing phosphonate-peptide conjugates as inhibitors of serine hydrolases.EBI Bioorg Med Chem Lett 21: 7216-8 (2011) Moscow State University 2D 3D TSV
22001031 6 Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.EBI Bioorg Med Chem Lett 21: 7099-101 (2011) Nippon Suisan Kaisha, Ltd 2D 3D TSV
22001029 28 Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors.EBI Bioorg Med Chem Lett 21: 7185-8 (2011) Korea Research Institute of Chemical Technology 2D 3D TSV
22001028 13 Synthesis and antimicrobial activity of brominated resorcinol dimers.EBI Bioorg Med Chem Lett 21: 7142-5 (2011) University of East Anglia 2D 3D TSV
22000948 50 Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.EBI Bioorg Med Chem 19: 6827-32 (2011) Nanjing University 2D 3D TSV
22000936 33 Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues.EBI Eur J Med Chem 46: 6119-30 (2011) University of Lisbon 2D 3D TSV
22000924 25 Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors.EBI Eur J Med Chem 46: 5825-32 (2011) National Organization for Drug Control & Research 2D 3D TSV
22000209 54 Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.EBI Eur J Med Chem 46: 5728-35 (2011) VU University Medical Center 2D 3D TSV

BDB Curated by BindingDB
EBI Curated by ChEMBL